REGISTER RAKA ZA SLOVENIJO
CANCER REGISTRY OF SLOVENIA
EPIDEMIOLOGIJA IN REGISTER RAKA
EPIDEMIOLOGY AND CANCER REGISTRY
Poročilo RR št. 43
Report No. 43
LJUBLJANA 2004
INCIDENCA RAKA V SLOVENIJI
CANCER INCIDENCE IN SLOVENIA
ISSN 1318-2471

REGISTER RAKA ZA SLOVENIJO
CANCER REGISTRY OF SLOVENIA
EPIDEMIOLOGIJA IN REGISTER RAKA
EPIDEMIOLOGY AND CANCER REGISTRY
Poročilo RR št. 43
Report No. 43
LJUBLJANA 2004
INCIDENCA RAKA V SLOVENIJI
CANCER INCIDENCE IN SLOVENIA
ISSN 1318-2471
Uredniški odbor / Editorial Board
Maja Primic–Žakelj, glavna urednica / Editor-in-chief
Matej Bračko
Marko Hočevar
Vera Pompe–Kirn
Primož Strojan
Vesna Zadnik
Branko Zakotnik
Osebje Registra raka / Staff of the Cancer Registry
Maja Primic–Žakelj, vodja od / head from  1. 2. 2003
Vera Pompe–Kirn, vodja do / head till  31. 1. 2003
Mojca Brus
Sonja Drobnič
Andrej Kirn
Nataša Koščak
Neža Milčič
Nataša Robek
Fani Škrlec
Računalniška obdelava / EDP analysis
Jurij Modic
Vesna Zadnik
Oblikovanje / Design
Monika Fink-Serša 
Studio N, studio za oblikovanje in grafično pripravo
Priprava za tisk / Typesetting
Studio N, studio za oblikovanje in grafično pripravo
Izdal / Published by
Onkološki inštitut Ljubljana / Insitute of Oncology Ljubljana, Slovenia
Direktor / Director
Zvonimir Rudolf
Naslov / Correspondence to
Maja Primic–Žakelj
Onkološki inštitut / Institute of Oncology
Zaloška c. 2, 1001 Ljubljana, p.p. 2217, Slovenia
Telefon / Phone: + 386 (1) 5879 450
E-pošta / E-mail: mzakelj@onko-i.si
Spletna stran / Web site: http://www.onko-i.si/
Tisk / Printed by
Studio N, studio za oblikovanje in grafično pripravo
Nasvet za citiranje / Recommended reference
Incidenca raka v Sloveniji 2001. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2004.
Cancer incidence in Slovenia 2001. Ljubljana: Onkološki inštitut, Register raka za Slovenijo, 2004.
Vse pravice pridržane.
All rights reserved.
VSEBINSKO KAZALO / CONTENTS
Stran / Page
Uvod in pojasnila
Introduction and Comments  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Slike / Figures
1 Breme raka - Slovenija 2001
Cancer burden - Slovenia 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2 Prevalenca glede na obdobje opazovanja - Slovenija, 31. 12. 2001
Prevalence by period of observation - Slovenia, December 31, 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
3 Stabilnost podatkov - število in odstotek novih primerov raka, prijavljenih 
po izdaji letnega poročila, po obdobju - Slovenija 1965–2000
Data stability - number and percentage of new cases reported after the publication 
of annual reports, by time period - Slovenia 1965–2000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
4 Najpogostejše rakave bolezni po spolu - Slovenija 2001
The leading cancer sites by sex - Slovenia 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
5 Odstotni delež vseh rakov po starostnih skupinah in spolu - Slovenija 2001
Percentage distribution of all cancer sites by age groups and sex - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
6 Najpogostejše rakave bolezni po starostnih skupinah in spolu - Slovenija 1999–2001
The leading cancer sites by age groups and sex - Slovenia 1999–2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
7 Povprečna letna incidenca raka po zdravstvenih regijah - Slovenija 1999–2001
Average annual incidence rate by health regions and sex - Slovenia 1999–2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
8 Odstotni odklon grobe incidenčne stopnje raka po zdravstvenih regijah 
od povprečne slovenske - Slovenija 1999–2001 
Percentage deviation of crude cancer incidence rate in health regions from average - 
Slovenia 1999–2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
9 Groba in kumulativna letna incidenca vseh rakov po spolu - Slovenija 1950–2001
Crude and cumulative annual cancer incidence; all sites by sex - Slovenia 1950–2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
10 Groba letna incidenca izbranih rakov po spolu - Slovenija 1950–2001
Crude annual cancer incidence by selected primary sites and sex - Slovenia 1950–2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
11 Vsi raki - moški
Vsi raki - moški  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
12 Vsi raki - ženske
All sites - females  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
13 Ledvica - moški
Kidney - males  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
14 Ledvica - ženske
Kidney - females  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
15 Levkemije - moški 
Leukaemias - males  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
16 Levkemije - ženske 
Leukaemias - females  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Cancer Incidence in Slovenia 2001 3
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabele / Tables
1 Prebivalstvo Slovenije po starosti in spolu na dan 30. 6. 2001
Population of Slovenia by age and sex on June 30, 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2 Prebivalstvo Slovenije po zdravstvenih regijah po spolu na dan 30. 6. 2001
Population of Slovenia by health regions by sex on June 30, 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3 Število novih primerov raka ter število in odstotek primerov, registriranih samo 
iz zdravniških poročil o vzroku smrti, po lokaciji in spolu - Slovenija 2001
Total number of new cancer cases, number and percentage of cases registered 
from death certificates only, by site and sex - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
4a Število novih primerov raka po lokaciji (MKB-10), spolu in starosti - Slovenija 2001
Number of new cancer cases by site (ICD-10), sex, and age - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
4b Število novih primerov raka po lokaciji (MKB-8), spolu in starosti - Slovenija 2001
Number of new cancer cases by site (ICD-8), sex, and age - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
5 Incidenca raka na 100.000 prebivalcev po spolu in starosti 
ter kumulativna stopnja (KS) po lokaciji - Slovenija 2001
Cancer incidence per 100.000 population by sex and age, and cumulative rate (CR) 
by site - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
6a Število novih primerov raka po zdravstvenih regijah, 
po najpogostejših lokacijah in spolu - Slovenija 2001
Number of new cancer cases by health regions, by most frequent sites and sex - Slovenia 2001 . . . . . . . . . . . . . . . . . . . 50
6b Starostno standardizirana incidenca raka po zdravstvenih regijah, 
po najpogostejših lokacijah in spolu - Slovenija 2001
Age standardised cancer incidence rate by health regions, 
by most frequent sites and sex - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
7 Število novih primerov raka, ugotovljenih v bolnišnicah, ter število in odstotek 
mikroskopsko potrjenih primerov, po lokaciji in spolu - Slovenija 2001
Total number of new cancer cases diagnosed in hospitals and number and percentage 
of microscopically confirmed cases - by site and sex - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
8 Število histološko (in citološko) potrjenih novih primerov raka  
po histološki vrsti in lokaciji - Slovenija 2001
Number of histologically (and cytologically) confirmed new cancer cases 
by histologic type and site - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
9 Število primerov ne-Hodgkinovih limfomov po lokaciji (MKB-8), 
spolu in starosti - Slovenija 2001
Total number of non-Hodgkin's lymphomas by site (ICD-8), sex, and age - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
10 Število novih primerov raka po bolnišnicah ugotovitve diagnoze ter število 
in odstotek primerov, napotenih na Onkološki inštitut Ljubljana - Slovenija 2001
Number of new cancer cases diagnosed by reporting hospitals, and number and percentage 
of cases referred to the Institute of Oncology Ljubljana - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
11 Število in odstotek novih primerov raka, ugotovljenih v bolnišnicah, 
po stadiju, lokaciji in spolu - Slovenija 2001
Number and percentage of new cancer cases reported by hospitals 
by stage, site and sex - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
12 Število umrlih za rakom po lokaciji, spolu in starosti - Slovenija 2001
Number of cancer deaths by site, sex and age - Slovenia 2001  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
13 Število vseh živih bolnikov z rakom po spolu in izbrani primarni lokaciji - 
Slovenija, 31. 12. 2001
Prevalence of cancer patients by sex and selected primary site - Slovenia, December 31, 2001 . . . . . . . . . . . . . . . . . . . . 78
Izbor publikacij / Selected publications  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Cancer Incidence in Slovenia 2001 5
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
UVOD
Register raka za Slovenijo (Register) je eden
najstarejših populacijski registrov v Evropi.
Ustanovljen je bil leta 1950 na Onkološkem inšti-
tutu v Ljubljani kot posebna služba za zbiranje
in obdelavo podatkov o incidenci raka in pre-
živetju bolnikov z rakom. Pred letom 1950 so bili
populacijski registri raka le v Hamburgu, na
Danskem in v Veliki Britaniji. Od ustanovitve do
leta 1975 je Register vodila pokojna profesorica
dr. Božena Ravnihar, dologoletna direktorica
Onkološkega inštituta. Njeno delo je nato pre-
vzela profesorica dr. Vera Pompe Kirn, ki je do
leta 2003 skrbela za nadaljnjo uveljavljanje
Registra v domačem in mednarodnem merilu.
Tega leta je Onološki inštitut dobil nov statut, ki
je združil Register z Enoto za epidemiologijo v
enotno službo Epidemiologija in register raka. V
njej so poleg Registra še bolnišnični register
Onkološkega inštituta, oddelek za epidemiolo-
gijo, kjer tečejo epidemiološke raziskave, in na
novo ustanovljeni Register organiziranega pre-
sejanja za raka materničnega vratu (ZORA),
kjer je tudi koordinacija državnega programa
presejanja za raka materničnega vratu.
Prijavljanje raka je že od ustanovitve Registra v
Republiki Sloveniji obvezno in zakonsko predpi-
sano (Ur. l. SRS, št. 10/50, št. 29/50, št. 14/65, št. 1/80,
št. 45/82, št. 42/85; Ur. l. RS, št. 9/92 in št. 65/00).
Zbrani podatki so podlaga za ocenjevanje bre-
mena rakavih bolezni v državi, za načrtovanje
in ocenjevanje onkološkega varstva na področju
primarne in sekundarne preventive, diagnostike,
zdravljenja in rehabilitacije, za načrtovanje
zmogljivosti in sredstev, ki so potrebni za obvla-
dovanje rakavih bolezni (osebje, medicinska
oprema, posteljne zmogljivosti), ter za klinične in
epidemiološke raziskave v Sloveniji in v sklopu
širših mednarodnih raziskav
Populacijski register raka opravičuje svoj obstoj,
če se zbrani podatki tudi redno obdelujejo,
objavljajo in uporabljajo. Ena izmed stalnih
oblik vračanja obdelanih informacij so letna
poročila. Ker je virov informacij več, je čas,
potreben za dokončanje zbirke, povezavo in
objavo podatkov pri nas in po svetu daljši, obi-
čajno 2 do 3 leta.
Register je prva letna poročila izdajal že v letih
1953-57 za leta 1951-55. Prva analiza podatkov
za leto 1950 je bila objavljena v Zdravstvenem
INTRODUCTION
The Cancer Registry of Slovenia (Registry) is one
of the oldest population-based registries in
Europe. It was founded in 1950 at the Institute of
Oncology in Ljubljana as a special service for
collecting and processing data on cancer inci-
dence and cancer patients' survival. Before 1950,
population-based registries existed only in
Hamburg, Denmark and in Great Britain. From its
foundation and until 1975, the Registry was head-
ed by the late Professor Božena Ravnihar who
was also director general of the Institute of
Oncology for almost 20 years. At the Registry, she
was succeeded by Professor Vera Pompe-Kirn
who successfully carried on her work until last
year and contributed a lot to the further devel-
opment of the Registry as well as to its promotion
and recognition at the national and international
level. Last year, a new Statute was adopted by
the Institute that enacted the merging of the
Registry and Epidemiology Unit in a single serv-
ice, Epidemiology and Cancer Registry. The new
service comprises, besides Cancer Registry of
Slovenia, also the hospital-based Cancer Registry
of the Institute of Oncology, Epidemiology Unit for
epidemiologic studies and the newly established
Cancer Screening Registry, a unit that is in
charge of coordinating the nationally organised
cervical cancer screening programme.
Notification of cancer has been compulsory in
Slovenia since the foundation of the Registry
and is prescribed by law (Official Gazette of
SRS, No. 10/50, No. 29/50, No. 14/65, No. 1/80,
No. 45/82, No. 42/85; Official Gazette of RS, No.
9/92 and No. 65/00). The data collected serve
as the basis for assessing the cancer burden in
the country, for programming and evaluating
primary prevention, diagnosis, treatment and
rehabilitation, planning facilities and funding
needed for cancer control (personnel, equip-
ment and hospital capacities) as well as for clin-
ical and epidemiological research in Slovenia
and in international multicentric studies.
The existence of a population-based cancer
registry is justified only by regular processing,
publishing and using the data collected. The
Registry's Annual Reports are one of the regular
ways of disseminating information. Because of
a variety of data sources, data collection, their
linking and publication is rather time consum-
ing (with us and elsewhere) and usually takes
two to three years.
6 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
vestniku leta 1951. Podatki za leta 1957-71 so bili
objavljani v periodičnih publikacijah Svetovne
zdravstvene organizacije Epidemiological and
Vital Statistics in v World Health Statistics
Report. Od leta 1965 so bili podatki spet redno
objavljani v posebnih letnih poročilih z naslo-
vom Rak v Sloveniji (1965-77) in Incidenca raka
v Sloveniji (1978-2000), in sicer v slovenskem in
angleškem jeziku. Za vsebino publikacije skrbi
uredniški odbor, v katerem smo zbrani specia-
listi raznih vej onkologije. Glede na želje in pred-
loge uporabnikov letna poročila iz leta v leto
dopolnjujemo, vendar skrbimo tudi za to, da so
objavljeni podatki iz leta v leto primerljivi.
Incidenca raka je po svetu zelo različna, za raz-
iskovanje teh razlik pa so ključni kakovostni
podatki. Prav zato so bili in so naši podatki o
incidenci raka zanimivi tudi za svet. Leta 1957 je
izšlo prvo obsežnejše poročilo za leta 1950-55 v
angleščini. Podatke za leta 1956-60, 1961-65,
1968-72, 1973-76, 1978-81, 1982-87, 1988-92 in
1993-97 so objavili tudi v vseh osmih zvezkih knji-
ge Cancer Incidence in Five Continents, ki jo
izdaja Mednarodna agencija za raziskovanje
raka. Podatki o incidenci in umrljivosti za rakom
so vključeni tudi v mednarodne podatkovne
baze EUROCIM, GLOBOCAN, ACCIS, preživetje
slovenskih bolnikov pa je obdelano v medna-
rodnih študijah EUROCARE II in EUROCARE III.
Zbrane podatke v Registru obdelujemo in
pojasnjujemo v skladu s trenutno perečo pro-
blematiko v Sloveniji, z lastnim raziskovalnim
programom in s predlogi uporabnikov. Izsledke
objavljamo v člankih v domačem in tujem stro-
kovnem in poljudnem tisku. Med najpomemb-
nejšimi so tri knjige: Zemljevidi incidence raka
v Sloveniji 1978-1987, Preživetje bolnikov z
rakom v Sloveniji 1963-1990 in Preživetje bolni-
kov z rakom v Sloveniji 1983-1997. Seznam dru-
gih pomembnejših del, objavljenih v zadnjih
petih letih, je v dodatku na koncu poročila.
Letošnje poročilo je v celoti dostopno v elektronski
obliki na spletni strani Onkološkega inštituta
http://www.onko-i.si.
The first annual reports of the Registry for the peri-
od 1951-55 were issued during the years 1953-57.
The first data analysis for the year 1950 was pub-
lished in Zdravstveni vestnik in 1951. The data for
the period 1957-71 were appearing in the period-
icals Epidemiological and Vital Statistics Report
and World Health Statistics Report, both edited by
World Health Organization. From 1965 onwards,
the data have been appearing regularly in spe-
cial bi-lingual (Slovene-English) annual reports, first
entitled Cancer in Slovenia (1965-77), and then
Cancer Incidence in Slovenia (1978-2000). The
editorial board, responsible for the contents of the
report, consists of experts of different specialties in
oncology. Our endeavours have always been
directed towards further improvement of these
publications, by taking into account as much the
requests and comments of the users as the com-
parability of the data from year to year. 
There are great differences in cancer incidence
among different populations and to evaluate
them, good quality data are needed from differ-
ent parts of the world. That is why our data on can-
cer incidence have always been interesting also
for professional public abroad. In 1957, the first
comprehensive report, covering the period 1950-
55, was issued in English under the title Cancer in
Slovenia 1955. The data for the periods 1956-60,
1961-65, 1968-72, 1973-76, 1978-81, 1982-87, 1988-92
and 1993-97 were published in all eight volumes of
the Cancer Incidence in Five Continents issued by
International Agency for Research on Cancer. The
data on cancer incidence and mortality for the
years 1983-99 were also included in international
databases EUROCIM, GLOBOCAN, ACCIS. The
survival of Slovenian cancer patients is included
into and analysed by the international studies
EUROCARE II and EUROCARE III.
The data collected have been processed in
accordance with the current problems in
Slovenia, as well as with respect to our research
program and suggestions from our users. These
data are published in national and foreign
medical literature and as publications for lay
readers. Among the most important are three
special publications: Atlas of Cancer Incidence
in Slovenia 1978-1987, Cancer Patients' Survival
in Slovenia 1963-1990 and Cancer Patients'
Survival in Slovenia 1983-1997. The list of other
relevant publications is at the end of this report. 
The current annual report is available in pdf for-
mat on the website of the Institute of Oncology:
http://www.onko-i.si.
Cancer Incidence in Slovenia 2001 7
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
GRADIVO IN METODE
Osnovni vir podatkov so prijavnice rakave
bolezni. Registru jih pošiljajo iz vseh bolnišnic in
diagnostičnih centrov v Sloveniji, iz ordinacij
osnovnega zdravstvenega varstva pa le izje-
moma, če bolnik ni napoten na nadaljnje pre-
iskave in/ali zdravljenje. Dodatni vir podatkov
so zdravniška poročila o vzroku smrti in obduk-
cijski zapisniki z diagnozo maligne bolezni.
Zbiranje podatkov za to letno poročilo smo
zaključili 31. januarja 2003.
Zanesljivost podatkov osvetljujeta dva kazalca:
odstotni delež raka, registriranega samo iz
zdravniških poročil o vzroku smrti (tabela 3), in
odstotni delež mikroskopsko (histološko ali cito-
loško) potrjenih primerov (tabela 7). Majhen
delež primerov, prijavljenih po izdaji letnega
poročila v raznih časovnih obdobjih, kaže, da
do izdaje poročila registriramo večino novih pri-
merov raka. Ta delež je stabilen in kaže na
popolnost podatkov (slika 3).
Od leta 1993 je obvezno prijavljanje sprememb
materničnega vratu, označenih kot CIN III (šifra
219 po 8. reviziji MKB), dotlej pa so se registrirale
le spremembe, označene v tabelah s šifro
234.0 (karcinom in situ). Primerjava s podatki za
obdobje 1961-92 tako ni možna. Po 10. reviziji
MKB so vse intraepiteljiske spremembe mater-
ničnega vratu uvrščene v šifro D06. Od leta
1995 registriramo tudi prijavljene intraepitelijske
karcinome mehurja in maligne melanome
Clark I.
Za razvrščanje neoplazem po lokacijah
Register od leta 1997 uporablja 10. revizijo
Mednarodne klasifikacije bolezni, poškodb in
vzrokov smrti, do takrat pa je uporabljal osmo.
Za vse, ki želijo primerjati podatke iz prejšnjih
poročil, je dodana tabela 4b. Klasifikaciji različno
uvrščata bolezni med maligne, zato število
novih primerov raka po obeh klasifikacijah ni
enako. 
Prav pri uvrščanju med maligne bolezni je
treba opozoriti še na klasifikacijo za morfologijo
neoplazem. Podatki za leto 2001 so razvrščeni
po morfološkem delu tretje izdaje Mednarodne
klasifikacije bolezni za onkologijo. V tej izdaji je
nekaj sprememb, tudi katere histološke vrste
sodijo med maligne. Po tretji reviziji so med
maligne uvrščene kronične mieloproliferativne
bolezni in mielodisplastični sindromi (sedaj v
MATERIAL AND METHODS
The main sources of data are notifications
gathered from all hospitals and diagnostic cen-
tres in Slovenia, exceptionally also from primary
health care centres in case the patient was not
referred for further diagnostic investigations.
This information is completed by death certifi-
cates and autopsy protocols stating cancer
diagnosis. The collection of data for the current
report was completed on January 31, 2003.
The reliability of information can be assessed by
two parameters: the percentage of cancer
cases registered solely on the basis of death
certificates (Table 3), and by the percentage of
microscopically (histologically or cytologically)
confirmed cases (Table 7). The small and stable
proportion of cases registered after the publi-
cation of annual reports shows that the majority
of cases are reported to the Registry by the time
of the publication of annual reports and that
the registration is complete (Figure 3).
In 1993, compulsory registration of all cervical
intraepithelial dysplasias classified as CIN III was
introduced (code 219 according to ICD-8). Till
then, only carcinoma in situ (code 234.0) was
registered. Thus, the comparison with the data for
the period 1961-1992 is not possible. According to
ICD-10, all cervical intraepithelial neoplasms (in
situ and CIN III) are coded as D06. Since 1995, the
number of all reported intraepithelial carcinomas
of the bladder and all malignant melanomas
Clark I have been registered.
Since 1997, cancer sites are coded according
to the 10th revision of the International Statistical
Classification of Diseaseses and Related
health Problems (ICD-10); before, the 8th revision
was used (ICD-8). As in earlier reports, Table 4b
contains also the data coded according to the
8th revision in order to allow the comparison
with the earlier reports. There are differences in
coding neoplasms as malignant or benign
according to both classifications, so, according
to the two classifications, the number of new
cancer cases is not equal.
When classifying tumours as malignant, the
behaviour digit of the morphology code of the
third edition of International Classification of
Diseases for Oncology is used in the current
annual report. In this edition, some changes
were introduced in terms of morphology and
behaviour code. According to this classification,
8 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
topografski šifri C96.7). V skladu z novimi pravili
tudi mejno malignih ovarijskih tumorjev ne uvr-
ščamo več v kategorijo C56, pač pa v D39.1.
Opozarjamo še, da so v tabeli 8 histološke vrste
združene v nove, drugačne skupine kot v prejšnjih
poročilih in so prilagojene tretji reviziji morfolo-
škega dela Mednarodne klasifikacije bolezni
za onkologijo.
DEFINICIJE
Incidenca pomeni število vseh v enem koledar-
skem letu na novo ugotovljenih primerov raka v
točno določeni populaciji. V incidenco ne šte-
jemo novih primarnih rakov parnega organa
iste lokacije, če je bila histološka vrsta obeh
rakov, npr. leve in desne dojke, enaka. Prav tako
v incidenco ne štejemo novega pojava raka
iste histološke vrste na istem organu, npr. multi-
ple lezije v debelem črevesu. V incidenco so
vključeni primeri bolezni bolnikov s stalnim biva-
liščem na območju Republike Slovenije, ne
glede na to, kje so bili ti bolniki zdravljeni.
Prevalenca je število vseh živih bolnikov z rakom
na določen datum ne glede na leto diagnoze.
Groba incidenčna stopnja je število novih pri-
merov na 100.000 oseb opazovane populacije,
starostno specifična stopnja pove to relativno
število v posamezni petletni starostni skupini.
Kumulativna incidenčna stopnja (v zadnjem
stolpcu tabele 5) je petkratna vsota starostno
specifičnih incidenc na 100 prebivalcev posa-
meznih petletnih starostnih skupin do 74. leta sta-
rosti. Je neposredna, na dejansko populacijo
posamezne petletne starostne skupine standar-
dizirana incidenca ali približek kumulativnemu
tveganju. Kumulativno tveganje je verjetnost
posameznika, da zboli za rakom v izbranem sta-
rostnem obdobju, npr. do 74. leta starosti, za
rakom (če, seveda, ne umre prej zaradi drugih
vzrokov). Kumulativno stopnjo računamo na 100
in jo izražamo v odstotkih. Kumulativna stopnja
raka dojk pri ženskah 6,4/100 pomeni, npr., da bo
verjetno 6,4 % deklic, rojenih leta 2001 (ali ena od
16) do 75. leta starosti zbolelo za rakom dojk.
Starostna standardizacija je potrebna, če anali-
ziramo incidenco v daljšem časovnem obdobju
chronic myeloproliferative disorders and
myelodisplastic syndromes are classified as
malignant (topography code C96.7), while
ovarian tumours of borderline malignancy are
currently coded as D39.1 (and not C56).
It should be noted that in Table 8 the morphology
codes are grouped in new categories and are
adapted to the third revision of morphology
part of International Classification of Diseases
for Oncology.
DEFINITIONS
Incidence is the number of newly diagnosed
cancer cases in a defined population, reported
to the Registry for a given calendar year. New
primary cancers of the same histology in paired
organs, e. g. on the left and right breast, are not
comprised in the incidence figures, neither are any
new cancers of the same histology appearing
in the same organ, e.g. multiple lesions of the
colon. The incidence includes only the data on
patients with permanent residence in Slovenia,
regardless of the place of treatment.
Prevalence is the number of all surviving cancer
patients, irrespective of the year of diagnosis.
Crude incidence rate is the number of new
cases per 100.000 population, while the age
specific rate expresses this relative number in
an individual five-year age group.
The cumulative incidence rate (the last column
in Table 5) is five times the sum of the age-spe-
cific incidence rates per 100 population, calcu-
lated over five-year age groups up to the age of
74 years. It is a directly age-standardized rate with
the same population size in each age group, or
as an approximation to the cumulative risk. The
cumulative risk is the risk an individual would
have of developing the disease in question
during a certain age period if no other causes
of death were in operation. The cumulative
rate is expressed per hundred (per cent). Thus,
the cumulative rate (0-74) of 6.4/100 for breast
cancer in females means that 6.3% of women
(each l6th woman) are expected to develop
breast cancer by their age of 75.
When analysing the incidence rate within
longer time period (if the age structure of popu-
lation changes) or comparing the incidence
Cancer Incidence in Slovenia 2001 9
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
(če se starostna struktura prebivalstva v času spre-
minja) ali če primerjamo incidenco med popula-
cijami z različno starostno strukturo. Ena od mož-
nosti je uporaba kumulativne stopnje incidence,
kot je za Slovenijo prikazana na spodnjem delu
slike 5. Primerjava oblike krivulj grobih in kumula-
tivnih stopenj na sliki 9 kaže, da povečevanja inci-
dence raka ne moremo pripisati le staranju pre-
bivalstva RS, ampak da k temu prispevajo še
drugi nevarnostni dejavniki. Kumulativne stopnje
smo uporabili tudi pri zemljevidih. V tabeli 6b je za
primerjavo incidenčnih stopenj med slovenskimi
zdravstvenimi regijami uporabljena neposredna
metoda starostne standardizacije; za standard je
uporabljena starostna struktura prebivalcev
Slovenije ob popisu leta 2002.
POJASNILA
Slike 1-4 prikazujejo osnovne podatke o bremenu
raka v Sloveniji: število vseh zbolelih in umrlih za
rakom v letu 2001, prevalenco in najpogostejše
rakave bolezni po spolu. 
Sliki 5 in 6 opozarjata na različno breme raka v
raznih življenjskih obdobjih; rak je skoraj izjema
pri mladih do 19 let; če pa zbolijo, najpogoste-
je za levkemijo. Štiri odstotke vseh rakov je med
20. in 34. letom starosti, ko je pri moških najpo-
gostejši rak mod, pri ženskah pa rak maternič-
nega vratu. Pljučni rak pri moških in rak dojk pri
ženskah sta na prvem mestu od 35. leta staro-
sti, več kot tri četrtine vseh rakov pa je pri bolni-
kih, starejših od 50 let.
Na sliki 7 so prikazane grobe incidenčne stop-
nje vseh rakov po zdravstvenih regijah po
spolu, na sliki 8 pa odstotni delež, za katerega
posamezne regije odstopajo od slovenskega
povprečja. Med najbolj obremenjenimi izsto-
pajo ljubljanska in novogoriška zdravstvena
regija. Ti podatki so pomembni za načrtovanje
zdravstvenih zmogljivosti. Starostno standardi-
zirane incidenčne stopnje (tabela 6b) pa
kažejo, da je pretežni del razlik med regijami
posledica različne starostne strukture njihovih
prebivalcev.
Sliki 9 in 10 kažeta trende incidence vseh in
izbranih rakov po spolu. V letu 2001 smo pri gra-
fičnih prikazih v eno skupino združili rake debe-
lega črevesa in danke in v drugo rake ust, žrela
between populations with different age struc-
ture, age standardisation is needed to adjust
the rate for the effect of age. One of the
methods is the cumulative rate as in Figure 9
(bottom). The comparison of the curves of
crude incidence per 100.000 population and
cumulative incidence rates in Figure 9 indicates
that the increasing cancer incidence rate in
both sexes cannot be attributed only to the
aging of population, but also to additional risk
factors. Cumulative rate is used also in cancer
maps. In Table 6b, direct age standardisation of
the Slovenian population derived from the 2002
census is used as standard for the comparison
of incidence rates between health regions, con-
trolling for differences in their age composition.
COMMENTS
Figures 1-4 present the data on cancer burden
in Slovenia: the number of new, deceased and
prevalent cancer patients in 2000 and the most
frequent cancer sites by sex. 
Figures 5 and 6 point to the different proportion
of cancer in different age groups; up to the
age of 19, cancer is more an exception, with
leukaemia being the most frequent cancer in
this age group. Four percent of all cancers
develop in the age group of 20-34 years, in
which the most frequent is testicular cancer in
males and cervical cancer in females. The
lung in males and the breast in females are the
most frequent cancer sites after the age of 35;
more than three quarters of all cancers develop
after the age of 50.
Figure 7 shows crude cancer incidence rates in
nine health regions, while in Figure 8, the per-
centage deviation from Slovenian average
incidence rate is presented. The highest inci-
dence rates are in the Ljubljana and Nova
Gorica region. While these data are important
for planning health care facilities, the age stan-
dardised rates in Table 6b indicate that the
majority of differences are due to different age
structure of population in these regions.
Figures 9 and 10 show the incidence trends for all
and selected sites by sex. In graphical presenta-
tions, colon and rectal cancers are grouped in
one category as colorectal, as well as oral, pha-
10 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
in grla (glava in vrat). Opozoriti velja, da se v
letu 2001 nadaljuje zmanjševanje incidence
pljučnega raka pri moških, kar je odsev manj-
šanja deleža rednih kadilcev med odraslimi
moškimi v zadnjih 20 letih.
S slikami 11 do 16 zaključujemo prvi krog
ponovnih objav zemljevidov incidence raka od
izida knjige Zemljevidi incidence raka v
Sloveniji 1978-87. Tokrat poleg zemljevidov
grobe in kumulativne incidenčne stopnje po
spolu za vse rake, levkemije in ledvičnega raka
v letih 1992-2001 prikazujemo še trend incidence
in umrljivosti in starostno specifično incidenco.
Tabele prikazujejo podatke o prebivalcih in
incidenci raka v Sloveniji leta 2001 po spolu, sta-
rosti, lokaciji, histološki vrsti in stadiju bolezni ob
diagnozi, o incidenci po zdravstvenih regijah
ter podatke o številu novih primerov raka, ugo-
tovljenih v tem letu po posameznih bolnišnicah,
število smrti za rakom po spolu, starosti in loka-
ciji ter prevalenco najpogostejših rakov.
Iz tabel 3, 4a, 7 in 8 je mogoče povzeti, da je
bilo leta 2001 na novo registriranih 9058 prime-
rov raka, 149 (2 %) samo na osnovi zdravni-
škega poročila o vzroku smrti (tabela 3). Ta
delež, ki je že več let podoben, kaže bolnike, ki
verjetno zaradi starosti ali napredovale bolezni
niso bili zdravljeni v bolnišnici. Od 8909 bolnikov
, ki so jim diagnozo postavili v bolnišnicah ali
diagnostičnih centrih, je bila pri 8318 (93 %)
bolezen potrjena mikroskopsko (tabela 7).
Kakšna je bila morfološka slika malignomov,
kaže tabela 8. V njej so posebej primeri, ki so
potrjeni histološko (88 %) in tisti, ki so bili potrje-
ni samo citološko (12 %).
Po 8. reviziji MKB, po kateri so raki razvrščeni v
tabeli 4b, je novih primerov raka 8999. Razlika
za 59 primerov je posledica novega razvršča-
nja neoplazem glede na tretjo izdajo morfolo-
škega dela Mednarodne klasifikacije bolezni
za onkologijo. 
Tabela 5 prikazuje grobo in starostno specifič-
no incidenčno stopnjo na 100.000 prebivalcev
ter kumulativno stopnjo na 100. Število vseh
novih primerov raka iz leta 2001 je preračunano
na število prebivalcev R Slovenije na dan 30.
junija 2001.
V tabeli 6a je število novih primerov vseh in
izbranih rakov prikazano po zdravstvenih regi-
jah. Te številke so pomembne za načrtovanje
zdravstvenih zmogljivosti. V tabeli 6b starostno
ryngeal and laryngeal cancers as head and
neck. It should be noted that, in 2001, the inci-
dence of lung cancer in males decreased by
10% compared to the year 2000, which is a
reflection of the decreasing proportion of smok-
ers among adult males in the last 20 years. 
With figures 11-16, the first cycle of new maps
on cancer incidence, appearing since the
publication of Atlas of Cancer Incidence in
Slovenia 1978-1987, is closed. Along with the
maps on crude and cumulative rates of all
cancer sites, leukaemias and kidney cancers in
the years 1992-2001, trends in incidence and
mortality and age specific rates are presented.
Tables show the data on population and on
cancer incidence in Slovenia in 2001 by sex,
age, primary site, histology, stage of the disease
at diagnosis, on the incidence in the individual
health regions, and on new cancer cases
diagnosed in the current year in different hos-
pitals in Slovenia, on deaths and on preva-
lence of most frequent cancer sites.
Tables 3, 4a, 7 and 8 show that, in the year 2001,
9058 new cancer cases were registered, 149
(2%) from death certificates only (Table 3). This
percentage has been similar for several years
and represents those patients that, due to
advanced age or disease have not been
treated in the hospital. From 8909 cases, diag-
nosed in hospitals or diagnostic centres, 8318
(93 %) diagnoses were confirmed microscopi-
cally (Table 7). The morphology of tumours is
presented in Table 8, where histologically veri-
fied cases (88 %) are presented separately
from those confirmed by cytology only (12 %).
In Table 4b, the diagnoses are coded according
to the 8th revision of International Classification of
Diseases. According to this classification, 8999
new cancer cases were detected. The differ-
ence of 59 cases is due to new morphology clas-
sification of the third revision of International
Classification of Diseases for Oncology.
Table 5 shows crude and age specific inci-
dence rate per 100.000 population and cumu-
lative rate per 100. For calculation of crude rate,
the Slovenian population census on June 30,
2001 was used.
In Table 6a, the number of new cases of all
and selected cancer sites by different health
regions is presented. These numbers are impor-
tant for planning health care facilities. The age
Cancer Incidence in Slovenia 2001 11
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
standardizirana incidenca kaže, da so razlike
med regijami tudi posledica različnega deleža
starejših.
Tabela 9 kaže starostno porazdelitev ekstrano-
dalnih in nodalnih lokacij ne-Hodgkinovih malig-
nih limfomov. Ker je število ekstranodalnih loka-
cij majhno, so prikazane le absolutne številke.
Iz tabele 10 je razvidno, kje vse bolnikom posta-
vijo diagnozo. Tako kot že vrsto let, polovica od
vseh bolnikov z rakom, ki jim diagnozo postavi-
jo v slovenskih bolnišnicah ali jih tam tudi začne-
jo zdraviti, v nadaljnjem poteku bolezni pride na
posvet ali na zdravljenje na Onkološki inštitut.
Tabela 11 prikazuje porazdelitev bolnikov po
stadiju, v katerem je bila bolezen odkrita.
Uporabljena je poenostavljena opredelitev
stadijev, ki upošteva vse preiskovalne metode,
vključno operacijo; če bolnik ni bil poprej
zdravljen, tudi obdukcijo. Uporabljamo in nava-
jamo jo zato, ker so podatki o stadiju bolezni po
klasifikaciji TNM na prijavnicah pogosto
pomanjkljivi. Poenostavljena opredelitev stadi-
jev pri solidnih tumorjih praviloma sledi klasifika-
ciji TNM. V omejeni stadij je razvrščena bolezen,
kjer je tumor označen kot Tl in T2 (razen pri dojki,
malignem melanomu in ščitnici, kjer so vključe-
ni tudi tumorji T3, in materničnem vratu, telesu in
sarkomih, kjer so vključeni le tumorji T1) in pri
kateri niso prizadete regionarne bezgavke in ni
zasevkov v oddaljenih organih (N0, M0). V sta-
diju regionarne razširitve je bolezen, kjer je
tumor opredeljen kot T3 in T4 (razen v omenje-
nih izjemah) in/ali so prizadete tudi regionarne
bezgavke (N 1), zasevkov v oddaljenih bezgav-
kah in organih pa ni (M0). V stadiju oddaljene
razširitve pa je tista bolezen, pri kateri so zasev-
ki že v oddaljenih bezgavkah ali organih (M 1).
Maligni limfomi so opredeljeni po klasifikaciji
Ann-Arbor.
V tabeli 12 so uradni podatki o umrljivosti za
rakom. Tabelo je pripravila dr. Jožica Šelb-Šemrl
z Inštituta za varovanje zdravja RS.
Tabela 13 prikazuje prevalenco vseh in najpo-
gostejših rakov na dan 31. 12. 2001.
Preživetja bolnikov tokrat ne prikazujemo, saj je
lani izšla knjiga Preživetje bolnikov z rakom v
Sloveniji 1983-1997 z izčrpnimi podatki in
komentarji klinikov. Vse, ki se zanje zanimate,
vabimo, da knjigo naročite v Registru.
standardised rates in Table 6b indicate that the
majority of the differences are due to different
age structure of population in these regions.
Age distribution of extranodal and nodal sites of
non-Hodgkin malignant lymphomas is present-
ed in Table 9. Owing to a small number of extra-
nodal sites, only the absolute numbers are given.
From Table 10 it is evident, in which hospitals can-
cer cases are diagnosed. Observations of many
years show that half of the patients diagnosed or
initially treated in regional hospitals are later on
referred to the Institute of Oncology Ljubljana.
A simplified definition of stages at diagnosis is pre-
sented in Table 11. The simplified definition is
based on all investigation methods, including sur-
gery. In case the patient was not treated before
death, the autopsy record is considered as well.
The simplified stage definition is used because, in
cancer notification forms, the data on stage
according to TNM Classification System are often
lacking. However in solid tumours, the simplified
stage definition often follows the TNM Classifi-
cation. Localised stage includes all cancers
where the tumour has been classified as T1 and
T2 (except in breast, malignant melanoma and
thyroid cancer, where T3 is also included, and uter-
ine cervix, uterine corpus and sarcomas, where T1
only is included), where neither regional node
involvement nor distant metastases are found
(N0, MO). The regional stage includes tumours
classified as T3 and T4 (exceptions already men-
tioned) and/or regional node metastases (N 1),
if no metastases in distant lymph nodes or organs
(MO) are found. The disease with metastases in
distant nodes or organs is classified as the
remote stage (M 1). Malignant lymphomas are
classified according to AnnArbor System.
Official data on cancer mortality are given in
Table 12. The table has been prepared by
Dr. Jožica Šelb-Šemrl from the Institute of Public
Health of the Republic of Slovenia.
Data on prevalence of all and most frequent
cancers are presented in Table 13. 
Survival of cancer patients is not presented in
current report because they are presented in
Cancer Patients Survival in Slovenia 1983-1997,
which was published last year and contains
also comments of clinicians specialised in the
treatment of individual cancer sites. All interested
in these data are invited to order the book in
the Registry.
12 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
ZAHVALA
Zdravniki, medicinske sestre in administrativno
osebje iz slovenskih bolnišnic in drugih zdrav-
stvenih ustanov so Registru pošiljali prijavnice s
podatki o novih bolnikih z rakom in njihovi
nadaljnji usodi in nam pomagali dopolnjevati
prijave z manjkajočimi informacijami. 
Vsaj polovico podatkov, obdelanih v tem poro-
čilu, sta prispevali sodelavki Bolnišničnega regi-
stra Onkološkega inštituta v Ljubljani Ana
Dotzauer in Maruška Ferjančič.
Naše delo bi bilo bistveno težje brez dolgolet-
nega sodelovanja s Centralnim Registrom pre-
bivalstva RS, z Inštitutom za varovanje zdravja
RS in Statističnim uradom RS.
Vsem imenovanim in tudi drugim, ki so kakorkoli
prispevali, da smo lahko prikazali rezultate
našega dela v tem poročilu, se najlepše
zahvaljujemo.
Uredniški odbor
ACKNOWLEDGEMENT
Physicians, nurses, and administrative staff from
Slovenian hospitals and other health institutions
have provided the data on new cancer
patients and their medical history as well as
helped us in obtaining additional information
when needed.
Our co-workers at the Hospital Registry of the
Institute of Oncology, Mrs. Ana Dotzauer and
Maruška Ferjančič have contributed at least a
half of the information presented in this report. 
The long-term collaboration with the Population
Registry of the Republic of Slovenia, the Institute
of Public Health of the Republic of Slovenia
and the Statistical Office of the Republic of
Slovenia is indispensable for our work.
We thank all of them as well as to all others
who have helped to present the results of our
work in this report. 
Editors
Cancer Incidence in Slovenia 2001 13
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
REFERENCE / References
– Ravnihar B, Gruden I. Statističen pregled in kratka
analiza prijavljenih rakovnih obolenj iz področja
LRS za leto 1950. Zdrav Vestn 1951; 20: 264-77.
– Epidemiological and Vital Statistics Report.
Geneva: World Health Organization, 1961-1966.
– World Health Statistics Report. Geneva: World Health
Organization, 1970-1974.
– Rak v Sloveniji (1965-77). Ljubljana: Onkološki inštitut,
Register raka za Slovenijo, 1967-1980.
– Incidenca raka v Sloveniji (1978-2000). Ljubljana:
Onkološki inštitut, Register raka za Slovenijo, 1981-2003.
– Doll R, Payne P, Waterhouse J, eds. Cancer incidence
in five continents. Vol 1. Berlin: Springer, 1966.
– Doll R, Muir C, Waterhouse J, eds. Cancer incidence
in five continents. Vol 2. Lyon: International Agency
for Research on Cancer, 1970.
– Waterhouse J, Muir C, Correa C, Powell J, eds.
Cancer incidence in five continents. Vol 3. Lyon:
International Agency for Research on Cancer,
1976 (IARC Sci Publ 15).
– Waterhouse J, Muir C, Shanmugaratnam K, Powell
J, eds. Cancer incidence in five continents. Vol 4.
Lyon: International Agency for Research on Cancer,
1982 (IARC Sci Publ 42).
– Muir C, Waterhouse J, Mack T, Powell J, Whelan S,
eds. Cancer incidence in five continents. Vol 5.
Lyon: International Agency for Research on Cancer,
1987 (IARC Sci Publ 88).
– Parkin DM, Muir C, Whelan S, Gao Y, Ferlay J, Powell J,
eds. Cancer incidence in five continents. Vol 6. Lyon:
International Agency for Research on Cancer,
1992 (IARC Sci Publ 120).
– Parkin DM, Whelan S, Ferlay J, Raymond L, Young
J, eds. Cancer incidence in five continents. Vol 7.
Lyon: International Agency for Research on Cancer,
1997 (IARC Sci Publ 143).
– Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas
DB, eds. Cancer incidence in five continents. Vol 8.
Lyon: International Agency for Research on Cancer,
2002 (IARC Sci Publ 155).
– European Network of Cancer Registries. EUROCIM
version 4.0. European incidence database V2.4,
ICD-10 dictionary (2003), Lyon 2001.
– Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN
2000. Cancer incidence, mortality and prevalence
worldwide. Version 1.0. IARC CancerBase No. 5.
Lyon: IARC Press, 2001.
– Šteliarova-Foucher E, Berrino F, Coebergh JW et al.
ACCISpass 1.01 software for analysis and presen-
tation of data on incidence and survival of chil-
dren and adolescents in Europe. Lyon: ENCE, 2002.
– Berrino F, Capocaccia R, Esteve J et al, eds.
Survival of cancer patients in Europe: the EURO-
CARE-2 study. Lyon: International Agency for
Research on Cancer, 1999.
– Berrino F, Capocaccia R, Gatta G et al, eds.
Survival of cancer patients in Europe: the EURO-
CARE-3 study. Ann Oncol 2003: 14 (Suppl 5).
– Pompe-Kirn V, Primic-Žakelj M, Ferligoj A, Škrk J.
Zemljevidi incidence raka v Sloveniji 1978-1987
(Atlas of Cancer Incidence in Slovenia 1978-1987).
Ljubljana: Onkološki inštitut, Register raka za
Slovenijo, 1992.
– Pompe-Kirn V, Zakotnik B, Benulič T, Volk N, Škrk J.
Preživetje bolnikov z rakom v Sloveniji 1963-1990
(Cancer Patients’ Survival in Slovenia 1963-1990).
Ljubljana: Onkološki inštitut, Register raka za
Slovenijo, 1995.
– Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bol-
nikov z rakom v Sloveniji 1983-1997 (Cancer
Patients’ Survival in Slovenia 1983-1997). Ljubljana:
Onkološki inštitut, Register raka za Slovenijo, 2003.
– Jensen OM, Parkin DM et al, eds. Cancer registrati-
on principles and methods. Lyon: International
Agency for Research on Cancer, 1991. (IARC Sci
Publ 95).
– Savezni zavod za zdravstvenu zaštitu. Međunarod-
na klasifikacija bolesti, povreda i uzroka smrti. 8.
revizija. Novi sad: Savezni zavod za zdravstvenu
zaštitu, 1970.
– Inštitut za varovanje zdravja RS. Mednarodna kla-
sifikacija bolezni in sorodnih zdravstvenih proble-
mov za statistične namene. 10. revizija (Interna-
tional Statistical Classification of Diseaseses and
Related health Problems). Ljubljana: Inštitut za
varovanje zdravja, 1995.
– World Health Organisation. International Calssifi-
cation of Diseases for Oncology. Geneva: World
Health Organisation, 2000.
– Statistični letopis republike Slovenije 2002.
Ljubljana: Statistični urad Republike Slovenije, 2002.
14 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Slika 1. Breme raka - Slovenija 2001
Figure 1. Cancer burden - Slovenia 2001
Slika 2. Prevalenca glede na obdobje opazovanja – Slovenija, 31. 12. 2001
Figure 2. Prevalence by period of observation – Slovenia, December 31, 2001
Skupaj Moški Ženske
Total Males Females
Incidenca 9058 4565 4493Incidence
Umrljivost 4813 2692 2121Mortality
Prevalenca 51271 19623 31648Prevalence
Od tega izgubljenih
Lost to follow-up
Obdobje Število bolnikov Število Odstotek
Period Number of patients Number Percentage
1950-2001 51271 2437 4,8
1962-2001 49753 1436 2,9
1972-2001 47795 1020 2,1
1982-2001 43235 459 1,1
1992-2001 33322 106 0,3
Slika 3. Stabilnost podatkov - število in odstotek novih primerov raka, prijavljenih po izdaji letnega
poročila, po obdobju – Slovenija 1965–2000
Figure 3. Data stability - number and percentage of new cases reported after the publication of annual reports,
by time period – Slovenia 1965–2000
Naknadno prijavljeni
Subsequently registered
Obdobje Letno poročilo 31.1.2004 Število Odstotek
Period Annual report January 31, 2004 Number Percentage
1965-68 14696 14860 164 1,1
1969-72 15719 16176 457 2,8
1973-76 17711 18298 587 3,2
1977-80 19176 19907 731 3,7
1981-84 20701 21421 720 3,4
1985-88 22715 23367 652 2,8
1989-92 25973 26677 740 2,8
1993-96 29141 30277 1136 3,8
1997-00 33859 34754 895 2,6
Cancer Incidence in Slovenia 2001 15
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Slika 4. Najpogostejše rakave bolezni po spolu – Slovenija 2001
Figure 4. The leading cancer sites by sex – Slovenia 2001
* Pojasnilo – Explantion
Debelo črevo in danka – Colorectum: C18-C20
Glava in vrat – Head and neck: C00-C14, C30-C32
NHL: ne-Hodgkinovi limfomi – NHL: non-Hodkgin's lymphoma: C82-C85
16 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Slika 5. Odstotni delež vseh rakov po starostnih skupinah in spolu – Slovenija 2001
Figure 5. Percentage distribution of all cancer sites by age groups and sex – Slovenia 2001
Slika 6. Najpogostejše rakave bolezni po starostnih skupinah in spolu – Slovenija 1999–2001
Figure 6. The leading cancer sites by age groups and sex – Slovenia 1999–2001
nadaljevanje / cont’d ➝
*Opomba: Slika 5 v tiskani verziji ne odgovarja dejanskim podatkom.
Note: Figure 5 in the printable version do not correspond to the real data.
Cancer Incidence in Slovenia 2001 17
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Slika 6. – Figure 6. Nadaljevanje – Continued
nadaljevanje / cont’d ➝
18 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Slika 6. – Figure 6. Nadaljevanje – Continued
* Pojasnilo – Explantion
Levkemije – Leukaemias: C91-C95
Ledvica – Kidney: C64-C65
Debelo črevo in danka – Colorectum: C18-C20
NHL: ne-Hodgkinovi limfomi – 
NHL: non-Hodkgin's lymphoma: C82-C85
Glava in vrat – Head and neck: C00-C14, C30-C32
Cancer Incidence in Slovenia 2001 19
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Slika 7. Povprečna letna incidenca raka po zdravstvenih regijah – Slovenija 1999–2001
Figure 7. Average annual incidence rate by health regions and sex – Slovenia 1999–2001
Slika 8. Odstotni odklon grobe incidenčne stopnje raka po zdravstvenih regijah 
od povprečne slovenske – Slovenija 1999–2001
Figure 8. Percentage deviation of crude cancer incidence rate in health regions 
from average – Slovenia 1999–2001
20 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Slika 9. Groba in kumulativna letna incidenca vseh rakov po spolu – 
Slovenija 1950–2001
Figure 9. Crude and cumulative annual cancer incidence; all sites by sex – 
Slovenia 1950–2001
Cancer Incidence in Slovenia 2001 21
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Slika 10. Groba letna incidenca izbranih rakov po spolu – 
Slovenija 1950–2001
Figure 10. Crude annual cancer incidence by selected primary sites and sex – 
Slovenia 1950–2001
MOŠKI – MALES
ŽENSKE – FEMALES
Povprečne letne kumulativne incidenčne stopnje 1992–2001
22 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Vsi raki - moški
All sites - males
MKB-10/ICD-10 : C00–C96
Povprečne letne grobe incidenčne stopnje 1992–2001
Povprečne letne starostno specifične incidenčne stopnje 1992–2002 
Slike 11 - Figures 11
Slovenija 38,5 /100
31,40–34,54
34,55–37,68
37,69–40,82
40,83–43,96
43,97–47,10
Incidenca in umrljivost 1985–2001
Slovenija
426,4 /100.000
319,7– 362,0
362,1– 404,3
404,4– 446,6
446,7– 488,9
489,0– 531,2
Cancer Incidence in Slovenia 2001 23
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Average annual cumulative incidence rates 1992–2001
Vsi raki - ženske
All sites - females
MKB-10/ICD-10 :  C00–C96
Average annual crude incidence rates 1992–2001
Average annual age specific incidence rates 1992–2001
Slike 12 - Figures 12
Slovenia 25,9 /100
20,40–23,52
23,53–26,64
26,65–29,76
29,77–32,88
32,89–36,00
Slovenia
390,8 / 100.000
293,40–345,06
345,07 –396,72
396,73–448,38
448,39–500,04
500,05– 551,70
Incidence and mortality 1985–2001
24 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Povprečne letne kumulativne incidenčne stopnje 1992–2001
Ledvica - moški
Kidney - males
MKB-10/ICD-10 : C64–C65
Povprečne letne grobe incidenčne stopnje 1992–2001
Povprečne letne starostno specifične incidenčne stopnje 1992–2002 
Slike 13 - Figures 13
Slovenija 1,1 /100
0,20–0,54
0,55–0,88
0,89–1,22
1,23–1,56
1,57 –1,90
Incidenca in umrljivost 1985–2001
Slovenija
11,7 /100.000
2,30– 6,48
6,49–10,66
10,67 –14,84
14,85–19,02
19,03–23,20
Cancer Incidence in Slovenia 2001 25
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Average annual cumulative incidence rates 1992–2001
Ledvica - ženske
Kidney - females
MKB-10/ICD-10 : C64–C65
Average annual crude incidence rates 1992–2001
Average annual age specific incidence rates 1992–2001
Slike 14 - Figures 14
Slovenia 0,5 /100
0,1 – 0,3
0,4– 0,5
0,6– 0,7
0,8– 0,9
1,0 – 1,1
Slovenia
7,6 / 100.000
2,2 – 5,1
5,2 – 8,0
8,1 –10,9
11,0 –13,8
13,9 –16,7
Incidence and mortality 1985–2001
26 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Povprečne letne kumulativne incidenčne stopnje 1992–2001
Levkemije - moški
Leukaemias - males
MKB-10/ICD-10 : C91–C95
Povprečne letne grobe incidenčne stopnje 1992–2001
Povprečne letne starostno specifične incidenčne stopnje 1992–2002 
Slike 15 - Figures 15
Slovenija 0,8 /100
0,20–0,48
0,49–0,76
0,77–1,04
1,05–1,32
1,33–1,60
Incidenca in umrljivost 1985–2001
Slovenija
9,9 /100.000
2,50– 6,06
5,07– 9,62
9,63–13,18
13,19 –16,74
16,75–20,30
Cancer Incidence in Slovenia 2001 27
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Average annual cumulative incidence rates 1992–2001
Levkemije - ženske
Leukaemias - females
MKB-10/ICD-10 : C91–C95
Average annual crude incidence rates 1992–2001
Average annual age specific incidence rates 1992–2001
Slike 16 - Figures 16
Slovenia 0,5 /100
0,20–0,38
0,39–0,56
0,57 –0,74
0,75–0,92
0,93–1,10
Slovenia
7,7 / 100.000
2,20– 4,44
4,45– 6,68
6,69– 8,92
8,93–11,16
11,17 –13,40
Incidence and mortality 1985–2001
Tabela 1. Prebivalstvo Slovenije po starosti in spolu na dan 30. 6. 2001*
Table 1. Population of Slovenia by age and sex on June 30, 2001*
Starost Skupaj Moški Ženske
Age Total Males Females
0 -  4 90704 46725 43979
5 -  9 99069 50915 48154
10 - 14 120343 61609 58734
15 - 19 134245 68666 65579
20 - 24 151430 78295 73135
25 - 29 147922 76224 71698
30 - 34 145447 73790 71657
35 - 39 156107 79018 77089
40 - 44 155518 79243 76275
45 - 49 159750 82826 76924
50 - 54 138343 70756 67587
55 - 59 104441 51079 53362
60 - 64 103837 49366 54471
65 - 69 95746 41796 53950
70 - 74 82447 32308 50139
75 - 79 58473 18031 40442
80+ 48220 13067 35153
Vse starosti
Total
1992042 973714 1018328
*Vir: Statistični urad Republike Slovenije
Source: Statistical Office of the Republic of Slovenia 
28 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Tabela 2. Prebivalstvo Slovenije po zdravstvenih regijah po spolu na dan 30. 6. 2001*
Table 2. Population of Slovenia by health regions by sex on June 30, 2001*
Zdravstvena regija Skupaj Moški Ženske
Health region Total Males Females
Celje 299419 146996 152423
Gorica 103130 50890 52240
Koper 138773 68343 70430
Kranj 197102 96151 100951
Ljubljana 601423 292071 309352
Mestna občina Ljubljana 326822 157217 169605
Maribor 320052 156043 164009
Mariborske občine 181106 87844 93262
Murska Sobota 124081 60075 64006
Novo mesto 134046 66277 67769
Ravne 74016 36868 37148
Slovenija Skupaj 1992042 973714 1018328
Total
*Vir: Statistični urad Republike Slovenije
Source: Statistical Office of the Republic of Slovenia
Cancer Incidence in Slovenia 2001 29
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 3. Število novih primerov raka ter število in odstotek primerov, registriranih samo iz zdravniških
poročil o vzroku smrti, po lokaciji in spolu - Slovenija 2001
Table 3. Total number of new cancer cases, number and percentage of cases registered from death certificates
only, by site and sex - Slovenia 2001
Šifra Število novih Registrirani samo iz
MKB* Primarna lokacija Spol primerov zdravniških poročil
o vzroku smrti
Število Odstotek**
ICD Number of Registered from death
code* Primary site Sex new cases certificates only
Number Per cent**
C00 Vse lokacije M+Ž 9058 149 2
– M 4565 61 1
C96 All sites Ž 4493 88 2
C00 Ustnica M 13 –
Lip Ž 6 –
C01 Baza jezika M 16 – –
Base of tongue Ž 3 –
C02 Jezik, drugi deli M 29 – –
Tongue, other & unspecified parts Ž 6 –
C03 Dlesen M 1 –
Gum Ž 5 –
C04 Ustno dno M 34 – –
Floor of mouth Ž 2 –
C05 Nebo M 14 –
Palate Ž 2 –
C06 Usta, drugi deli M 15 – –
Mouth, other & unspecified parts Ž 2 –
C07 Parotidna žleza M 2 –
Parotid gland Ž 5 –
C08 Druge in neopredeljene velike žleze slinavke M – –
Other & unspecified major salivary glands Ž 2 –
C09 Tonzila M 36 – –
Tonsil Ž 9 –
C10 Orofarinks M 42 – –
Oropharynx Ž 3 –
C11 Nazofarinks M 8 –
Nasopharynx Ž 1 –
C12 Piriformni sinus M 29 – –
Pyriform sinus Ž 1 –
C13 Hipofarinks M 22 – –
Hypopharynx Ž 3 –
C14
Druga in slabo opredeljena mesta 
na ustnici, v ustni votlini in farinksu M 1 –
Other and ill-defined sites in the lip, oral cavity and pharynx
Ž – –
30 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 3. – table 3. Nadaljevanje – continued
Šifra Število novih Registrirani samo iz
MKB* Primarna lokacija Spol primerov zdravniških poročil
o vzroku smrti
Število Odstotek**
ICD Number of Registered from death
code* Primary site Sex new cases certificates only
Number Per cent**
C15 Požiralnik M 81 3 4
Oesophagus Ž 17 2 12
C16 Želodec M 288 10 3
Stomach Ž 177 12 7
C17 Tanko črevo M 6 –
Small intestine Ž 5 –
C18 Debelo črevo M 333 5 2
Colon Ž 287 11 4
C19 Rektosigmoidna zveza M 59 – –
Rectosigmoid junction Ž 48 – –
C20 Rektum M 231 2 1
Rectum Ž 152 – –
C21 Anus in analni kanal M 7 –
Anus and anal canal Ž 8 –
C22 Jetra in intrahepatični vodi M 73 4 5
Liver and intrahepatic bile ducts Ž 35 3 9
C23 Žolčnik M 14 –
Gallbladder Ž 44 1 2
C24 Drugi in neopredeljeni deli biliarnega trakta M 37 – –
Billiary tract, other and unspecified parts Ž 31 – –
C25 Trebušna slinavka M 129 3 2
Pancreas Ž 118 7 6
C26
Druga in slabo opredeljena mesta 
v prebavnih organih
M 1 –
Other and ill-defined digestive organs
Ž 6 1
C30 Nosna votlina in srednje uho M 8 –
Nasal cavity and middle ear Ž 4 –
C31 Obnosni sinusi M 12 –
Accessory sinuses Ž 5 –
C32 Grlo M 112 1 1
Larynx Ž 12 –
C33 Sapnik M 5 –
Trachea Ž 1 –
C34 Sapnica in pljuča M 750 8 1
Bronchus and lung Ž 254 6 2
C37 Timus M 2 –
Thymus Ž 2 –
C38 Srce, mediastinum, plevra M 3 –
Heart, mediastinum, pleura Ž 2 –
Cancer Incidence in Slovenia 2001 31
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
nadaljevanje / cont’d ➝
Tabela 3. – table 3. Nadaljevanje – continued
Šifra Število novih Registrirani samo iz
MKB* Primarna lokacija Spol primerov zdravniških poročil
o vzroku smrti
Število Odstotek**
ICD Number of Registered from death
code* Primary site Sex new cases certificates only
Number Per cent**
C39
Druga in slabo opredeljena mesta 
v dihalih in prsnih organih M – –
Other and ill-defined sites in the respiratory Ž – –
system and intrathoracic organs
C40 Kosti, sklepni hrustanec udov M 4 –
Bone and articular cartilage of limbs Ž 7 –
C41 Kosti, sklepni hrustanec, drugje M 4 –
Bone and articular cartilage of other and unspecified parts Ž 1 –
C43 Maligni melanom kože M 122 1 1
Malignant melanoma of skin Ž 141 – –
C44 Druge maligne neoplazme kože M 602 – –
Skin, other malignomas Ž 644 2 –
C45 Mezoteliom M 15 – –
Mesothelioma Ž 12 –
C46 Kaposijev sarkom M 1 –
Kaposi's sarcoma Ž – –
C47 Periferni živci in avtonomno živčevje M 2 –
Peripheral nerves and autonomic nervous system Ž 2 –
C48 Retroperitonej in peritonej M 8 –
Retroperitoneum and peritoneum Ž 7 –
C49 Drugo vezivno in mehko tkivo M 22 – –
Other connective and soft tissue Ž 13 –
C50 Dojka M 10 –
Breast Ž 964 16 2
C51 Žensko zunanje spolovilo M – –
Vulva Ž 32 – –
C52 Nožnica M – –
Vagina Ž 8 –
C53 Maternični vrat M – –
Cervix uteri Ž 201 2 1
C54 Maternično telo M – –
Corpus uteri Ž 295 1 –
C55 Maternica, neopredeljeno M – –
Uterus, unspecified part Ž 8 2
C56 Jajčnik M – –
Ovary Ž 164 2 1
C57 Drugi in neopredeljeni ženski spolni organi M – –
Other & unspecified parts of female genital organs Ž 10 –
32 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 3. – table 3. Nadaljevanje – continued
Šifra Število novih Registrirani samo iz
MKB* Primarna lokacija Spol primerov zdravniških poročil
o vzroku smrti
Število Odstotek**
ICD Number of Registered from death
code* Primary site Sex new cases certificates only
Number Per cent**
C58 Posteljica M – –
Placenta Ž – –
C60 Penis M 7 –
Penis Ž – –
C61 Prostata M 449 15 3
Prostate Ž – –
C62 Modo M 99 – –
Testis Ž – –
C63 Drugi in neopredeljeni moški spolni organi M 4 –
Other and unspecified male genital organs Ž – –
C64 Ledvica razen meha M 112 3 3
Kidney, except renal pelvis Ž 62 – –
C65 Ledvični meh M 6 –
Renal pelvis Ž 11 –
C66 Sečevod M 3 –
Ureter Ž 3 –
C67 Sečni mehur M 135 – –
Bladder Ž 42 3 7
C68 Drugi in neopredeljeni sečni organi M 1 –
Other and unspecified urinary organs Ž 1 –
C69 Oko in očesni adneksi M 5 –
Eye and adnexa Ž 5 –
C70 Meninge M 1 –
Meninges Ž 3 –
C71 Možgani M 79 – –
Brain Ž 52 – –
C72 Hrbtni mozeg, možganski živci in drugi deli CŽS M 4 –
Spinal cord, cranial nerves and other parts of CNS Ž 1 –
C73 Ščitnica M 24 – –
Thyroid gland Ž 64 1 2
C74 Nadledvična žleza M 3 –
Adrenal gland Ž – –
C75 Druge endokrine žleze in sorodne strukture M – –
Other endocrine glands and related structures Ž – –
C76 Druga in slabo opredeljena mesta M 4 –
Other and ill-defined sites Ž 26 8 31
C77
Metastaza in neopredeljena 
maligna neoplazma bezgavk M 16 – –
Metastasis and unspecified Ž 17 – –
malignant neoplasm of lymph nodes
Cancer Incidence in Slovenia 2001 33
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
nadaljevanje / cont’d ➝
Tabela 3. – table 3. Nadaljevanje – continued
Šifra Število novih Registrirani samo iz
MKB* Primarna lokacija Spol primerov zdravniških poročil
o vzroku smrti
Število Odstotek**
ICD Number of Registered from death
code* Primary site Sex new cases certificates only
Number Per cent**
C78 Metastaze dihal in prebavil M 48 1 2
Metastases of respiratory and digestive organs Ž 42 – –
C79 Metastaze, drugje M 17 1 6
Metastases of other sites Ž 15 – –
C80 Maligna neoplazma brez opredeljenega mesta M 46 3 7
Malignant neoplasm without specification of site Ž 38 6 16
C81 Hodgkinova bolezen M 23 – –
Hodgkin's disease Ž 28 – –
C82 Folikularni ne-Hodgkinov limfom M 23 – –
Follicular non-Hodgkin's lymphoma Ž 27 – –
C83 Difuzni ne-Hodgkinov limfom M 65 – –
Diffuse non-Hodgkin's lymphoma Ž 60 – –
C84 Limfomi celic T in kožni limfom celic T M 11 –
Peripheral and cutaneous T-cell lymphomas Ž 11 –
C85
Druge in neopredeljene vrste 
ne-Hodgkinovega limfoma
M 19 – –
Other and unspecified types of non-Hodgkin's lymphoma
Ž 31 – –
C88 Maligne imunoproliferativne bolezni M 1 –
Malignant immunoproliferative diseases Ž – –
C90
Difuzni plazmocitom in 
maligne neoplazme plazmocitov
M 30 – –
Multiple myeloma and malignant plasma cell neoplasms
Ž 53 1 2
C91.0 Limfatična levkemija, akutna M 12 –
Lymphoblastic leukaemia, acute Ž 16 – –
C91.1 – Limfatična levkemija, druga M 52 1 2
C91.9 Lymphoid leukaemia, other Ž 33 – –
C92 Mieloična levkemija M 25 – –
Myeloid leukaemia Ž 35 – –
C93 Monocitna levkemija M 2 –
Monocytic leukaemia Ž – –
C94 Druge opredeljene levkemije M 1 –
Other leukaemias of specified cells Ž 2 –
C95 Levkemija z neopredeljenim celičnim tipom M 1 –
Leukaemia, unspecified cell type Ž 2 1
C96
Druge in neopredeljene maligne neoplazme
limfatičnega, krvotvornega in sorodnega tkiva M 34 – –
Other and unspecified malignant neoplasms 
of lymphoid, haematopoietic and related tissue
Ž 46 – –
34 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 3. – table 3. Nadaljevanje – continued 
Šifra Število novih Registrirani samo iz
MKB* Primarna lokacija Spol primerov zdravniških poročil
o vzroku smrti
Število Odstotek**
ICD Number of Registered from death
code* Primary site Sex new cases certificates only
Number Per cent**
Zgoraj neupoštevani
Not included above
D03 Melanom, in situ M 12 –
Melanoma, in situ Ž 12 –
D05 Dojka, in situ M 1 –
Breast, in situ Ž 60 – –
D06 Maternični vrat, in situ (CIN III) M – –
Cervix uteri, in situ (CIN III) Ž 868 – –
D09.0 Karcinom in situ mehurja M 32 – –
Bladder, in situ Ž 21 – –
D32.0 Meninge, benigna neoplazma M 18 – –
Benign neoplasm of meninges Ž 47 – –
D33.0 Možgani, benigna neoplazma M – –
- D33.2 Benign neopasm of brain Ž 1 –
D39.1 Jajčnik, neopl. negotovega značaja M – –
Ovary, neopl. of uncertain behavior Ž 32 – –
D43.0 Možgani, neopredeljeno M 8 –
- D43.2 Brain, uncertain or unknown Ž 5 –
* MKB - Mednarodna klasifikacija bolezni, deseta revizija, 1995
ICD - International Classification of Diseases, Tenth revision, 1995
** Odstotki niso računani pri številih pod 15
Percentages are not calculated for less than 15 cases
Cancer Incidence in Slovenia 2001 35
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 4a. Število novih primerov raka po lokaciji (MKB-10), spolu in starosti - Slovenija 2001
Table 4a. Number of new cancer cases by site (ICD-10), sex, and age - Slovenia 2001
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Skupaj 9058 23 9 17 25 53 82 134 183 312 534 719 818 1054 1350 1459 1205 1081
C00 Vse lokacije Total
– Moški 4565 13 5 9 12 34 48 52 65 120 231 381 436 621 782 784 545 427
C96 All sites Male
Ženske 4493 10 4 8 13 19 34 82 118 192 303 338 382 433 568 675 660 654
Female
C00 Ustnica M 13 – – – – – – 1 – – – 1 1 2 2 2 3 1Lip Ž 6 – – – – – – – – – – 1 – – – 2 – 3
C01 Baza jezika M 16 – – – – – – – – 2 2 3 2 2 3 2 – –Base of tongue Ž 3 – – – – – – – – – 1 – – 1 – – 1 –
C02
Jezik, drugi deli M 29 – – – – – – 1 – – 7 4 4 4 2 4 2 1Tongue, other & Ž 6 – – – – – – – – – 1 – 1 2 1 1 – –unspecified parts
C03 Dlesen M 1 – – – – – – – – – – – – – 1 – – –Gum Ž 5 – – – – – – – – – 1 – 2 1 – – 1 –
C04 Ustno dno M 34 – – – – – – – 1 2 9 6 4 5 5 1 – 1Floor of mouth Ž 2 – – – – – – – – – – – 2 – – – – –
C05 Nebo M 14 – – – – – – – – 1 3 4 3 2 1 – – –Palate Ž 2 – – – – – – – – 1 – – 1 – – – – –
C06
Usta, drugi deli M 15 – – – – – – – – 2 – 3 1 5 1 – 3 –Mouth, other & Ž 2 – – – 1 – – – – – 1 – – – – – – –unspecified parts
C07 Parotidna žleza M 2 – – – – 1 – – – – – – – – – 1 – –Parotid gland Ž 5 – – – – – – – – – – – 1 – 1 1 1 1
C08
Druge in neopredeljene 
M – – – – – – – – – – – – – – – – – –velike žleze slinavke
Other & unspecified Ž 2 – – – – – – – – – 1 – – – 1 – – –
major salivary glands
C09 Tonzila M 36 – – – – – – – 1 4 4 1 2 7 8 5 2 2Tonsil Ž 9 – – – – – – – 1 – 2 – 1 3 1 1 – –
C10 Orofarinks M 42 – – – – – – – 1 4 6 8 9 4 6 4 – –Oropharynx Ž 3 – – – – – – – – – – 2 – – – 1 – –
C11 Nazofarinks M 8 – – – – – – 1 – 1 – 1 – 1 2 1 1 –Nasopharynx Ž 1 – – – – – – – – 1 – – – – – – – –
C12 Piriformni sinus M 29 – – – – – – – – 2 3 7 5 6 2 3 – 1Pyriform sinus Ž 1 – – – – – – – – – 1 – – – – – – –
C13 Hipofarinks M 22 – – – – – – – – 2 1 5 5 1 6 1 – 1Hypopharynx Ž 3 – – – – – – – – – – 2 – – – – 1 –
C14
Druga in slabo oprede-
ljena mesta na ustnici, 
v ustni votlini in farinksu M 1 – – – – – – – – – – – – – 1 – – –
Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – –
in the lip, oral cavity 
and pharynx
C15 Požiralnik M 81 – – – – – – – – 2 5 5 8 19 18 11 5 8Oesophagus Ž 17 – – – – – – – – – – 3 1 2 3 1 – 7
C16 Želodec M 288 – – – – – – – 1 4 9 16 32 43 43 57 41 42Stomach Ž 177 – – – – – – 3 – 6 8 7 10 12 21 39 32 39
C17 Tanko črevo M 6 – – – – – – – – – – 3 – 1 – – 2 –Small intestine Ž 5 – – – – – – – – – 1 – – 1 1 – 2 –
C18 Debelo črevo M 333 – – – – – – 2 3 1 14 32 25 46 76 67 38 29Colon Ž 287 – – – – 1 – – 1 9 6 17 17 37 43 54 51 51
C19 Rektosigmoidna zveza M 59 – – – – – – – – 1 4 5 5 6 11 12 9 6Rectosigmoid junction Ž 48 – – – – – – 1 – 1 2 2 5 2 5 10 8 12
C20 Rektum M 231 – – – – – – 1 3 4 8 16 27 44 46 35 27 20Rectum Ž 152 – – – – – – 1 1 3 3 11 9 16 25 28 27 28
C21 Anus in analni kanal M 7 – – – – – – – – 1 – 1 – 1 1 – 2 1Anus and anal canal Ž 8 – – – – – – – – – – – 1 – 2 1 2 2
C22
Jetra in intrahepatični vodi M 73 – – – – – – – – 3 1 8 7 13 18 14 5 4Liver and intrahepatic Ž 35 – – – – – 1 – – – – 3 1 6 5 7 7 5bile ducts
C23 Žolčnik M 14 – – – – – – – – – 1 1 1 1 2 2 3 3Gallbladder Ž 44 – – – – – – – – – 1 – 6 2 5 9 9 12
C24
Drugi in neopredeljeni 
deli biliarnega trakta M 37 – – – – – – – – 1 2 2 3 3 9 8 6 3
Billiary tract, other and Ž 31 – – – – – – – – – – 1 1 5 4 5 4 11
unspecified parts
C25 Trebušna slinavka M 129 – – – – 1 – 1 3 4 9 13 8 13 15 25 17 20Pancreas Ž 118 – – – – – – 1 – 1 6 6 7 8 22 21 28 18
36 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 4a. – table 4a. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Druga in slabo opredeljena
mesta v prebavnih organih M 1 – – – – – – – – – – – 1 – – – – –C26 Other and ill-defined Ž 6 – – – – – – – – – – – – – 1 2 – 3
digestive organs
C30
Nosna votlina 
in srednje uho M 8 – – – – – 1 – – – – 2 – 2 1 1 1 –
Nasal cavity and Ž 4 – – – – – – – 1 – – – – – – 1 – 2
middle ear
C31 Obnosni sinusi M 12 – 1 – – – – – – – 2 3 1 1 2 2 – –Accessory sinuses Ž 5 – – – – – – – – – – – – – 1 1 1 2
C32 Grlo M 112 – – – – – – – 1 4 8 22 20 14 24 10 4 5Larynx Ž 12 – – – – – – – – – 1 2 2 2 1 – 3 1
C33 Sapnik M 5 – – – – – – – – 2 – – – – 1 1 1 –Trachea Ž 1 – – – – – – – – – – – 1 – – – – –
C34 Sapnica in pljuča M 750 – – – – – – 1 4 15 43 68 82 111 155 135 94 42Bronchus and lung Ž 254 – – – – – 1 1 5 7 20 24 28 26 38 46 39 19
C37 Timus M 2 – – – – – – – – – – – – 1 1 – – –Thymus Ž 2 – – – – – – – – – – 1 1 – – – – –
C38 Srce, mediastinum, plevra M 3 – – – – – 1 – – – – 1 – – – 1 – –Heart, mediastinum, pleura Ž 2 – – 1 – – – 1 – – – – – – – – – –
Druga in slabo oprede-
ljena mesta v dihalih 
C39 in prsnih organih M – – – – – – – – – – – – – – – – – –Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – –
in the respiratory system 
and intrathoracic organs
C40
Kosti, sklepni hrustanec udov M 4 – – 1 – – – – 1 – – – – – 2 – – –Bone and articular Ž 7 – – – – – 1 – – 2 – – 1 – – 1 – 2cartilage of limbs
Kosti, sklepni hrustanec, 
drugje
C41 Bone and articular M 4 – – – – – – – – – – – 2 2 – – – –
cartilage of other and Ž 1 – – – – – – 1 – – – – – – – – – –
unspecified parts
C43
Maligni melanom kože M 122 – 1 1 – 4 2 5 5 16 8 10 12 8 21 14 12 3Malignant melanoma Ž 141 – 1 – 1 5 2 11 8 14 10 11 7 12 16 17 13 13of skin
Druge maligne 
C44 neoplazme kože M 602 – – – 1 1 2 6 6 9 11 42 54 88 80 132 80 90
Skin, other malignomas Ž 644 – – – 1 – 2 3 10 10 34 20 50 65 85 94 112 158
C45 Mezoteliom M 15 – – – – – – – – – 1 2 1 4 1 2 3 1Mesothelioma Ž 12 – – – – – – – – – – – 2 3 – 2 5 –
C46 Kaposijev sarkom M 1 – – – – – – – – – – – – – – – – 1Kaposi's sarcoma Ž – – – – – – – – – – – – – – – – – –
C47
Periferni živci in 
avtonomno živčevje M 2 – 1 – – – – – – – 1 – – – – – – –
Peripheral nerves and Ž 2 – – – – – – – – – – – 2 – – – – –
autonomic nervous system
C48 Retro- in peritonej M 8 1 – – – – – 1 – 1 – 3 – – – 2 – –Retro- and peritoneum Ž 7 – – – – – – – – – 2 1 1 – 2 – – 1
Drugo vezivno in 
C49 mehko tkivo M 22 2 – – – 2 2 – 2 – 2 – 2 2 2 2 2 2Other connective Ž 13 – – – – – – 1 2 – – – 2 – 2 – 2 4
and soft tissue
C50 Dojka M 10 – – – – – – – – – 1 1 1 4 2 – 1 –Breast Ž 964 – – – – 1 3 15 33 75 100 101 102 103 103 131 113 84
C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – –Vulva Ž 32 – – – – 1 – – 1 – 3 2 2 1 3 8 8 3
C52 Nožnica M – – – – – – – – – – – – – – – – – –Vagina Ž 8 – – – – – – – – – – – 1 – – 2 3 2
C53 Maternični vrat M – – – – – – – – – – – – – – – – – –Cervix uteri Ž 201 – – – – 1 8 27 28 30 32 16 12 14 9 11 7 6
C54 Maternično telo M – – – – – – – – – – – – – – – – – –Corpus uteri Ž 295 – – – – – 2 – 4 6 9 35 43 41 50 41 40 24
C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – –Uterus, unspecified Ž 8 – – – – – – – – – 1 – – 1 – 2 – 4
C56 Jajčnik M – – – – – – – – – – – – – – – – – –Ovary Ž 164 – – – 2 – 1 3 4 7 20 20 19 16 23 16 20 13
Cancer Incidence in Slovenia 2001 37
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
nadaljevanje / cont’d ➝
Tabela 4a. – table 4a. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Drugi in neopredeljeni 
ženski spolni organi M – – – – – – – – – – – – – – – – – –
C57 Other and unspecified parts Ž 10 – – – – – – – – 1 – – – 4 1 4 – –
of female genital organs
C58 Posteljica M – – – – – – – – – – – – – – – – – –Placenta Ž – – – – – – – – – – – – – – – – – –
C60 Penis M 7 – – – – – – – 1 – 1 – – 1 1 2 – 1Penis Ž – – – – – – – – – – – – – – – – – –
C61 Prostata M 449 – – – – – – – – – 1 16 30 60 100 98 82 62Prostate Ž – – – – – – – – – – – – – – – – – –
C62 Modo M 99 1 – – 4 15 24 20 12 11 7 2 – 1 – 2 – –Testis Ž – – – – – – – – – – – – – – – – – –
C63
Drugi in neopredeljeni 
moški spolni organi M 4 – – – – – – – – – – 3 – 1 – – – –
Other and unspecified Ž – – – – – – – – – – – – – – – – – –
male genital organs
C64 Ledvica razen meha M 112 3 – – – – – 1 2 4 12 8 12 8 16 24 12 10Kidney, except renal pelvis Ž 62 1 – – – – 1 3 – 2 3 4 7 6 6 11 5 13
C65 Ledvični meh M 6 – – – – – – – – 1 1 1 – – – – 1 2Renal pelvis Ž 11 – – – – – – – – – 2 – 1 1 3 – 3 1
C66 Sečevod M 3 – – – – – – – – – – – 1 1 1 – – –Ureter Ž 3 – – – – – – – – – – – – – 1 1 – 1
C67 Sečni mehur M 135 – – – – – – – – 1 4 12 10 15 24 26 23 20Bladder Ž 42 – – – – – – – – – 1 2 1 3 4 10 7 14
Drugi in neopredeljeni 
sečni organi M 1 – – – – – – – – – – – – – – 1 – –
C68 Other and unspecified Ž 1 – – – – – – – – – – – – – – 1 – –
urinary organs
C69 Oko in očesni adneksi M 5 – – – – – – – 1 – – – 1 – – 1 2 –Eye and adnexa Ž 5 – – – – – – – 1 – – 1 – – – 1 1 1
C70 Meninge M 1 – – – – – – – – – 1 – – – – – – –Meninges Ž 3 – – – – – – – 1 – – – – 1 1 – – –
C71 Možgani M 79 1 1 1 – 2 4 2 3 2 11 11 11 6 11 7 5 1Brain Ž 52 2 1 – 1 2 3 3 3 1 6 6 4 2 9 4 3 2
Hrbtni mozeg, možganski 
živci in drugi deli CŽS M 4 – – – 1 – – – 1 – 2 – – – – – – –
C72 Spinal cord, cranial nerves Ž 1 – – – – – – – – – – – – – – – 1 –
and other parts of CNS
C73 Ščitnica M 24 – – 2 2 – – – 5 1 2 4 – 1 – 5 2 –Thyroid gland Ž 64 – – 2 1 5 1 1 4 3 9 6 4 5 7 7 8 1
C74 Nadledvična žleza M 3 – – – – – – – – – – – – 1 2 – – –Adrenal gland Ž – – – – – – – – – – – – – – – – – –
C75
Druge endokrine žleze 
in sorodne strukture M – – – – – – – – – – – – – – – – – –
Other endocrine glands Ž – – – – – – – – – – – – – – – – – –
and related structures
Druga in slabo 
opredeljena mesta M 4 1 – – – – – – – – – – 1 – – – 1 1C76
Other and ill-defined sites Ž 26 1 – – – – – – – 2 – 1 – – – 2 7 13
C77
Metastaza in neoprede-
ljena maligna 
neoplazma bezgavk M 16 – – – – – – – – 1 1 1 4 1 3 2 – 3
Metastasis and unspecified Ž 17 – – – – – – – – 1 – 2 1 – 2 3 6 2
malignant neoplasm of 
lymph nodes
Metastaze dihal 
in prebavil M 48 – – – – – 1 – – 1 2 4 6 6 11 3 9 5
C78 Metastases of respiratory Ž 42 – – – – – – – – – 2 2 2 7 4 6 7 12
and digestive organs
C79 Metastaze, drugje M 17 – – – – – – – – – – 1 3 3 3 3 2 2Metastases of other sites Ž 15 – – – – – – – – 3 – 1 1 – – 5 2 3
Maligna neoplazma brez 
opredeljenega mesta M 46 – – – – – – – 1 1 1 8 2 10 5 7 6 5C80 Malignant neoplasm Ž 38 – – – – – 1 – – 1 – 5 2 2 3 7 9 8
without specification of site
C81 Hodgkinova bolezen M 23 – – 1 1 3 8 1 1 1 1 – – 2 1 2 1 –Hodgkin's disease Ž 28 – – 2 2 2 6 – 2 2 – 1 2 2 2 1 1 3
Folikularni ne-Hodgkinov 
limfom M 23 – – – – – – – 2 1 1 3 3 4 2 5 1 1C82 Follicular non-Hodgkin's Ž 27 – – – – – – 1 1 1 3 – 4 3 4 3 4 3
lymphoma
38 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 4a. – table 4a. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Difuzni ne-Hodgkinov 
limfom M 65 1 – 1 2 3 – 3 1 4 6 – 5 4 7 9 12 7C83 Diffuse non-Hodgkin's Ž 60 – – 1 1 – 1 1 1 1 3 3 1 4 12 13 11 7
lymphoma
C84
Limfomi celic T in kožni
limfom celic T M 11 – – 1 – – 1 – – – 2 1 1 1 – 3 1 –
Peripheral and cutaneous Ž 11 – – – 1 – – 2 2 – – – – 1 2 1 1 1
T-cell lymphomas
Druge in neopredeljene vrste 
ne-Hodgkinovega limfoma M 19 – – – – – – – – 2 1 1 1 4 1 3 4 2C85 Other and unspecified types Ž 31 – – – – – – – – 1 1 1 3 1 2 4 6 12
of non-Hodgkin's lymphoma
C88
Maligne imunoprolife-
rativne bolezni M 1 – – – – – – – – – – – – – 1 – – –
Malignant immunopro- Ž – – – – – – – – – – – – – – – – – –
liferative diseases
Difuzni plazmocitom in 
maligne neoplazme 
plazmocitov M 30 – – – – – 1 – – – 2 1 5 4 4 4 5 4C90 Multiple myeloma and Ž 53 – – – – – – – – – 3 6 2 4 12 9 9 8
malignant plasma cell 
neoplasms
C91.0
Limfatična levkemija, 
akutna M 12 2 – 1 1 2 1 2 1 – – – – 1 – – – 1
Lymphoblastic Ž 16 5 2 2 2 – – 1 1 – – – 1 – 1 1 – –
leukaemia, acute
C91.1 - Limfatična levkemija, druga M 52 – – – – – – – 1 – 2 4 4 13 10 6 7 5
C91.9 Lymphoid leukaemia, other Ž 33 – – – – – – – – – – 2 1 2 7 4 11 6
C92 Mieloična levkemija M 25 1 – – – – – 3 – – 3 – 2 2 2 4 2 6Myeloid leukaemia Ž 35 1 – – – 1 – – 2 – 2 3 1 1 5 6 8 5
C93 Monocitna levkemija M 2 – – – – – – – – – – – – – 1 – 1 –Monocytic leukaemia Ž – – – – – – – – – – – – – – – – – –
C94
Druge opredeljene 
levkemije M 1 – – – – – – – – – – – – 1 – – – –
Other leukaemias Ž 2 – – – – – – – – – – 1 – – – – – 1
of specified cells
Levkemija z neoprede-
ljenim celičnim tipom M 1 – – – – – – – – – – – – – – 1 – –C95 Leukaemia, unspecified Ž 2 – – – – – – – – – – – – – – 1 1 –
cell type
Druge in neopredeljene 
maligne neoplazme 
limfatičnega, krvotvornega 
C96 in sorodnega tkiva M 34 – 1 – – – – – 1 1 2 1 6 4 5 9 2 2Other and unspecified Ž 46 – – – – – – 1 1 – 1 3 2 2 6 14 9 7
malignant neoplasms of 
lymphoid, haematopoietic 
and related tissue
Zgoraj neupoštevani
Not included above
D03 Melanom, in situ M 12 – – – – – – – – – 1 5 1 3 1 1 – –Melanoma, in situ Ž 12 – – – – 1 – – 1 1 2 – 2 2 1 – 1 1
D05 Dojka, in situ M 1 – – – – – – – – 1 – – – – – – – –Breast, in situ Ž 60 – – – – – 1 1 1 4 16 9 3 7 3 8 5 2
D06 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – –Cervix uteri, in situ (CIN III) Ž 868 – – – 1 67 136 184 183 145 88 26 14 13 6 4 – 1
D09.0 Karcinom in situ mehurja M 32 – – – – – – 1 1 – – 3 2 7 6 5 4 3Bladder, in situ Ž 21 – – – – – – – – – 1 2 4 2 5 2 4 1
Meninge, benigna 
neoplazma M 18 – – – 1 – – 2 – – 1 2 – – 4 3 4 1D32.0 Benign neoplasm of Ž 47 – – – – – – – – 4 4 9 6 3 9 7 5 –
meninges
D33.0 Možgani, benigna neoplazma M – – – – – – – – – – – – – – – – – –- D33.2 Benign neopasm of brain Ž 1 – – – – – – – 1 – – – – – – – – –
Jajčnik, neopl. 
negotovega značaja M – – – – – – – – – – – – – – – – – –D39.1 Ovary, neopl. of Ž 32 – – – 1 2 – 2 – 4 7 4 3 1 3 1 2 2
uncertain behavior
D43.0 Možgani, neopredeljeno M 8 – – – – – – – – – 2 – – 1 – 4 1 –
- D43.2 Brain, uncertain or unknown Ž 5 – – – – 1 – – – – – – – – 1 1 – 2
Cancer Incidence in Slovenia 2001 39
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 4b. Število novih primerov raka po lokaciji (MKB-8), spolu in starosti - Slovenija 2001
Table 4b. Number of new cancer cases by site (ICD-8), sex, and age - Slovenia 2001
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Skupaj 8999 23 8 17 25 53 82 133 181 312 532 716 814 1049 1344 1442 1196 1072
140 Vse lokacije Total
– Moški 4542 13 4 9 12 34 48 52 64 120 230 380 433 618 780 777 543 425
209 All sites Male
Ženske 4457 10 4 8 13 19 34 81 117 192 302 336 381 431 564 665 653 647
Female
140 Ustnica M 13 – – – – – – 1 – – – 1 1 2 2 2 3 1Lip Ž 6 – – – – – – – – – – 1 – – – 2 – 3
141 Jezik M 46 – – – – – – 1 – 3 9 7 6 6 5 6 2 1Tongue Ž 9 – – – – – – – – – 2 – 1 3 1 1 1 –
142 Slinavke M 2 – – – – 1 – – – – – – – – – 1 – –Salivary glands Ž 11 – – – – – – – – – 1 – 1 1 3 2 1 2
143 Dlesni M 1 – – – – – – – – – – – – – 1 – – –Gum Ž 5 – – – – – – – – – 1 – 2 1 – – 1 –
144 Ustno dno M 34 – – – – – – – 1 2 9 6 4 5 5 1 – 1Floor of mouth Ž 2 – – – – – – – – – – – 2 – – – – –
145 Usta, drugo M 29 – – – – – – – – 3 3 7 4 7 2 – 3 –Mouth, other parts Ž 4 – – – 1 – – – – 1 1 – 1 – – – – –
146 Orofarinks M 82 – – – – – – – 2 9 10 9 11 11 15 10 2 3Oropharynx Ž 14 – – – – – – – 1 – 3 2 2 3 1 2 – –
147 Epifarinks M 11 – – – – – – 1 1 2 1 1 – 1 2 1 1 –Epipharynx Ž 1 – – – – – – – – 1 – – – – – – – –
148 Hipofarinks M 51 – – – – – – – – 4 4 12 10 7 8 4 – 2Hypopharynx Ž 4 – – – – – – – – – 1 2 – – – – 1 –
149 Žrelo, neoznačeno M 1 – – – – – – – – – – – – – 1 – – –Pharynx, not specified Ž – – – – – – – – – – – – – – – – – –
150 Požiralnik M 81 – – – – – – – – 2 5 5 8 19 18 11 5 8Oesophagus Ž 18 – – – – – – – – – – 3 1 2 3 2 – 7
151 Želodec M 311 – – – 2 – – – 1 5 11 19 36 45 43 61 45 43Stomach Ž 193 – – – – – – 3 – 6 9 7 11 13 24 42 37 41
152 Tanko črevo M 9 – – – – – – 1 – – – 3 – 2 – 1 2 –Small intestine Ž 10 – – – – – – 1 1 – 1 – 1 1 1 2 2 –
153 Debelo črevo M 335 – – – – – – 2 3 1 14 32 25 46 76 67 40 29Colon Ž 290 – – – – 1 – – 2 9 6 17 17 37 43 54 52 52
154 Rektum M 299 – – – – – – 1 3 6 12 22 32 52 58 47 38 28Rectum Ž 208 – – – – – – 2 1 4 5 13 15 18 32 39 37 42
155 Jetra M 56 – – – – – – – – 2 1 7 6 12 13 10 4 1Liver Ž 23 – – – – – 1 – – – – 3 – 5 1 6 5 2
156 Žolčnik, žolčni vodi M 51 – – – – – – – – 1 3 3 4 4 11 10 9 6Gallbladder, bile ducts Ž 75 – – – – – – – – – 1 1 7 7 9 14 13 23
157 Trebušna slinavka M 130 – – – – 1 – 1 3 4 9 13 8 13 15 26 17 20Pancreas Ž 119 – – – – – – 2 – 1 6 6 7 8 22 21 28 18
158 Retro- in peritonej M 9 – – – – – – 1 – 1 1 3 – 1 – 2 – –Retro- and peritoneum Ž 9 – – – – – – – – – 2 1 2 – 2 – 1 1
159 Prebavila, drugo M 1 – – – – – – – – – – – 1 – – – – –Digestive organs, other Ž 5 – – – – – – – – – – – – – 1 2 – 2
160 Nos, obnosne votline,drugo M 22 – 1 – – – 1 – – – 2 5 1 3 4 4 1 –Nose, sinuses, etc. Ž 11 – – – – – – – 2 – – – – – 1 2 2 4
161 Grlo M 112 – – – – – – – 1 4 8 22 20 14 24 10 4 5Larynx Ž 12 – – – – – – – – – 1 2 2 2 1 – 3 1
162 Sapnik, sapnica, pljuča M 758 – – – – – – 1 4 17 43 68 82 112 157 136 96 42Trachea, bronchus, lung Ž 258 – – – – – 1 1 5 7 20 24 29 26 38 46 39 22
163 Plevra, mediastinum, drugo M 17 – – – – – 1 – – – – 3 1 4 1 3 3 1Pleura, mediastinum, etc. Ž 12 – – 1 – – – 1 – – – – 1 4 – 2 3 –
170 Kosti M 10 – – 1 – 1 – – 1 – – – 2 3 2 – – –Bone Ž 8 – – – – – 1 1 – 2 – – 1 – – 1 – 2
171 Mehka tkiva M 22 2 – – – 2 2 – 2 – 2 – 2 2 2 2 2 2Soft tissues Ž 20 – – – – – – 1 2 – – – 3 – 6 1 3 4
172 Koža, maligni melanom M 123 – 1 1 – 4 2 5 5 16 8 11 12 8 21 14 12 3Skin, malignant melanoma Ž 141 – 1 – 1 5 2 11 8 14 10 11 7 12 16 17 13 13
173 Koža, drugi malignomi M 608 – – – 1 1 3 7 6 9 11 43 54 89 80 133 80 91Skin, other malignancies Ž 645 – – – 1 – 2 3 10 10 34 20 50 66 85 94 112 158
174 Dojka M 10 – – – – – – – – – 1 1 1 4 2 – 1 –Breast Ž 965 – – – – 1 3 15 33 75 100 101 102 103 103 132 113 84
40 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 4b. – table 4b. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
180 Maternica, vrat M – – – – – – – – – – – – – – – – – –Uterus, cervix Ž 201 – – – – 1 8 27 28 30 32 16 12 14 9 11 7 6
181 Horioepiteliom M – – – – – – – – – – – – – – – – – –Chorioepithelioma Ž – – – – – – – – – – – – – – – – – –
182 Maternica, telo, drugo M – – – – – – – – – – – – – – – – – –Uterus, corpus, etc. Ž 304 – – – – – 2 – 4 6 10 35 43 42 50 43 40 29
183 Jajčnik, jajcevod, drugo M – – – – – – – – – – – – – – – – – –Ovary, Fallopian tube, other Ž 170 – – – 2 – 1 3 4 7 20 20 19 18 24 19 20 13
184 Nožnica, vulva, drugo M – – – – – – – – – – – – – – – – – –Vagina, vulva, etc. Ž 45 – – – – 1 – – 1 1 3 2 3 3 3 11 12 5
185 Prostata M 449 – – – – – – – – – 1 16 30 60 100 98 82 62Prostate Ž – – – – – – – – – – – – – – – – – –
186 Modo M 100 1 – – 4 15 24 20 12 11 7 2 – 1 – 2 1 –Testis Ž – – – – – – – – – – – – – – – – – –
187 Penis, obmodek, drugo M 8 – – – – – – – 1 – 1 1 – 1 1 2 – 1Penis, epididymis, etc. Ž – – – – – – – – – – – – – – – – – –
188 Sečni mehur M 135 – – – – – – – – 1 4 12 10 15 24 26 23 20Bladder Ž 42 – – – – – – – – – 1 2 1 3 4 10 7 14
189 Ledvica, sečevod, drugo M 122 3 – – – – – 1 2 5 13 9 13 9 17 25 13 12Kidney, ureter, etc. Ž 79 1 – – – – 1 3 – 2 6 4 8 7 10 14 8 15
190 Oko M 6 – – – – – – – 1 – – – 1 – – 2 2 –Eye Ž 7 – – – – – – – 1 – – 1 – – – 2 2 1
191 Možgani M 81 1 1 1 – 2 4 2 3 2 11 11 11 7 11 7 6 1Brain Ž 55 2 1 – 1 2 3 3 3 2 6 6 5 2 9 4 3 3
192 Živčevje, drugo M 8 1 1 – 1 – – – 1 – 4 – – – – – – –Nervous system, other Ž 6 – – – – – – – 1 – – – 2 1 1 – 1 –
193 Ščitnica M 24 – – 2 2 – – – 5 1 2 4 – 1 – 5 2 –Thyroid Ž 64 – – 2 1 5 1 1 4 3 9 6 4 5 7 7 8 1
194 Endokrine žleze, druge M 5 – – – – – – – – – – – – 2 3 – – –Endocrine glands, other Ž 3 – – – – – – – – – – 1 1 1 – – – –
195 Slabo opredeljene lokacije M 4 1 – – – – – – – – – – 1 – – – 1 1Ill-defined site Ž 25 1 – – – – – – – 2 – 1 – – – 2 7 12
196 Metastaze v bezgavkah M 16 – – – – – – – – 1 1 1 4 1 3 2 – 3Lymph node metastases Ž 17 – – – – – – – – 1 – 2 1 – 2 3 6 2
197
Metastaze v dihalih, 
prebavilih M 65 – – – – – 1 – – 2 2 5 7 7 16 7 10 8
Respirative, digestive Ž 55 – – – – – – – – – 2 2 3 8 8 8 9 15
tract metastases
198 Metastaze, drugje M 17 – – – – – – – – – – 1 3 3 3 3 2 2Metastases, other Ž 16 – – – – – – – – 3 – 1 1 – – 5 2 4
199 Malignomi, neopredeljeni M 46 – – – – – – – 1 1 1 8 2 10 5 7 6 5Malignancies, unspecified Ž 38 – – – – – 1 – – 1 – 5 2 2 3 7 9 8
200 + Ne-Hodgkinovi limfomi M 66 1 – 2 – 2 – 1 2 3 7 2 6 6 7 11 9 7
202 Non-Hodgkin's lymphoma Ž 73 – – 1 2 – 1 2 1 2 4 4 3 4 12 9 13 15
201 Hodgkinov limfom M 23 – – 1 1 3 8 1 1 1 1 – – 2 1 2 1 –Hodgkin's disease Ž 28 – – 2 2 2 6 – 2 2 – 1 2 2 2 1 1 3
203 Plazmocitom M 28 – – – – – 1 – – – 2 1 5 3 4 3 5 4Plasmocytoma Ž 53 – – – – – – – – – 3 6 2 4 12 9 9 8
204.0
Levkemija, limfatična, 
akutna M 12 2 – 1 1 2 1 2 1 – – – – 1 – – – 1
Leukaemia, lymphatic, Ž 16 5 2 2 2 – – 1 1 – – – 1 – 1 1 – –
acute
Levkemija, limfatična, 
204.1 drugo M 43 – – – – – – – – – 2 3 3 12 7 4 7 5
- 204.9 Leukaemia, lymphatic, Ž 32 – – – – – – – – – – 2 1 2 7 4 10 6
other
205 Levkemija, mieloična M 21 1 – – – – – 2 – – 3 – 1 2 2 3 2 5Leukaemia, myeloic Ž 23 1 – – – 1 – – 1 – 1 – – 1 4 5 6 3
206 Levkemija, monocitna M 6 – – – – – – 1 – – – – 1 – 1 1 1 1Leukaemia, monocytic Ž 12 – – – – – – – 1 – 1 3 1 – 1 1 2 2
207 Levkemije, druge M 11 – – – – – – – 1 – – 1 1 2 3 3 – –Leukaemias, other Ž 5 – – – – – – – – – – 1 – – – 1 2 1
208 Policitemija, prava M 9 – – – – – – – – 1 1 – 2 1 2 2 – –Polycithemia vera Ž 6 – – – – – – – – – – 1 – – 1 3 1 –
209 Mielofibroza M 3 – – – – – – – – – – – 1 – 2 – – –Myelofibrosis Ž 4 – – – – – – – – – – – 1 – 1 1 1 –
Cancer Incidence in Slovenia 2001 41
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
nadaljevanje / cont’d ➝
Tabela 4b. – table 4b. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Zgoraj neupoštevani
Not included above
219 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – –
+ 234 Cervix uteri, in situ (CIN III) Ž 868 – – – 1 67 136 184 183 145 88 26 14 13 6 4 – 1
225.0 Možgani, benigni tumor M 18 – – – 1 – – 2 – – 1 2 – – 4 3 4 1
+ 225.2 Brain, benign tumor Ž 49 – – – – 1 – – 1 4 4 9 6 3 9 7 5 –
232.2 Maligni melanom, in situ M 12 – – – – – – – – – 1 5 1 3 1 1 – –Malignant melanoma, in situ Ž 12 – – – – 1 – – 1 1 2 – 2 2 1 – 1 1
233 Dojka, in situ M 1 – – – – – – – – 1 – – – – – – – –Breast, in situ Ž 60 – – – – – 1 1 1 4 16 9 3 7 3 8 5 2
Jajčnik, neopl. 
negotovega značaja M – – – – – – – – – – – – – – – – – –235 Ovary, neopl.  Ž 32 – – – 1 2 – 2 – 4 7 4 3 1 3 1 2 2
of uncertain behavior
237.6 Sečni mehur, in situ M 32 – – – – – – 1 1 – – 3 2 7 6 5 4 3Urinary bladder, in situ Ž 21 – – – – – – – – – 1 2 4 2 5 2 4 1
238.1 Možgani, neopredeljeno M 8 – – – – – – – – – 2 – – 1 – 4 1 –Brain, unspecified Ž 4 – – – – – – – – – – – – – 1 1 – 2
42 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 5. Incidenca raka na 100.000 prebivalcev po spolu in starosti ter kumulativna stopnja (KS) po lokaciji - Slovenija 2001
Table 5. Cancer incidence per 100.000 population by sex and age, and cumulative rate (CR) by site - Slovenia 2001
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
Skupaj 454,7 25,4 9,1 14,1 18,6 35,0 55,4 92,1 117,2 200,6 334,3 519,7 783,2 1015,1 1410,0 1769,6 2060,8 2241,8 32,0
C00 Vse lokacije Total
– Moški 468,8 27,8 9,8 14,6 17,5 43,4 63,0 70,5 82,3 151,4 278,9 538,5 853,6 1258,0 1871,0 2426,6 3022,6 3267,8 38,5
C96 All sites Male
Ženske 441,2 22,7 8,3 13,6 19,8 26,0 47,4 114,4 153,1 251,7 393,9 500,1 715,9 794,9 1052,8 1346,3 1632,0 1860,4 27,3
Female
C00 Ustnica M 1,3 – – – – – – 1,4 – – – 1,4 2,0 4,1 4,8 6,2 16,6 7,7 0,1
Lip Ž 0,6 – – – – – – – – – – 1,5 – – – 4,0 – 8,5 0,0
C01 Baza jezika M 1,6 – – – – – – – – 2,5 2,4 4,2 3,9 4,1 7,2 6,2 – – 0,2
Base of tongue Ž 0,3 – – – – – – – – – 1,3 – – 1,8 – – 2,5 – 0,0
C02
Jezik, drugi deli M 3,0 – – – – – – 1,4 – – 8,5 5,7 7,8 8,1 4,8 12,4 11,1 7,7 0,2
Tongue, other & Ž 0,6 – – – – – – – – – 1,3 – 1,9 3,7 1,9 2,0 – – 0,1
unspecified parts
C03 Dlesen M 0,1 – – – – – – – – – – – – – 2,4 – – – 0,0
Gum Ž 0,5 – – – – – – – – – 1,3 – 3,7 1,8 – – 2,5 – 0,0
C04 Ustno dno M 3,5 – – – – – – – 1,3 2,5 10,9 8,5 7,8 10,1 12,0 3,1 – 7,7 0,3
Floor of mouth Ž 0,2 – – – – – – – – – – – 3,7 – – – – – 0,0
C05 Nebo M 1,4 – – – – – – – – 1,3 3,6 5,7 5,9 4,1 2,4 – – – 0,1
Palate Ž 0,2 – – – – – – – – 1,3 – – 1,9 – – – – – 0,0
C06
Usta, drugi deli M 1,5 – – – – – – – – 2,5 – 4,2 2,0 10,1 2,4 – 16,6 – 0,1
Mouth, other & Ž 0,2 – – – 1,5 – – – – – 1,3 – – – – – – – 0,0
unspecified parts
C07 Parotidna žleza M 0,2 – – – – 1,3 – – – – – – – – – 3,1 – – 0,0
Parotid gland Ž 0,5 – – – – – – – – – – – 1,9 – 1,9 2,0 2,5 2,8 0,0
C08
Druge in neopredeljene 
velike žleze slinavke M – – – – – – – – – – – – – – – – – – –
Other & unspecified Ž 0,2 – – – – – – – – – 1,3 – – – 1,9 – – – 0,0
major salivary glands
C09 Tonzila M 3,7 – – – – – – – 1,3 5,0 4,8 1,4 3,9 14,2 19,1 15,5 11,1 15,3 0,3
Tonsil Ž 0,9 – – – – – – – 1,3 – 2,6 – 1,9 5,5 1,9 2,0 – – 0,1
C10 Orofarinks M 4,3 – – – – – – – 1,3 5,0 7,2 11,3 17,6 8,1 14,4 12,4 – – 0,4
Oropharynx Ž 0,3 – – – – – – – – – – 3,0 – – – 2,0 – – 0,0
C11 Nazofarinks M 0,8 – – – – – – 1,4 – 1,3 – 1,4 – 2,0 4,8 3,1 5,5 – 0,1
Nasopharynx Ž 0,1 – – – – – – – – 1,3 – – – – – – – – 0,0
C
a
ncer Incid
ence in Slovenia
 2001
43
Institue of O
ncolog
y Ljub
lja
na
, C
a
ncer Reg
istry of Slovenia
nadaljevanje / cont’d ➝
Tabela 5. – table 5. Nadaljevanje – continued
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
C12 Piriformni sinus M 3,0 – – – – – – – – 2,5 3,6 9,9 9,8 12,2 4,8 9,3 – 7,7 0,3
Pyriform sinus Ž 0,1 – – – – – – – – – 1,3 – – – – – – – 0,0
C13 Hipofarinks M 2,3 – – – – – – – – 2,5 1,2 7,1 9,8 2,0 14,4 3,1 – 7,7 0,2
Hypopharynx Ž 0,3 – – – – – – – – – – 3,0 – – – – 2,5 – 0,0
Druga in slabo opredeljena 
mesta na ustnici, 
C14 v ustni votlini in farinksu M 0,1 – – – – – – – – – – – – – 2,4 – – – 0,0
Other and ill-defined sites in Ž – – – – – – – – – – – – – – – – – – –
the lip, oral cavity and pharynx
C15 Požiralnik M 8,3 – – – – – – – – 2,5 6,0 7,1 15,7 38,5 43,1 34,0 27,7 61,2 0,7
Oesophagus Ž 1,7 – – – – – – – – – – 4,4 1,9 3,7 5,6 2,0 – 19,9 0,1
C16 Želodec M 29,6 – – – – – – – 1,3 5,0 10,9 22,6 62,6 87,1 102,9 176,4 227,4 321,4 2,3
Stomach Ž 17,4 – – – – – – 4,2 – 7,9 10,4 10,4 18,7 22,0 38,9 77,8 79,1 110,9 1,0
C17 Tanko črevo M 0,6 – – – – – – – – – – 4,2 – 2,0 – – 11,1 – 0,0
Small intestine Ž 0,5 – – – – – – – – – 1,3 – – 1,8 1,9 – 4,9 – 0,0
C18 Debelo črevo M 34,2 – – – – – – 2,7 3,8 1,3 16,9 45,2 48,9 93,2 181,8 207,4 210,7 221,9 3,0
Colon Ž 28,2 – – – – 1,4 – – 1,3 11,8 7,8 25,2 31,9 67,9 79,7 107,7 126,1 145,1 1,7
C19 Rektosigmoidna zveza M 6,1 – – – – – – – – 1,3 4,8 7,1 9,8 12,2 26,3 37,1 49,9 45,9 0,5
Rectosigmoid junction Ž 4,7 – – – – – – 1,4 – 1,3 2,6 3,0 9,4 3,7 9,3 19,9 19,8 34,1 0,3
C20 Rektum M 23,7 – – – – – – 1,4 3,8 5,0 9,7 22,6 52,9 89,1 110,1 108,3 149,7 153,1 2,0
Rectum Ž 14,9 – – – – – – 1,4 1,3 3,9 3,9 16,3 16,9 29,4 46,3 55,8 66,8 79,7 0,9
C21 Anus in analni kanal M 0,7 – – – – – – – – 1,3 – 1,4 – 2,0 2,4 – 11,1 7,7 0,0
Anus and anal canal Ž 0,8 – – – – – – – – – – – 1,9 – 3,7 2,0 4,9 5,7 0,0
C22 Jetra in intrahepatični vodi M 7,5 – – – – – – – – 3,8 1,2 11,3 13,7 26,3 43,1 43,3 27,7 30,6 0,7
Liver and intrahepatic bile ducts Ž 3,4 – – – – – 1,4 – – – – 4,4 1,9 11,0 9,3 14,0 17,3 14,2 0,2
C23 Žolčnik M 1,4 – – – – – – – – – 1,2 1,4 2,0 2,0 4,8 6,2 16,6 23,0 0,1
Gallbladder Ž 4,3 – – – – – – – – – 1,3 – 11,2 3,7 9,3 18,0 22,3 34,1 0,2
Drugi in neopredeljeni  
deli biliarnega trakta M 3,8 – – – – – – – – 1,3 2,4 2,8 5,9 6,1 21,5 24,8 33,3 23,0 0,3C24 Billiary tract, other and Ž 3,0 – – – – – – – – – – 1,5 1,9 9,2 7,4 10,0 9,9 31,3 0,2
unspecified parts
C25 Trebušna slinavka M 13,2 – – – – 1,3 – 1,4 3,8 5,0 10,9 18,4 15,7 26,3 35,9 77,4 94,3 153,1 1,0
Pancreas Ž 11,6 – – – – – – 1,4 – 1,3 7,8 8,9 13,1 14,7 40,8 41,9 69,2 51,2 0,6
Druga in slabo 
opredeljena mesta 
C26 v prebavnih organih M 0,1 – – – – – – – – – – – 2,0 – – – – – 0,0
Other and ill-defined Ž 0,6 – – – – – – – – – – – – – 1,9 4,0 – 8,5 0,0
digestive organs
44
Incid
enca
 ra
ka
 v Sloveniji 2001
O
nkološki inštitut Ljub
lja
na
, Reg
ister ra
ka
 za
 Slovenijo
nadaljevanje / cont’d ➝
Tabela 5. – table 5. Nadaljevanje – continued
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
Nosna votlina in 
srednje uho M 0,8 – – – – – 1,3 – – – – 2,8 – 4,1 2,4 3,1 5,5 – 0,1C30
Nasal cavity and middle ear Ž 0,4 – – – – – – – 1,3 – – – – – – 2,0 – 5,7 0,0
C31 Obnosni sinusi M 1,2 – 2,0 – – – – – – – 2,4 4,2 2,0 2,0 4,8 6,2 – – 0,1
Accessory sinuses Ž 0,5 – – – – – – – – – – – – – 1,9 2,0 2,5 5,7 0,0
C32 Grlo M 11,5 – – – – – – – 1,3 5,0 9,7 31,1 39,2 28,4 57,4 31,0 22,2 38,3 1,0
Larynx Ž 1,2 – – – – – – – – – 1,3 3,0 3,7 3,7 1,9 – 7,4 2,8 0,1
C33 Sapnik M 0,5 – – – – – – – – 2,5 – – – – 2,4 3,1 5,5 – 0,0
Trachea Ž 0,1 – – – – – – – – – – – 1,9 – – – – – 0,0
C34 Sapnica in pljuča M 77,0 – – – – – – 1,4 5,1 18,9 51,9 96,1 160,5 224,9 370,8 417,9 521,3 321,4 6,7
Bronchus and lung Ž 24,9 – – – – – 1,4 1,4 6,5 9,2 26 35,5 52,5 47,7 70,4 91,7 96,4 54 1,7
C37 Timus M 0,2 – – – – – – – – – – – – 2,0 2,4 – – – 0,0
Thymus Ž 0,2 – – – – – – – – – – 1,5 1,9 – – – – – 0,0
C38 Srce, mediastinum, plevra M 0,3 – – – – – 1,3 – – – – 1,4 – – – 3,1 – – 0,0
Heart, mediastinum, pleura Ž 0,2 – – 1,7 – – – 1,4 – – – – – – – – – – 0,0
C39
Druga in slabo opredeljena 
mesta v dihalih in 
prsnih organih M – – – – – – – – – – – – – – – – – – –
Other and ill-defined sites Ž – – – – – – – – – – – – – – – – – – –
in the respiratory system 
and intrathoracic organs
Kosti, sklepni hrustanec 
udov M 0,4 – – 1,6 – – – – 1,3 – – – – – 4,8 – – – 0,0
C40 Bone and articular Ž 0,7 – – – – – 1,4 – – 2,6 – – 1,9 – – 2,0 – 5,7 0,0
cartilage of limbs
C41
Kosti, sklepni hrustanec, 
drugje M 0,4 – – – – – – – – – – – 3,9 4,1 – – – – 0,0
Bone and articular cartilage Ž 0,1 – – – – – – 1,4 – – – – – – – – – – 0,0
of other and unspecified parts
C43 Maligni melanom kože M 12,5 – 2,0 1,6 – 5,1 2,6 6,8 6,3 20,2 9,7 14,1 23,5 16,2 50,2 43,3 66,6 23,0 1,0
Malignant melanoma of skin Ž 13,8 – 2,1 – 1,5 6,8 2,8 15,4 10,4 18,4 13,0 16,3 13,1 22,0 29,7 33,9 32,1 37,0 0,9
C44
Druge maligne 
neoplazme kože M 61,8 – – – 1,5 1,3 2,6 8,1 7,6 11,4 13,3 59,4 105,7 178,3 191,4 408,6 443,7 688,8 4,9
Skin, other malignomas Ž 63,2 – – – 1,5 – 2,8 4,2 13,0 13,1 44,2 29,6 93,7 119,3 157,6 187,5 276,9 449,5 3,3
C45 Mezoteliom M 1,5 – – – – – – – – – 1,2 2,8 2,0 8,1 2,4 6,2 16,6 7,7 0,1
Mesothelioma Ž 1,2 – – – – – – – – – – – 3,7 5,5 – 4,0 12,4 – 0,1
C46 Kaposijev sarkom M 0,1 – – – – – – – – – – – – – – – – 7,7 0,0
Kaposi's sarcoma Ž – – – – – – – – – – – – – – – – – – –
C
a
ncer Incid
ence in Slovenia
 2001
45
Institue of O
ncolog
y Ljub
lja
na
, C
a
ncer Reg
istry of Slovenia
nadaljevanje / cont’d ➝
Tabela 5. – table 5. Nadaljevanje – continued
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
Periferni živci in 
avtonomno živčevje M 0,2 – 2,0 – – – – – – – 1,2 – – – – – – – 0,0
C47 Peripheral nerves and Ž 0,2 – – – – – – – – – – – 3,7 – – – – – 0,0
autonomic nervous system
C48 Retro- in peritonej M 0,8 2,1 – – – – – 1,4 – 1,3 – 4,2 – – – 6,2 – – 0,1Retro- and peritoneum Ž 0,7 – – – – – – – – – 2,6 1,5 1,9 – 3,7 – – 2,8 0,0
Drugo vezivno in 
mehko tkivo M 2,3 4,3 – – – 2,6 2,6 – 2,5 – 2,4 – 3,9 4,1 4,8 6,2 11,1 15,3 0,2C49 Other connective and Ž 1,3 – – – – – – 1,4 2,6 – – – 3,7 – 3,7 – 4,9 11,4 0,1
soft tissue
C50 Dojka M 1,0 – – – – – – – – – 1,2 1,4 2,0 8,1 4,8 – 5,5 – 0,1Breast Ž 94,7 – – – – 1,4 4,2 20,9 42,8 98,3 130,0 149,4 191,1 189,1 190,9 261,3 279,4 239,0 6,4
C51 Žensko zunanje spolovilo M – – – – – – – – – – – – – – – – – – –Vulva Ž 3,1 – – – – 1,4 – – 1,3 – 3,9 3,0 3,7 1,8 5,6 16,0 19,8 8,5 0,2
C52 Nožnica M – – – – – – – – – – – – – – – – – – –Vagina Ž 0,8 – – – – – – – – – – – 1,9 – – 4,0 7,4 5,7 0,0
C53 Maternični vrat M – – – – – – – – – – – – – – – – – – –Cervix uteri Ž 19,7 – – – – 1,4 11,2 37,7 36,3 39,3 41,6 23,7 22,5 25,7 16,7 21,9 17,3 17,1 1,4
C54 Maternično telo M – – – – – – – – – – – – – – – – – – –Corpus uteri Ž 29 – – – – – 2,8 – 5,2 7,9 11,7 51,8 80,6 75,3 92,7 81,8 98,9 68,3 2,0
C55 Maternica, neopredeljeno M – – – – – – – – – – – – – – – – – – –Uterus, unspecified Ž 0,8 – – – – – – – – – 1,3 – – 1,8 – 4,0 – 11,4 0,0
C56 Jajčnik M – – – – – – – – – – – – – – – – – – –Ovary Ž 16,1 – – – 3,0 – 1,4 4,2 5,2 9,2 26,0 29,6 35,6 29,4 42,6 31,9 49,5 37,0 1,1
Drugi in neopredeljeni 
ženski spolni organi M – – – – – – – – – – – – – – – – – – –C57 Other and unspecified parts Ž 1,0 – – – – – – – – 1,3 – – – 7,3 1,9 8,0 – – 0,1
of female genital organs
C58 Posteljica M – – – – – – – – – – – – – – – – – – –Placenta Ž – – – – – – – – – – – – – – – – – – –
C60 Penis M 0,7 – – – – – – – 1,3 – 1,2 – – 2,0 2,4 6,2 – 7,7 0,1Penis Ž – – – – – – – – – – – – – – – – – – –
C61 Prostata M 46,1 – – – – – – – – – 1,2 22,6 58,7 121,5 239,3 303,3 454,8 474,5 3,7Prostate Ž – – – – – – – – – – – – – – – – – – –
C62 Modo M 10,2 2,1 – – 5,8 19,2 31,5 27,1 15,2 13,9 8,5 2,8 – 2,0 – 6,2 – – 0,7Testis Ž – – – – – – – – – – – – – – – – – – –
C63
Drugi in neopredeljeni 
moški spolni organi M 0,4 – – – – – – – – – – 4,2 – 2,0 – – – – 0,0
Other and unspecified Ž – – – – – – – – – – – – – – – – – – –
male genital organs
46
Incid
enca
 ra
ka
 v Sloveniji 2001
O
nkološki inštitut Ljub
lja
na
, Reg
ister ra
ka
 za
 Slovenijo
nadaljevanje / cont’d ➝
Tabela 5. – table 5. Nadaljevanje – continued
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
C64 Ledvica razen meha M 11,5 6,4 – – – – – 1,4 2,5 5,0 14,5 11,3 23,5 16,2 38,3 74,3 66,6 76,5 1,0
Kidney, except renal pelvis Ž 6,1 2,3 – – – – 1,4 4,2 – 2,6 3,9 5,9 13,1 11,0 11,1 21,9 12,4 37,0 0,4
C65 Ledvični meh M 0,6 – – – – – – – – 1,3 1,2 1,4 – – – – 5,5 15,3 0,0
Renal pelvis Ž 1,1 – – – – – – – – – 2,6 – 1,9 1,8 5,6 – 7,4 2,8 0,1
C66 Sečevod M 0,3 – – – – – – – – – – – 2,0 2,0 2,4 – – – 0,0
Ureter Ž 0,3 – – – – – – – – – – – – – 1,9 2,0 – 2,8 0,0
C67 Sečni mehur M 13,9 – – – – – – – – 1,3 4,8 17,0 19,6 30,4 57,4 80,5 127,6 153,1 1,1
Bladder Ž 4,1 – – – – – – – – – 1,3 3,0 1,9 5,5 7,4 19,9 17,3 39,8 0,2
Drugi in neopredeljeni 
sečni organi M 0,1 – – – – – – – – – – – – – – 3,1 – – 0,0
C68 Other and unspecified Ž 0,1 – – – – – – – – – – – – – – 2,0 – – 0,0
urinary organs
C69 Oko in očesni adneksi M 0,5 – – – – – – – 1,3 – – – 2,0 – – 3,1 11,1 – 0,0
Eye and adnexa Ž 0,5 – – – – – – – 1,3 – – 1,5 – – – 2,0 2,5 2,8 0,0
C70 Meninge M 0,1 – – – – – – – – – 1,2 – – – – – – – 0,0
Meninges Ž 0,3 – – – – – – – 1,3 – – – – 1,8 1,9 – – – 0,0
C71 Možgani M 8,1 2,1 2,0 1,6 – 2,6 5,2 2,7 3,8 2,5 13,3 15,5 21,5 12,2 26,3 21,7 27,7 7,7 0,7
Brain Ž 5,1 4,5 2,1 – 1,5 2,7 4,2 4,2 3,9 1,3 7,8 8,9 7,5 3,7 16,7 8,0 7,4 5,7 0,4
Hrbtni mozeg, možganski 
živci in drugi deli CŽS M 0,4 – – – 1,5 – – – 1,3 – 2,4 – – – – – – – 0,0
C72 Spinal cord, cranial nerves Ž 0,1 – – – – – – – – – – – – – – – 2,5 – 0,0
and other parts of CNS
C73 Ščitnica M 2,5 – – 3,2 2,9 – – – 6,3 1,3 2,4 5,7 – 2,0 – 15,5 11,1 – 0,2
Thyroid gland Ž 6,3 – – 3,4 1,5 6,8 1,4 1,4 5,2 3,9 11,7 8,9 7,5 9,2 13,0 14,0 19,8 2,8 0,4
C74 Nadledvična žleza M 0,3 – – – – – – – – – – – – 2,0 4,8 – – – 0,0
Adrenal gland Ž – – – – – – – – – – – – – – – – – – –
C75
Druge endokrine žleze 
in sorodne strukture M – – – – – – – – – – – – – – – – – – –
Other endocrine glands Ž – – – – – – – – – – – – – – – – – – –
and related structures
Druga in slabo 
opredeljena mesta M 0,4 2,1 – – – – – – – – – – 2,0 – – – 5,5 7,7 0,0C76
Other and ill-defined sites Ž 2,6 2,3 – – – – – – – 2,6 – 1,5 – – – 4,0 17,3 37,0 0,1
C77
Metastaza in neopredeljena
maligna neoplazma 
bezgavk M 1,6 – – – – – – – – 1,3 1,2 1,4 7,8 2,0 7,2 6,2 – 23,0 0,1
Metastasis and unspecified Ž 1,7 – – – – – – – – 1,3 – 3,0 1,9 – 3,7 6,0 14,8 5,7 0,1
malignant neoplasm
of lymph nodes
C
a
ncer Incid
ence in Slovenia
 2001
47
Institue of O
ncolog
y Ljub
lja
na
, C
a
ncer Reg
istry of Slovenia
nadaljevanje / cont’d ➝
Tabela 5. – table 5. Nadaljevanje – continued
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
Metastaze dihal in prebavil M 4,9 – – – – – 1,3 – – 1,3 2,4 5,7 11,7 12,2 26,3 9,3 49,9 38,3 0,4
Metastases of respiratory C78
and digestive organs Ž 4,1 – – – – – – – – – 2,6 3,0 3,7 12,9 7,4 12,0 17,3 34,1 0,2
C79 Metastaze, drugje M 1,7 – – – – – – – – – – 1,4 5,9 6,1 7,2 9,3 11,1 15,3 0,1
Metastases of other sites Ž 1,5 – – – – – – – – 3,9 – 1,5 1,9 – – 10,0 4,9 8,5 0,1
Maligna neoplazma brez 
opredeljenega mesta M 4,7 – – – – – – – 1,3 1,3 1,2 11,3 3,9 20,3 12,0 21,7 33,3 38,3 0,4
C80 Malignant neoplasm Ž 3,7 – – – – – 1,4 – – 1,3 – 7,4 3,7 3,7 5,6 14,0 22,3 22,8 0,2
without specification of site
C81 Hodgkinova bolezen M 2,4 – – 1,6 1,5 3,8 10,5 1,4 1,3 1,3 1,2 – – 4,1 2,4 6,2 5,5 – 0,2
Hodgkin's disease Ž 2,7 – – 3,4 3,0 2,7 8,4 – 2,6 2,6 – 1,5 3,7 3,7 3,7 2,0 2,5 8,5 0,2
Folikularni ne-Hodgkinov 
limfom M 2,4 – – – – – – – 2,5 1,3 1,2 4,2 5,9 8,1 4,8 15,5 5,5 7,7 0,2
C82 Follicular non-Hodgkin's Ž 2,7 – – – – – – 1,4 1,3 1,3 3,9 – 7,5 5,5 7,4 6,0 9,9 8,5 0,2
lymphoma
C83 Difuzni ne-Hodgkinov limfom M 6,7 2,1 – 1,6 2,9 3,8 – 4,1 1,3 5,0 7,2 – 9,8 8,1 16,7 27,9 66,6 53,6 0,5
Diffuse non-Hodgkin's lymphoma Ž 5,9 – – 1,7 1,5 – 1,4 1,4 1,3 1,3 3,9 4,4 1,9 7,3 22,2 25,9 27,2 19,9 0,4
Limfomi celic T in kožni 
limfom celic T M 1,1 – – 1,6 – – 1,3 – – – 2,4 1,4 2,0 2,0 – 9,3 5,5 – 0,1
C84 Peripheral and cutaneous Ž 1,1 – – – 1,5 – – 2,8 2,6 – – – – 1,8 3,7 2,0 2,5 2,8 0,1
T-cell lymphomas
C85
Druge in neopredeljene vrste 
ne-Hodgkinovega limfoma M 2,0 – – – – – – – – 2,5 1,2 1,4 2,0 8,1 2,4 9,3 22,2 15,3 0,1
Other and unspecified types Ž 3,0 – – – – – – – – 1,3 1,3 1,5 5,6 1,8 3,7 8,0 14,8 34,1 0,1
of non-Hodgkin's lymphoma
Maligne imunoproliferativne
bolezni M 0,1 – – – – – – – – – – – – – 2,4 – – – 0,0
C88 Malignant immunoproliferative Ž – – – – – – – – – – – – – – – – – – –
diseases
C90
Difuzni plazmocitom 
in maligne 
neoplazme plazmocitov M 3,1 – – – – – 1,3 – – – 2,4 1,4 9,8 8,1 9,6 12,4 27,7 30,6 0,2
Multiple myeloma and Ž 5,2 – – – – – – – – – 3,9 8,9 3,7 7,3 22,2 18,0 22,3 22,8 0,3
malignant plasma cell 
neoplasms
C91.0 Limfatična levkemija, akutna M 1,2 4,3 – 1,6 1,5 2,6 1,3 2,7 1,3 – – – – 2,0 – – – 7,7 0,1
Lymphoblastic leukaemia, acute Ž 1,6 11,4 4,2 3,4 3,0 – – 1,4 1,3 – – – 1,9 – 1,9 2,0 – – 0,2
C91.1 - Limfatična levkemija, druga M 5,4 – – – – – – – 1,3 – 2,4 5,7 7,8 26,4 23,9 18,6 38,8 38,2 0,4
C91.9 Lymphoid leukaemia, other Ž 3,2 – – – – – – – 1,3 – – 3,0 1,9 3,7 12,9 8,0 27,2 17,1 0,1
48
Incid
enca
 ra
ka
 v Sloveniji 2001
O
nkološki inštitut Ljub
lja
na
, Reg
ister ra
ka
 za
 Slovenijo
Tabela 5. – table 5. Nadaljevanje – continued
Šifra Primarna Vse S t a r o s t i KS
MKB lokacija Spol starosti
A g e CR
ICD Primary Sex All
code site ages 0 – 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 – 65 – 70 – 75 – 80 + 0 – 74
C92 Mieloična levkemija M 2,6 2,1 – – – – – 4,1 – – 3,6 – 3,9 4,1 4,8 12,4 11,1 45,9 0,2
Myeloid leukaemia Ž 3,4 2,3 – – – 1,4 – – 2,6 – 2,6 4,4 1,9 1,8 9,3 12,0 19,8 14,2 0,2
C93 Monocitna levkemija M 0,2 – – – – – – – – – – – – – 2,4 – 5,5 – 0,0
Monocytic leukaemia Ž – – – – – – – – – – – – – – – – – – –
C94 Druge opredeljene levkemije M 0,1 – – – – – – – – – – – – 2,0 – – – – 0,0
Other leukaemias Ž 0,2 – – – – – – – – – – 1,5 – – – – – 2,8 0,0
of specified cells
C95
Levkemija z neopredeljenim
celičnim tipom M 0,1 – – – – – – – – – – – – – – 3,1 – – 0,0
Leukaemia, unspecified cell type Ž 0,2 – – – – – – – – – – – – – – 2,0 2,5 – 0,0
Druge in neopredeljene 
maligne neoplazme 
limfatičnega, krvotvornega 
ali sorodnega tkiva M 3,5 – 2,0 – – – – – 1,3 1,3 2,4 1,4 11,7 8,1 12,0 27,9 11,1 15,3 0,3C96
Other and unspecified malignant Ž 4,5 – – – – – – 1,4 1,3 – 1,3 4,4 3,7 3,7 11,1 27,9 22,3 19,9 0,3
neoplasms of lymphoid, 
haematopoietic and related tissue
Zgoraj neupoštevani
Not included above
D03 Melanom, in situ M 1,2 – – – – – – – – – 1,2 7,1 2,0 6,1 2,4 3,1 – – 0,1
Melanoma, in situ Ž 1,2 – – – – 1,4 – – 1,3 1,3 2,6 – 3,7 3,7 1,9 – 2,5 2,8 0,1
D05 Dojka, in situ M 0,1 – – – – – – – – 1,3 – – – – – – – – 0,0
Breast, in situ Ž 5,9 – – – – – 1,4 1,4 1,3 5,2 20,8 13,3 5,6 12,9 5,6 16,0 12,4 5,7 0,4
D06 Maternični vrat, in situ (CIN III) M – – – – – – – – – – – – – – – – – – –
Cervix uteri, in situ (CIN III) Ž 85,2 – – – 1,5 91,6 189,7 256,8 237,4 190,1 114,4 38,5 26,2 23,9 11,1 8,0 – 2,8 5,9
D09.0 Karcinom in situ mehurja M 3,3 – – – – – – 1,4 1,3 – – 4,2 3,9 14,2 14,4 15,5 22,2 23 0,3
Bladder, in situ Ž 2,1 – – – – – – – – – 1,3 3,0 7,5 3,7 9,3 4,0 9,9 2,8 0,1
D32.0 Meninge, benigna neoplazma M 1,8 – – – 1,5 – – 2,7 – – 1,2 2,8 – – 9,6 9,3 22,2 7,7 0,1
Benign neoplasm of meninges Ž 4,6 – – – – – – – – 5,2 5,2 13,3 11,2 5,5 16,7 14,0 12,4 – 0,4
D33.0 - Možgani, benigna neoplazma M – – – – – – – – – – – – – – – – – – –
D33.2 Benign neoplasm of brain Ž 0,1 – – – – – – – 1,3 – – – – – – – – – 0,0
D39.1 Jajčnik, neopl. negotovega značaja M – – – – – – – – – – – – – – – – – – –
Ovary, neopl. Ž 3,1 – – – 1,5 2,7 – 2,8 – 5,2 9,1 5,9 5,6 1,8 5,6 2,0 4,9 5,7 0,2
of uncertain behavior
D43.0 - Možgani, neopredeljeno M 0,8 – – – – – – – – – 2,4 – – 2,0 – 12,4 5,5 – 0,1
D43.2 Brain, uncertain or unknown Ž 0,5 – – – – 1,4 – – – – – – – – 1,9 2,0 – 5,7 0,0
C
a
ncer Incid
ence in Slovenia
 2001
49
Institue of O
ncolog
y Ljub
lja
na
, C
a
ncer Reg
istry of Slovenia
Tabela 6a. Število novih primerov raka po zdravstvenih regijah, po najpogostejših lokacijah in spolu - 
Slovenija 2001
Table 6a. Number of new cancer cases by health regions, by most frequent sites and sex - Slovenia 2001
Zdravstvena Spol Skupaj Lokacija (šifre MKB-10) Druga
regija C00-C96 C16 C18 C19 C20 C34 C44 C50 C53 C54 C61
Other
D06*
Health region Sex All sites Site (ICD-10 code)
Slovenija, skupaj M 4565 288 333 59 231 750 602 10 – – 449 1843 –
Slovenia, total Ž 4493 177 287 48 152 254 644 964 201 295 – 1471 868
Celje
M 652 36 51 7 33 110 42 – – – 97 276 –
Ž 630 25 32 4 16 41 55 138 50 50 – 219 185
Nova Gorica
M 263 17 20 5 16 28 37 – – – 27 113 –
Ž 221 9 13 1 8 15 32 57 6 12 – 68 41
Koper
M 284 16 26 3 17 50 33 – – – 14 125 –
Ž 316 9 23 6 15 17 35 75 13 16 – 107 86
Kranj
M 449 24 35 3 22 76 67 1 – – 47 174 –
Ž 469 14 27 2 14 23 73 89 19 35 – 173 115
Ljubljana
M 1396 72 79 13 65 232 252 6 – – 116 561 –
Ž 1482 52 94 19 34 78 245 346 58 92 – 464 254
Mestna občina M 791 33 41 8 34 122 179 2 – – 66 306 –
Ljubljana Ž 897 29 57 10 22 48 142 219 33 54 – 283 147
Maribor
M 715 58 59 7 31 110 62 2 – – 75 311 –
Ž 689 35 56 10 33 40 62 147 31 51 – 224 86
Mariborske občine
M 437 26 37 4 19 77 45 1 – – 45 183 –
Ž 428 13 36 5 24 24 44 95 21 31 – 135 66
Murska Sobota
M 322 27 31 4 17 63 43 – – – 40 97 –
Ž 290 19 15 2 14 18 63 44 5 16 – 94 30
Novo mesto
M 312 28 22 10 22 46 35 1 – – 20 128 –
Ž 254 8 20 2 14 12 40 46 12 16 – 84 49
Ravne
M 172 10 10 7 8 35 31 – – – 13 58 –
Ž 142 6 7 2 4 10 39 22 7 7 – 38 22
Opis šifer MKB
Description of the ICD code
* Neupoštevano v skupnem številu: D06 - Maternični vrat, in situ (CIN III)
Not included in All sites: D06 - Cervix uteri, in situ (CIN III)
50 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
C16 Želodec
Stomach
C18 Debelo črevo
Colon
C19 Rektosigmoidna zveza
Rectosigmoid junction
C20 Rektum
Rectum
C34 Sapnica in pljuča
Bronchus and lung
C44 Druge maligne neoplazme kože
Skin, other malignomas
C50 Dojka
Breast
C53 Maternični vrat
Cervix uteri
C54 Maternično telo
Corpus uteri
C61 Prostata
Prostate
Tabela 6b. Starostno standardizirana* incidenca raka po zdravstvenih regijah, po najpogostejših
lokacijah in spolu - Slovenija 2001
Table 6b. Age standardised* cancer incidence rate by health regions, by most frequent sites and sex - Slovenia 2001
Zdravstvena Spol Skupaj Lokacija (šifre MKB-10) Druga
regija C00-C96 C16 C18 C19 C20 C34 C44 C50 C53 C54 C61
Other
D06**
Health region Sex All sites Site (ICD-10 code)
Slovenija, skupaj M 461,8 29,3 19,8 6,0 23,4 75,9 61,2 1,0 0,0 0,0 45,7 185,6 0,0
Slovenia, total Ž 337,0 11,7 19,8 3,2 10,4 19,7 43,2 78,4 19,0 23,1 108,7 88,0 0,0
Celje
M 454,4 25,4 36,0 4,9 23,1 76,7 29,5 0,0 0,0 0,0 68,5 189,1 0,0
Ž 333,0 10,3 15,3 1,3 8,6 22,2 25,3 80,2 31,3 27,7 0,0 110,8 124,9
Nova Gorica
M 462,1 29,7 35,7 9,2 28,9 49,8 60,5 0,0 0,0 0,0 47,8 200,6 0,0
Ž 321,5 11,7 16,2 0,7 8,7 22,5 38,7 97,6 10,1 19,3 0,0 98,2 85,1
Koper
M 367,3 19,9 33,9 4,1 21,9 65,1 42,0 0,0 0,0 0,0 17,3 163,1 0,0
Ž 328,9 9,2 20,6 4,0 15,0 18,2 34,3 84,4 17,6 16,9 0,0 108,6 125,1
Kranj
M 469,0 26,2 36,5 3,2 22,9 79,7 69,6 1,0 0,0 0,0 49,2 180,8 0,0
Ž 364,5 10,1 20,3 0,9 10,7 18,3 52,6 72,4 18,4 29,9 0,0 132,6 117,9
Ljubljana
M 468,8 24,3 26,4 4,4 21,9 78,1 84,8 2,0 0,0 0,0 39,3 187,6 0,0
Ž 364,0 11,9 21,5 4,7 6,9 19,1 53,4 92,2 18,2 23,1 0,0 113,1 84,2
Mestna občina M 471,1 19,6 24,5 4,8 20,5 73,0 106,2 1,2 0,0 0,0 39,0 182,4 0,0
Ljubljana Ž 388,9 11,8 23,1 4,1 7,9 20,4 56,2 101,3 18,6 23,6 0,0 121,9 89,3
Maribor
M 447,0 36,5 38,0 4,4 19,4 67,7 39,7 1,2 0,0 0,0 47,4 192,6 0,0
Ž 314,1 14,1 23,7 4,2 14,6 18,5 25,2 70,8 17,7 23,2 0,0 102,2 54,1
Mariborske občine
M 455,4 27,3 38,9 4,2 20,0 79,6 47,5 1,0 0,0 0,0 46,9 190,1 0,0
Ž 336,8 8,4 26,2 4,2 17,7 18,1 31,2 76,7 21,1 25,1 0,0 108,2 73,3
Murska Sobota
M 531,0 44,9 50,4 6,9 29,1 105,5 71,2 0,0 0,0 0,0 64,1 158,9 0,0
Ž 331,9 18,1 13,9 2,2 12,7 23,7 68,9 56,6 7,2 19,9 0,0 108,7 48,7
Novo mesto
M 503,4 45,9 35,5 17,0 35,6 74,0 57,8 1,5 0,0 0,0 34,3 201,5 0,0
Ž 292,7 8,9 21,9 2,8 15,6 15,9 38,4 56,9 18,6 21,5 0,0 92,3 76,2
Ravne
M 489,1 28,1 30,1 19,7 23,4 99,0 89,3 0,0 0,0 0,0 39,7 159,8 0,0
Ž 295,8 13,5 14,8 3,8 7,4 23,5 75,0 50,5 17,5 12,8 0,0 77,0 59,2
* standard - prebivalstvo Slovenije po popisu 2002
standard - population of Slovenia according to census 2002
Opis šifer MKB 
Description of the ICD code
** Neupoštevano v skupnem številu: D06 - Maternični vrat, in situ (CIN III)
Not included in All sites: D06 - Cervix uteri, in situ (CIN III)
C16 Želodec
Stomach
C18 Debelo črevo
Colon
C19 Rektosigmoidna zveza
Rectosigmoid junction
C20 Rektum
Rectum
C34 Sapnica in pljuča
Bronchus and lung
C44 Druge maligne neoplazme kože
Skin, other malignomas
C50 Dojka
Breast
C53 Maternični vrat
Cervix uteri
C54 Maternično telo
Corpus uteri
C61 Prostata
Prostate
Cancer Incidence in Slovenia 2001 51
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
52 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 7. Število novih primerov raka, ugotovljenih v bolnišnicah, ter število in odstotek mikroskopsko
potrjenih primerov, po lokaciji in spolu - Slovenija 2001
Table 7. Total number of new cancer cases diagnosed in hospitals and number and percentage 
of microscopically confirmed cases - by site and sex - Slovenia 2001
Šifra Število novih Mikroskopsko
MKB Primarna lokacija Spol primerov potrjeni
primeri
Število Odstotek*
ICD Number of Microscopically  
code Primary site Sex new cases confirmed cases
Number Per cent*
C00 Vse lokacije M+Ž 8909 8318 93
– M 4504 4187 93
C96 All sites Ž 4405 4131 94
C00 Ustnica M 13 13
Lip Ž 6 6
C01 Baza jezika M 16 16 100
Base of tongue Ž 3 3
C02 Jezik, drugi deli M 29 29 100
Tongue, other & unspecified parts Ž 6 6
C03 Dlesen M 1 1
Gum Ž 5 5
C04 Ustno dno M 34 34 100
Floor of mouth Ž 2 2
C05 Nebo M 14 14
Palate Ž 2 2
C06 Usta, drugi deli M 15 15 100
Mouth, other & unspecified parts Ž 2 2
C07 Parotidna žleza M 2 2
Parotid gland Ž 5 5
C08 Druge in neopredeljene velike žleze slinavke M – –
Other & unspecified major salivary glands Ž 2 2
C09 Tonzila M 36 36 100
Tonsil Ž 9 9
C10 Orofarinks M 42 41 98
Oropharynx Ž 3 3
C11 Nazofarinks M 8 8
Nasopharynx Ž 1 1
C12 Piriformni sinus M 29 28 97
Pyriform sinus Ž 1 1
C13 Hipofarinks M 22 22 100
Hypopharynx Ž 3 3
C14
Druga in slabo opredeljena mesta 
na ustnici, v ustni votlini in farinksu M 1 1
Other and ill-defined sites in the lip, Ž – –
oral cavity and pharynx
Cancer Incidence in Slovenia 2001 53
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
nadaljevanje / cont’d ➝
Tabela 7. – table 7. Nadaljevanje – continued
Šifra Število novih Mikroskopsko
MKB Primarna lokacija Spol primerov potrjeni
primeri
Število Odstotek*
ICD Number of Microscopically  
code Primary site Sex new cases confirmed cases
Number Per cent*
C15 Požiralnik M 78 74 95
Oesophagus Ž 15 14 93
C16 Želodec M 278 264 95
Stomach Ž 165 154 93
C17 Tanko črevo M 6 6
Small intestine Ž 5 4
C18 Debelo črevo M 328 317 97
Colon Ž 276 263 95
C19 Rektosigmoidna zveza M 59 56 95
Rectosigmoid junction Ž 48 46 96
C20 Rektum M 229 222 97
Rectum Ž 152 147 97
C21 Anus in analni kanal M 7 7
Anus and anal canal Ž 8 8
C22 Jetra in intrahepatični vodi M 69 53 77
Liver and intrahepatic bile ducts Ž 32 19 59
C23 Žolčnik M 14 11
Gallbladder Ž 43 28 65
C24 Drugi in neopredeljeni deli biliarnega trakta M 37 20 54
Billiary tract, other and unspecified parts Ž 31 16 52
C25 Trebušna slinavka M 126 70 56
Pancreas Ž 111 61 55
C26
Druga in slabo opredeljena mesta 
v prebavnih organih
M 1 1
Other and ill-defined digestive organs Ž 5 2
C30 Nosna votlina in srednje uho M 8 8
Nasal cavity and middle ear Ž 4 4
C31 Obnosni sinusi M 12 11
Accessory sinuses Ž 5 5
C32 Grlo M 111 110 99
Larynx Ž 12 12
C33 Sapnik M 5 5
Trachea Ž 1 1
C34 Sapnica in pljuča M 742 691 93
Bronchus and lung Ž 248 228 92
C37 Timus M 2 2
Thymus Ž 2 2
C38 Srce, mediastinum, plevra M 3 2
Heart, mediastinum, pleura Ž 2 2
54 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 7. – table 7. Nadaljevanje – continued
Šifra Število novih Mikroskopsko
MKB Primarna lokacija Spol primerov potrjeni
primeri
Število Odstotek*
ICD Number of Microscopically  
code Primary site Sex new cases confirmed cases
Number Per cent*
C39
Druga in slabo opredeljena mesta 
v dihalih in prsnih organih M – –
Other and ill-defined sites in the respiratory Ž – –
system and intrathoracic organs
C40 Kosti, sklepni hrustanec udov M 4 4
Bone and articular cartilage of limbs Ž 7 7
C41
Kosti, sklepni hrustanec, drugje M 4 4
Bone and articular cartilage Ž 1 1of other and unspecified parts
C43 Maligni melanom kože M 121 121 100
Malignant melanoma of skin Ž 141 141 100
C44 Druge maligne neoplazme kože M 602 590 98
Skin, other malignomas Ž 642 628 98
C45 Mezoteliom M 15 15 100
Mesothelioma Ž 12 11
C46 Kaposijev sarkom M 1 1
Kaposi's sarcoma Ž – –
C47 Periferni živci in avtonomno živčevje M 2 2
Peripheral nerves and autonomic nervous system Ž 2 2
C48 Retro- in peritonej M 8 8
Retro- and peritoneum Ž 7 7
C49 Drugo vezivno in mehko tkivo M 22 22 100
Other connective and soft tissue Ž 13 13
C50 Dojka M 10 10
Breast Ž 948 920 97
C51 Žensko zunanje spolovilo M – –
Vulva Ž 32 32 100
C52 Nožnica M – –
Vagina Ž 8 8
C53 Maternični vrat M – –
Cervix uteri Ž 199 198 99
C54 Maternično telo M – –
Corpus uteri Ž 294 293 100
C55 Maternica, neopredeljeno M – –
Uterus, unspecified Ž 6 5
C56 Jajčnik M – –
Ovary Ž 162 156 96
C57 Drugi in neopredeljeni ženski spolni organi M – –
Other and unspecified parts of female genital organs Ž 10 10
Cancer Incidence in Slovenia 2001 55
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
nadaljevanje / cont’d ➝
Tabela 7. – table 7. Nadaljevanje – continued
Šifra Število novih Mikroskopsko
MKB Primarna lokacija Spol primerov potrjeni
primeri
Število Odstotek*
ICD Number of Microscopically  
code Primary site Sex new cases confirmed cases
Number Per cent*
C58 Posteljica M – –
Placenta Ž – –
C60 Penis M 7 7
Penis Ž – –
C61 Prostata M 434 395 91
Prostate Ž – –
C62 Modo M 99 99 100
Testis Ž – –
C63 Drugi in neopredeljeni moški spolni organi M 4 4
Other and unspecified male genital organs Ž – –
C64 Ledvica razen meha M 109 92 84
Kidney, except renal pelvis Ž 62 51 82
C65 Ledvični meh M 6 4
Renal pelvis Ž 11 11
C66 Sečevod M 3 3
Ureter Ž 3 3
C67 Sečni mehur M 135 132 98
Bladder Ž 39 38 97
C68 Drugi in neopredeljeni sečni organi M 1 1
Other and unspecified urinary organs Ž 1 1
C69 Oko in očesni adneksi M 5 5
Eye and adnexa Ž 5 5
C70 Meninge M 1 1
Meninges Ž 3 3
C71 Možgani M 79 69 87
Brain Ž 52 43 83
C72 Hrbtni mozeg, možganski živci in drugi deli CŽS M 4 4
Spinal cord, cranial nerves and other parts of CNS Ž 1 –
C73 Ščitnica M 24 24 100
Thyroid gland Ž 63 63 100
C74 Nadledvična žleza M 3 3
Adrenal gland Ž – –
C75 Druge endokrine žleze in sorodne strukture M – –
Other endocrine glands and related structures Ž – –
C76 Druga in slabo opredeljena mesta M 4 3
Other and ill-defined sites Ž 18 7 39
C77
Metastaza in neopredeljena 
maligna neoplazma bezgavk M 16 16 100
Metastasis and unspecified Ž 17 15 88
malignant neoplasm of lymph nodes
56 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Tabela 7. – table 7. Nadaljevanje – continued
Šifra Število novih Mikroskopsko
MKB Primarna lokacija Spol primerov potrjeni
primeri
Število Odstotek*
ICD Number of Microscopically  
code Primary site Sex new cases confirmed cases
Number Per cent*
C78 Metastaze dihal in prebavil M 47 26 55
Metastases of respiratory and digestive organs Ž 42 22 52
C79 Metastaze, drugje M 16 7 44
Metastases of other sites Ž 15 8 53
C80 Maligna neoplazma brez opredeljenega mesta M 43 28 65
Malignant neoplasm without specification of site Ž 32 22 69
C81 Hodgkinova bolezen M 23 23 100
Hodgkin's disease Ž 28 28 100
C82 Folikularni ne-Hodgkinov limfom M 23 23 100
Follicular non-Hodgkin's lymphoma Ž 27 27 100
C83 Difuzni ne-Hodgkinov limfom M 65 65 100
Diffuse non-Hodgkin's lymphoma Ž 60 60 100
C84 Limfomi celic T in kožni limfom celic T M 11 11
Peripheral and cutaneous T-cell lymphomas Ž 11 11
C85
Druge in neopredeljene vrste 
ne-Hodgkinovega limfoma
M 19 19 100
Other and unspecified types of non-Hodgkin's lymphoma Ž 31 31 100
C88 Maligne imunoproliferativne bolezni M 1 1
Malignant immunoproliferative diseases Ž – –
C90
Difuzni plazmocitom in maligne 
neoplazme plazmocitov
M 30 29 97
Multiple myeloma and malignant plasma cell neoplasms Ž 52 51 98
C91.0 Limfatična levkemija, akutna M 12 12
Lymphoblastic leukaemia, acute Ž 16 16 100
C91.1 - Limfatična levkemija, druga M 51 51 100
C91.9 Lymphoid leukaemia, other Ž 33 33 100
C92 Mieloična levkemija M 25 25 100
Myeloid leukaemia Ž 35 35 100
C93 Monocitna levkemija M 2 2
Monocytic leukaemia Ž – –
C94 Druge opredeljene levkemije M 1 1
Other leukaemias of specified cells Ž 2 2
C95 Levkemija z neopredeljenim celičnim tipom M 1 1
Leukaemia, unspecified cell type Ž 1 1
C96
Druge in neopredeljene maligne neoplazme 
limfatičnega, krvotvornega ali sorodnega tkiva M 34 34 100
Other and unspecified malignant neoplasms Ž 46 46 100
of lymphoid, haematopoietic and related tissue
Tabela 7. – table 7. Nadaljevanje – continued
Šifra Število novih Mikroskopsko
MKB Primarna lokacija Spol primerov potrjeni
primeri
Število Odstotek*
ICD Number of Microscopically  
code Primary site Sex new cases confirmed cases
Number Per cent*
Zgoraj neupoštevani
Not included above
D03 Melanom, in situ M 12 12
Melanoma, in situ Ž 12 12
D05 Dojka, in situ M 1 1
Breast, in situ Ž 60 60 100
D06 Maternični vrat, in situ (CIN III) M – –
Cervix uteri, in situ (CIN III) Ž 868 868 100
D09.0 Karcinom in situ mehurja M 32 32 100
Bladder, in situ Ž 21 21 100
D32.0 Meninge, benigna neoplazma M 18 16 89
Benign neoplasm of meninges Ž 47 46 98
D33.0 Možgani, benigna neoplazma M – –
- D33.2 Benign neopasm of brain Ž 1 1
D39.1 Jajčnik, neopl. negotovega značaja M – –
Ovary, neopl. of uncertain behavior Ž 32 32 100
D43.0 Možgani, neopredeljeno M 8 –
-D43.2 Brain, uncertain or unknown Ž 5 1
* Odstotki niso računani pri številih pod 15
Percentages are not calculated for less than 15 cases
Cancer Incidence in Slovenia 2001 57
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 8. Število histološko (in citološko) potrjenih novih primerov raka po histološki vrsti in lokaciji - 
Slovenija 2001
Table 8. Number of histologically (and cytologically) confirmed new cancer cases by histologic type and site -
Slovenia 2001
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C00 C01 C02 C03 C04 C05 C06 C07 C08 C09
Vse vrste/ All Types 7361 957 17 2 19 – 35 – 6 – 35 1 15 1 16 1 7 – 2 – 43 2
Small cell carcinoma 116 62 – – – – – – – – – – – – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 17 2 18 – 33 – 6 – 35 1 14 1 13 – – – – – 41 2
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 – – 1 – – – – – – – 1 – 2 – 4 – 2 – 1 –
Other specified carcinomas 148 18 – – – – – – – – – – – – 1 – 3 – – – – –
Carcinoma, unspecified 225 171 – – – – 2 – – – – – – – – 1 – – – – – –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – – – – – – – 1 –
Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – – – – – – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – – – – – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – – – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – – – – – – – – – – –
Malignant complex mixed 26 – – – – – – – – – – – – – – – – – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – – – – – – – – – – – – – – – – – – –
58 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
nadaljevanje / cont’d ➝
Cancer Incidence in Slovenia 2001 59
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C10 C11 C12 C13 C14 C15 C16 C17 C18 C19
Vse vrste/ All Types 7361 957 44 – 9 – 29 – 25 – 1 – 85 3 411 7 10 – 576 4 102 –
Small cell carcinoma 116 62 – – – – – – – – – – – – – – – – 1 – 1 –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 44 – 8 – 28 – 24 – – – 63 3 1 – – – – – – –
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 – – 1 – – – – – 1 – 9 – 387 2 9 – 563 2 99 –
Other specified carcinomas 148 18 – – – – – – 1 – – – 3 – – – – – 3 – – –
Carcinoma, unspecified 225 171 – – – – 1 – – – – – 9 – 15 5 – – 9 1 2 –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – – – – – – – – –
Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – – – – – – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – 1 – – – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – – – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – 1 – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – – – – – – – – – – –
Malignant complex mixed 26 – – – – – – – – – – – – – 5 – 1 – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – – – – – – – – – 1 – 1 – – – – 1 – –
60 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C20 C21 C22 C23 C24 C25 C26 C30 C31 C32
Vse vrste/ All Types 7361 957 365 4 15 – 55 17 37 2 35 1 102 29 2 1 12 – 15 1 121 1
Small cell carcinoma 116 62 – – – – – – – – – – 1 – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 – – 3 – – – – – – – – – – – 5 – 6 – 114 1
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 352 2 9 – 54 16 31 1 33 1 92 21 2 – 2 – 4 – 1 –
Other specified carcinomas 148 18 1 – – – – – 1 – – – 2 – – – – – 1 – 2 –
Carcinoma, unspecified 225 171 12 1 2 – 1 1 4 1 2 – 6 7 – 1 1 – – – 2 –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – – – 3 – 1 – – –
Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – – – – 1 – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – – – – – 1 – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – – – – – – – – 1 – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – – 1 – – – 1 –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – – – – – – – – – – –
Malignant complex mixed 26 – – – – – – – – – – – – – – – – – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – 1 1 – – – 1 – – – 1 1 – – – – 1 – 1 –
nadaljevanje / cont’d ➝
Cancer Incidence in Slovenia 2001 61
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C33 C34 C37 C38 C39 C40 C41 C43 C44 C45
Vse vrste/ All Types 7361 957 4 2 568 351 4 – 2 2 – – 11 – 4 1 260 2 1164 54 22 4
Small cell carcinoma 116 62 2 – 107 60 – – – – – – – – – – – – – – – –
Non-small cell carcinoma 23 28 1 – 22 27 – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 – 2 210 104 – – – – – – – – – – – – 203 10 – –
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – 941 43 – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 1 – 167 131 – – – – – – – – – – – – 9 – – –
Other specified carcinomas 148 18 – – 41 12 – – – – – – – – – – – – 1 – – –
Carcinoma, unspecified 225 171 – – 18 15 – – – – – – – – – – – – 5 1 – –
Malignant thymoma 4 – – – – – 4 – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – – – 260 2 – – – –
Fibrosarcoma 4 – – – 1 – – – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – 1 – – – – – 3 – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – – – – – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – 1 – – – – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – 1 – – – – – – – 2 – 1 1 – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – 7 – 3 – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – 1 – – – – – – – – –
Malignant complex mixed 26 – – – – – – – – – – – – – – – – – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – 22 4
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – 1 – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – 1 – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – 1 2 – – 1 – – – – – – – – – 2 – – –
62 Incidenca raka v Sloveniji 2001
nadaljevanje / cont’d ➝ 
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C46 C47 C48 C49 C50 C51 C52 C53 C54 C55
Vse vrste/ All Types 7361 957 1 – 4 – 15 – 33 2 807 123 32 – 8 – 198 – 293 – 5 –
Small cell carcinoma 116 62 – – – – – – – – – – – – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 – – – – – – – – – – 29 – 6 – 155 – – – – –
Basal cell carcinoma 943 43 – – – – – – – – – – 2 – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 – – – – – – – – 788 21 – – 1 – 28 – 223 – 2 –
Other specified carcinomas 148 18 – – – – – – – – 2 – – – – – 12 – 63 – – –
Carcinoma, unspecified 225 171 – – – – – – – – 13 102 – – 1 – 2 – – – – –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – – – – – – – – –
Fibrosarcoma 4 – – – – – – – 1 – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – 6 – 1 – – – – – – – – – – –
Liposarcoma 7 1 – – – – 4 – 2 1 – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – 4 – 10 – – – – – – – 1 – 1 – 1 –
Rhabdomyosarcoma 6 2 – – – – 1 – 3 – – – 1 – – – – – – – – –
Synovial sarcoma 5 – – – – – – – 5 – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – 1 – – – – – – – – – – – –
Kaposi sarcoma 1 – 1 – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – 1 – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – 1 – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – 1 – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – 3 – – – – – – – – – – – – –
Malignant complex mixed 26 – – – – – 1 – – – 1 – – – – – – – 6 – 2 –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – 1 – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – 2 – – – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – 1 – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – 4 – 1 – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – – – 1 – – – 1 – – – – – – – – – – –
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝
Cancer Incidence in Slovenia 2001 63
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C56 C57 C58 C60 C61 C62 C63 C64 C65 C66
Vse vrste/ All Types 7361 957 147 9 9 1 – – 7 – 375 20 99 – 4 – 130 13 13 2 6 –
Small cell carcinoma 116 62 – – – – – – – – – – – – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 – – 1 – – – 7 – – – – – 3 – – – 1 – – –
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – 1 – – – – – – – 12 2 6 –
Adenocarcinoma 3546 251 131 8 6 1 – – – – 273 6 – – – – 123 11 – – – –
Other specified carcinomas 148 18 2 – 1 – – – – – 1 – – – – – – – – – – –
Carcinoma, unspecified 225 171 4 1 – – – – – – 100 14 – – – – – 2 – – – –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – 1 – – – – – – –
Fibrosarcoma 4 – 1 – – – – – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – – – – – – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – 1 – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – – – 1 – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – 1 – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – – – – – – – – – – –
Malignant complex mixed 26 – 4 – – – – – – – – – – – – – 4 – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – 1 – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – 45 – – – – – – – – –
Other malignant germ cell 46 – 3 – – – – – – – – – 39 – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – 14 – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 1 – 1 – – – – – – – – – – – 1 – – – – –
64 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C67 C68 C69 C70 C71 C72 C73 C74 C75 C76
Vse vrste/ All Types 7361 957 167 3 2 – 10 – 4 – 110 2 4 – 82 5 1 2 – – 9 1
Small cell carcinoma 116 62 1 – – – – – – – – – – – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 4 – – – 1 – – – – – – – – – – – – – 1 –
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 155 2 2 – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 4 – – – – – – – – – – – 77 1 – 1 – – 2 1
Other specified carcinomas 148 18 2 – – – – – – – – – – – 2 4 – 1 – – – –
Carcinoma, unspecified 225 171 1 1 – – – – – – – – – – 1 – – – – – 2 –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – 1 – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – 9 – – – – – – – – – – – – – 1 –
Fibrosarcoma 4 – – – – – – – – – 1 – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – – – – – – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – – – – – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – – – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – 2 – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – 1 – – – – – – – – – – – – –
Malignant complex mixed 26 – – – – – – – – – – – – – – – – – – – 1 –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – – – – – – – – – – – – – 1 –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – 109 2 4 – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – 2 – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – – – – – 1 – – – – – – – – – – – 1 –
nadaljevanje / cont’d ➝
Cancer Incidence in Slovenia 2001 65
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C77 C78 C79 C80 C81 C82 C83 C84 C85 C88
Vse vrste/ All Types 7361 957 24 7 28 20 10 5 28 22 45 6 46 4 107 18 18 4 21 29 – 1
Small cell carcinoma 116 62 – – 1 – – – 2 2 – – – – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – 1 – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 13 2 – 1 – – 2 1 – – – – – – – – – – – –
Basal cell carcinoma 943 43 – – – – – – – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 6 3 23 11 6 1 16 10 – – – – – – – – – – – –
Other specified carcinomas 148 18 1 – 1 – 1 – – 1 – – – – – – – – – – – –
Carcinoma, unspecified 225 171 2 2 2 6 2 3 4 6 – – – – – – – – – – – –
Malignant thymoma 4 – – – – – – – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 1 – – – – – 2 – – – – – – – – – – – – –
Fibrosarcoma 4 – – – – – – – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – – – – – – – –
Liposarcoma 7 1 – – – – – – – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – 1 – – – – – – – – – – – – – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – – – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – – – – – – – – – – –
Malignant complex mixed 26 – 1 – – – – – – – – – – – – – – – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – 46 4 107 18 18 4 21 29 – 1
Hodgkin lymphoma 45 6 – – – – – – – – 45 6 – – – – – – – – – –
Plasma cell tumors 45 35 – – – – – – – – – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – – – – – – – – – – – – – – – – – – –
Leukemia except chronic 77 29 – – – – – – – – – – – – – – – – – – – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – – – – – – – – –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – – – – – – – – –
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – – – – – – – – –
Other specified malignant tumors – – – – – – – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – – 2 1 1 2 1 – – – – – – – – – – – –
66 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Tabela 8. – table 8. Nadaljevanje – continued
Histološka vrsta Skupaj L o k a c i j a  ( š i f r a  M K B )
Histologic type All sites S i t e  ( I C D  c o d e )
C90 C91 C92 C93 C94 C95 C96
Vse vrste/ All Types 7361 957 45 35 65 47 46 14 2 – 2 1 1 1 13 67
Small cell carcinoma 116 62 – – – – – – – – – – – – – –
Non-small cell carcinoma 23 28 – – – – – – – – – – – – – –
Squamous cell carcinoma 1109 130 – – – – – – – – – – – – – –
Basal cell carcinoma 943 43 – – – – – – – – – – – – – –
Transitional cell carcinoma 176 4 – – – – – – – – – – – – – –
Adenocarcinoma 3546 251 – – – – – – – – – – – – – –
Other specified carcinomas 148 18 – – – – – – – – – – – – – –
Carcinoma, unspecified 225 171 – – – – – – – – – – – – – –
Malignant thymoma 4 – – – – – – – – – – – – – – –
Malignant paraganglioma 1 – – – – – – – – – – – – – – –
/pheochromocytoma
Malignant melanoma 279 2 – – – – – – – – – – – – – –
Fibrosarcoma 4 – – – – – – – – – – – – – – –
Fibrohistiocytic sarcoma 12 – – – – – – – – – – – – – – –
Liposarcoma 7 1 – – – – – – – – – – – – – –
Leiomyosarcoma 21 – – – – – – – – – – – – – – –
Rhabdomyosarcoma 6 2 – – – – – – – – – – – – – –
Synovial sarcoma 5 – – – – – – – – – – – – – – –
Angiosarcoma 2 1 – – – – – – – – – – – – – –
Kaposi sarcoma 1 – – – – – – – – – – – – – – –
Osteosarcoma 5 1 – – – – – – – – – – – – – –
Chondrosarcoma 13 – – – – – – – – – – – – – – –
Ewing sarcoma/PNET 1 – – – – – – – – – – – – – – –
Other specified sarcomas 1 – – – – – – – – – – – – – – –
Sarcoma, unspecified 5 – – – – – – – – – – – – – – –
Malignant complex mixed 26 – – – – – – – – – – – – – – –
and stromal tumors
Malignat fibroepithelial tumors 1 – – – – – – – – – – – – – – –
Malignant mesothelioma 22 4 – – – – – – – – – – – – – –
Malignant gonadal stromal 1 – – – – – – – – – – – – – – –
tumors
Dysgerminoma and seminoma 45 1 – – – – – – – – – – – – – –
Other malignant germ cell 46 – – – – – – – – – – – – – – –
tumors
Malignant trophoblastic tumors 14 – – – – – – – – – – – – – – –
Malignant gliomas 113 2 – – – – – – – – – – – – – –
Malignant neuroepithelial 1 – – – – – – – – – – – – – – –
tumors
Malignant meningioma 2 – – – – – – – – – – – – – – –
Malignant nerve sheath tumors 5 – – – – – – – – – – – – – – –
Non Hodgkin lymphoma 192 56 – – – – – – – – – – – – – –
Hodgkin lymphoma 45 6 – – – – – – – – – – – – – –
Plasma cell tumors 45 35 45 35 – – – – – – – – – – – –
Chronic lymphoid leukemia 39 34 – – 39 34 – – – – – – – – – –
Leukemia except chronic 77 29 – – 26 13 46 14 2 – 2 1 1 1 – –
lymphoid
Other lymphoreticular 2 – – – – – – – – – – – – – 2 –
neoplasms
Chronic myeloproliferative 6 37 – – – – – – – – – – – – 6 37
diseases
Myelodysplastic syndromes 5 30 – – – – – – – – – – – – 5 30
Other specified malignant tumors – – – – – – – – – – – – – – – –
Malignant tumor, unspecified 21 9 – – – – – – – – – – – – – –
Cancer Incidence in Slovenia 2001 67
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 9. Število primerov ne-Hodgkinovih limfomov* po lokaciji (MKB-8), spolu in starosti - Slovenija 2001
Table 9. Total number of non-Hodgkin's lymphomas* by site (ICD-8), sex, and age - Slovenia 2001
Šifra Vse S t a r o s t i
MKB Lokacija Spol starosti
A g e
ICD Site Sex All
code ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80+
Skupaj 247 1 – 3 4 3 2 7 7 10 17 9 18 22 30 41 40 33
Vse lokacije TotalMoški 118 1 – 2 2 3 1 3 3 7 10 5 10 13 10 20 18 10
All sites MaleŽenske 129 – – 1 2 – 1 4 4 3 7 4 8 9 20 21 22 23
Female
141 Jezik M 1 – – – – – – – – 1 – – – – – – – –Tongue Ž – – – – – – – – – – – – – – – – – –
142 Slinavke M – – – – – – – – – – – – – – – – – –Salivary glands Ž 4 – – – – – – – – – – – – 1 1 1 – 1
146 Orofarinks M 4 – – – – – – – – 1 – – – – 1 1 – 1Oropharynx Ž 2 – – – – – – – – – 1 – 1 – – – – –
147 Epifarinks M 3 – – – – – – – 1 1 1 – – – – – – –Epipharynx Ž – – – – – – – – – – – – – – – – – –
150 Požiralnik M – – – – – – – – – – – – – – – – – –Oesophagus Ž 1 – – – – – – – – – – – – – – 1 – –
151 Želodec M 23 – – – 2 – – – – 1 2 3 4 2 – 4 4 1Stomach Ž 16 – – – – – – – – – 1 – 1 1 3 3 5 2
152 Tanko črevo M 3 – – – – – – 1 – – – – – 1 – 1 – –Small intestine Ž 5 – – – – – – 1 1 – – – 1 – – 2 – –
153 Debelo črevo M 2 – – – – – – – – – – – – – – – 2 –Colon Ž 2 – – – – – – – 1 – – – – – – – 1 –
154 Rektum M 2 – – – – – – – – – – – – 1 – – – 1Rectum Ž – – – – – – – – – – – – – – – – – –
155 Jetra M – – – – – – – – – – – – – – – – – –Liver Ž 1 – – – – – – – – – – – – – – 1 – –
157 Trebušna slinavka M 1 – – – – – – – – – – – – – – 1 – –Pancreas Ž 1 – – – – – – 1 – – – – – – – – – –
160 Nos, obnosne votline, drugo M 1 – – – – – – – – – – – – – 1 – – –Nose, sinuses, etc. Ž 2 – – – – – – – 1 – – – – – – – 1 –
162 Sapnik, sapnica, pljuča M 3 – – – – – – – – – – – – 1 1 – 1 –Trachea, bronchus, lung Ž 3 – – – – – – – – – – – – – – – – 3
163 Plevra, mediastinum, drugo M – – – – – – – – – – – – – – – – – –Pleura, mediastinum, etc. Ž 1 – – – – – – – – – – – – 1 – – – –
170 Kosti M 2 – – – – 1 – – – – – – – 1 – – – –Bone Ž – – – – – – – – – – – – – – – – – –
171 Mehka tkiva M – – – – – – – – – – – – – – – – – –Soft tissues Ž 7 – – – – – – – – – – – 1 – 4 1 1 –
173 Koža, drugi malignomi M 3 – – – – – 1 1 – – – – – – – 1 – –Skin, other malignancies Ž 1 – – – – – – – – – – – – 1 – – – –
174 Dojka M – – – – – – – – – – – – – – – – – –Breast Ž 1 – – – – – – – – – – – – – – 1 – –
182 Maternica, telo, drugo M – – – – – – – – – – – – – – – – – –Uterus, corpus, etc. Ž 1 – – – – – – – – – – – – – – – – 1
186 Modo M 1 – – – – – – – – – – – – – – – 1 –Testis Ž – – – – – – – – – – – – – – – – – –
189 Ledvica, sečevod, drugo M – – – – – – – – – – – – – – – – – –Kidney, ureter, etc. Ž 2 – – – – – – – – – 1 – – – – 1 – –
190 Oko M 1 – – – – – – – – – – – – – – 1 – –Eye Ž 2 – – – – – – – – – – – – – – 1 1 –
191 Možgani M 2 – – – – – – – – – – – – 1 – – 1 –Brain Ž 3 – – – – – – – – 1 – – 1 – – – – 1
194 Endokrine žleze, druge M – – – – – – – – – – – – – – – – – –Endocrine glands, other Ž 1 – – – – – – – – – – – – 1 – – – –
202 Bezgavke M 66 1 – 2 – 2 – 1 2 3 7 2 6 6 7 11 9 7Lymph nodes Ž 73 – – 1 2 – 1 2 1 2 4 4 3 4 12 9 13 15
* Vključeni so samo citološko in histološko potrjeni primeri
All cases included have been verified citologicaly and histologically
Tabela 10. Število novih primerov raka po bolnišnicah ugotovitve diagnoze ter število in odstotek*
primerov, napotenih na Onkološki inštitut Ljubljana (OI) - Slovenija 2001
Table 10. Number of new cancer cases diagnosed by reporting hospitals, and number and percentage* 
of cases referred to the Institute of Oncology Ljubljana (IO) - Slovenia 2001
Bolnišnice Število novih Napoteni na OI
primerov Število Odstotek*
Hospitals Number of new Referred to the IO
cases Number Per cent*
Skupaj 8909 4466 50Total
Onkološki inštitut, Ljubljana 689 689 100
Institute of Oncology Ljubljana
Klinični center Ljubljana 2543 1185 47
Medical center Ljubljana
SPS Interna klinika 576 195 34
Klinični oddelek za gastroenterologijo 236 80 34
Drugi klinični oddelki 340 115 34
SPS Kirurška klinika 1201 536 45
Klinični oddelek za abdominalno kirurgijo 358 160 44
Klinični oddelek za nevrokirurgijo 105 75 71
Klinični oddelek za maksilofacialno in oralno kirurgijo 38 32 84
Klinični oddelek za plastično kirurgijo in opekline 429 74 17
Klinični oddelek za torakalno kirurgijo 94 63 67
Klinični oddelek za travmatologijo 5 5
Klinični oddelek za urologijo 172 127 74
SPS Ginekološka klinika 205 116 57
SPS Nevrološka klinika 31 18 58
SPS Pediatrična klinika 40 33 83
Dermatovenerološka klinika 182 30 16
Klinika za infekcijske bolezni in vročinska stanja 24 15 63
Klinika za nuklearno medicino – –
Klinika za otorinolaringologijo in cervikofacialno kirurgijo 259 228 88
Očesna klinika 14 3
Ortopedska klinika 11 11
68 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 10. – table 10. Nadaljevanje – continued
Bolnišnice Število novih Napoteni na OI
primerov Število Odstotek*
Hospitals Number of new Referred to the IO
cases Number Per cent*
Splošne in specialistične bolnišnice 5553 2504 45
General and special hospitals
Bolnišnica Golnik 410 278 68
Psihiatrična klinika Ljubljana 2 –
Splošna bolnišnica Brežice 101 54 53
Splošna bolnišnica Celje 746 391 52
Splošna bolnišnica Jesenice 224 88 39
Splošna bolnišnica Izola 231 106 46
Splošna bolnišnica Maribor 1376 521 38
Splošna bolnišnica Murska Sobota 420 143 34
Splošna bolnišnica Nova Gorica 411 178 43
Splošna bolnišnica Novo mesto 457 213 47
Splošna bolnišnica Ptuj 116 64 55
Splošna bolnišnica Slovenj Gradec 315 80 25
Splošna bolnišnica Trbovlje 78 47 60
Bolnišnica za ginekologijo in porodništvo Kranj 52 39 75
Bolnišnica Topolšica 157 111 71
Bolnišnica za ženske bolezni in porodništvo Postojna 25 15 60
Bolnica Ivana Regenta Sežana 33 13 39
Ortopedska bolnica Valdoltra 8 8
Psihiatrična bolnišnica Begunje – –
Psihiatrična bolnišnica Idrija – –
Zasebne ordinacije 391 156 40
Private clinics
Drugi zdravstveni zavodi 124 87 70
Other health institutions
* Odstotki niso računani pri številih pod 15
Percentages are not calculated for less than 15 cases
Cancer Incidence in Slovenia 2001 69
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
70 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 11. Število in odstotek* novih primerov raka, ugotovljenih v bolnišnicah, po stadiju, lokaciji 
in spolu - Slovenija 2001
Table 11. Number and percentage* of new cancer cases reported by hospitals by stage, site and sex - Slovenia 2001
S t a d i j
Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan
MKB  lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek*
S t a g e
ICD Primary Sex Number Localized Regional Remote Unknown
code site of cases Number Percent* Number Percent* Number Percent* Number Percent*
C00 Vse lokacije M+Ž 8909 3864 43 2632 30 2074 23 335 4
– M 4504 1819 40 1397 31 1099 24 188 4
C96 All sites
Ž 4405 2045 46 1235 28 975 22 147 3
C00 Ustnica M 13 10 3 – –Lip Ž 6 6 – – –
C01 Baza jezika M 16 1 6 15 94 – – – –Base of tongue Ž 3 1 2 – –
C02 Jezik, drugi deli M 29 11 38 17 59 – – 1 3Tongue, other & unspecified parts Ž 6 5 1 – –
C03 Dlesen M 1 1 – – –Gum Ž 5 2 3 – –
C04 Ustno dno M 34 6 18 27 79 1 3 – –Floor of mouth Ž 2 – 2 – –
C05 Nebo M 14 5 9 – –Palate Ž 2 1 1 – –
C06 Usta, drugi deli M 15 5 33 8 53 – – 2 13Mouth, other & unspecified parts Ž 2 1 1 – –
C07 Parotidna žleza M 2 1 1 – –Parotid gland Ž 5 3 2 – –
C08
Druge in neopredeljene 
velike žleze slinavke M – – – – –
Other & unspecified major Ž 2 1 – – 1
salivary glands
C09 Tonzila M 36 5 14 31 86 – – – –Tonsil Ž 9 1 8 – –
C10 Orofarinks M 42 7 17 33 79 1 2 1 2Oropharynx Ž 3 – 3 – –
C11 Nazofarinks M 8 1 6 – 1Nasopharynx Ž 1 – 1 – –
C12 Piriformni sinus M 29 3 10 24 83 1 3 1 3Pyriform sinus Ž 1 – 1 – –
C13 Hipofarinks M 22 5 23 17 77 – – – –Hypopharynx Ž 3 1 2 – –
C14
Druga in slabo opredeljena 
mesta na ustnici, 
v ustni votlini in farinksu M 1 – 1 – –
Other and ill-defined sites in the lip, Ž – – – – –
oral cavity and pharynx
C15 Požiralnik M 78 19 24 34 44 11 14 14 18Oesophagus Ž 15 4 27 6 40 1 7 4 27
C16 Želodec M 278 51 18 113 41 99 36 15 5Stomach Ž 165 42 25 77 47 34 21 12 7
C17 Tanko črevo M 6 2 – 4 –Small intestine Ž 5 1 2 1 1
C18 Debelo črevo M 328 40 12 199 61 82 25 7 2Colon Ž 276 28 10 168 61 70 25 10 4
C19 Rektosigmoidna zveza M 59 11 19 30 51 16 27 2 3Rectosigmoid junction Ž 48 6 13 32 67 9 19 1 2
nadaljevanje / cont’d ➝
Cancer Incidence in Slovenia 2001 71
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 11. – table 11. Nadaljevanje – continued
S t a d i j
Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan
MKB  lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek*
S t a g e
ICD Primary Sex Number Localized Regional Remote Unknown
code site of cases Number Percent* Number Percent* Number Percent* Number Percent*
C20 Rektum M 229 46 20 120 52 52 23 11 5Rectum Ž 152 29 19 82 54 29 19 12 8
C21 Anus in analni kanal M 7 2 3 – 2Anus and anal canal Ž 8 3 1 1 3
C22 Jetra in intrahepatični vodi M 69 30 43 7 10 28 41 4 6Liver and intrahepatic bile ducts Ž 32 4 13 8 25 18 56 2 6
C23 Žolčnik M 14 1 4 9 –Gallbladder Ž 43 5 12 11 26 26 60 1 2
C24
Drugi in neopredeljeni deli 
biliarnega trakta M 37 11 30 11 30 7 19 8 22
Billiary tract, other Ž 31 5 16 18 58 3 10 5 16
and unspecified parts
C25 Trebušna slinavka M 126 9 7 39 31 66 52 12 10Pancreas Ž 111 10 9 35 32 56 50 10 9
C26
Druga in slabo opredeljena 
mesta v prebavnih organih M 1 – – 1 –
Other and ill-defined Ž 5 – 1 2 2
digestive organs
C30 Nosna votlina in srednje uho M 8 2 5 1 –Nasal cavity and middle ear Ž 4 3 – 1 –
C31 Obnosni sinusi M 12 – 8 1 3Accessory sinuses Ž 5 – 5 – –
C32 Grlo M 111 54 49 55 50 1 1 1 1Larynx Ž 12 4 7 1 –
C33 Sapnik M 5 2 2 1 –Trachea Ž 1 – – 1 –
C34 Sapnica in pljuča M 742 133 18 319 43 268 36 22 3Bronchus and lung Ž 248 54 22 75 30 114 46 5 2
C37 Timus M 2 1 1 – –Thymus Ž 2 – 1 1 –
C38 Srce, mediastinum, plevra M 3 1 1 1 –Heart, mediastinum, pleura Ž 2 1 – 1 –
C39
Druga in slabo opredeljena mesta 
v dihalih in prsnih organih M – – – – –
Other and ill-defined sites in the respi- Ž – – – – –
ratory system and intrathoracic organs
C40 Kosti, sklepni hrustanec udov M 4 2 2 – –Bone and articular cartilage of limbs Ž 7 – 5 1 1
C41 Kosti, sklepni hrustanec, drugje M 4 1 3 – –Bone and articular cartilage Ž 1 – 1 – –
of other and unspecified parts
C43 Maligni melanom kože M 121 100 83 15 12 4 3 1 1Malignant melanoma of skin Ž 141 123 87 10 7 4 3 4 3
C44 Druge maligne neoplazme kože M 602 586 97 16 3 – – – –Skin, other malignomas Ž 642 626 98 14 2 – – 1 –
C45 Mezoteliom M 15 9 60 5 33 – – 1 7Mesothelioma Ž 12 5 4 – 3
C46 Kaposijev sarkom M 1 1 – – –Kaposi's sarcoma Ž – – – – –
72 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 11. – table 11. Nadaljevanje – continued 
S t a d i j
Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan
MKB  lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek*
S t a g e
ICD Primary Sex Number Localized Regional Remote Unknown
code site of cases Number Percent* Number Percent* Number Percent* Number Percent*
C47
Periferni živci in avtonomno živčevje M 2 – 1 1 –
Peripheral nerves and 
Ž 2 – 1 1 –autonomic nervous system
C48 Retro- in peritonej M 8 2 3 2 1Retro- and peritoneum Ž 7 4 3 – –
C49 Drugo vezivno in mehko tkivo M 22 10 45 12 55 – – – –Other connective and soft tissue Ž 13 7 4 1 1
C50 Dojka M 10 6 4 – –Breast Ž 948 459 48 389 41 92 10 8 1
C51 Žensko zunanje spolovilo M – – – – –Vulva Ž 32 22 69 10 31 – – – –
C52 Nožnica M – – – – –Vagina Ž 8 – 7 – 1
C53 Maternični vrat M – – – – –Cervix uteri Ž 199 122 61 70 35 3 2 2 1
C54 Maternično telo M – – – – –Corpus uteri Ž 294 225 77 47 16 19 6 3 1
C55 Maternica, neopredeljeno M – – – – –Uterus, unspecified Ž 6 2 2 – 2
C56 Jajčnik M – – – – –Ovary Ž 162 23 14 16 10 120 74 3 2
C57
Drugi in neopredeljeni ženski
spolni organi M – – – – –
Other and unspecified parts of Ž 10 4 1 5 –
female genital organs
C58 Posteljica M – – – – –Placenta Ž – – – – –
C60 Penis M 7 5 2 – –Penis Ž – – – – –
C61 Prostata M 434 281 65 50 12 68 16 35 8Prostate Ž – – – – –
C62 Modo M 99 59 60 34 34 6 6 – –Testis Ž – – – – –
Drugi in neopredeljeni moški 
spolni organi M 4 3 1 – –
C63 Other and unspecified male Ž – – – – –
genital organs
C64 Ledvica razen meha M 109 56 51 20 18 28 26 5 5Kidney, except renal pelvis Ž 62 38 61 10 16 9 15 5 8
C65 Ledvični meh M 6 2 – 4 –Renal pelvis Ž 11 4 5 2 –
C66 Sečevod M 3 1 2 – –Ureter Ž 3 2 1 – –
C67 Sečni mehur M 135 87 64 34 25 12 9 2 1Bladder Ž 39 26 67 6 15 4 10 3 8
C68 Drugi in neopredeljeni sečni organi M 1 1 – – –Other and unspecified urinary organs Ž 1 1 – – –
C69 Oko in očesni adneksi M 5 4 1 – –Eye and adnexa Ž 5 4 1 – –
C70 Meninge M 1 1 – – –Meninges Ž 3 3 – – –
C71 Možgani M 79 78 99 – – 1 1 – –Brain Ž 52 51 98 1 2 – – – –
Tabela 11. – table 11. Nadaljevanje – continued 
S t a d i j
Šifra Primarna Spol Število Lokaliziran Reg. razširitev Odd. razširitev Neznan
MKB  lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek*
S t a g e
ICD Primary Sex Number Localized Regional Remote Unknown
code site of cases Number Percent* Number Percent* Number Percent* Number Percent*
C72
Hrbtni mozeg, možganski živci 
in drugi deli CŽS M 4 4 – – –
Spinal cord, cranial nerves Ž 1 1 – – –
and other parts of CNS
C73 Ščitnica M 24 14 58 9 38 1 4 – –Thyroid gland Ž 63 38 60 16 25 9 14 – –
C74 Nadledvična žleza M 3 1 1 1 –Adrenal gland Ž – – – – –
Druge endokrine žleze 
in sorodne strukture M – – – – –C75 Other endocrine glands Ž – – – – –
and related structures
C76 Druga in slabo opredeljena mesta M 4 – 3 1 –Other and ill-defined sites Ž 18 – – 12 67 4 22 2 11
Metastaza in neopredeljena 
maligna neoplazma bezgavk M 16 – – – – – – 16 100C77 Metastasis and unspecified Ž 17 – – – – – – 17 100
malignant neoplasm of lymph nodes
C78
Metastaze dihal in prebavil M 47 – – – – 47 100 – –Metastases of respiratory Ž 42 – – – – 42 100 – –and digestive organs
C79 Metastaze, drugje M 16 – – – – 16 100 – –Metastases of other sites Ž 15 – – – – 15 100 – –
C80
Maligna neoplazma brez 
opredeljenega mesta M 43 – – – – 43 100 – –
Malignant neoplasm without Ž 32 – – – – 32 100 – –
specification of site
S t a d i j  ( A n n – A r b o r )
Šifra Primarna Spol Število I II III + IV Neznan
MKB  lokacija primerov Število Odstotek* Število Odstotek* Število Odstotek* Število Odstotek*
S t a g e
ICD Primary Sex Number I II III + IV Unknown
code site of cases Number Percent* Number Percent* Number Percent* Number Percent*
C81 Hodgkinova bolezen M 23 3 13 10 43 10 43 – –Hodgkin's disease Ž 28 4 14 15 54 7 25 2 7
C82- Ne-Hodgkinov limfom M 118 25 21 26 22 48 41 19 16
C85 Ne-Hodgkin's lymphoma Ž 129 30 23 28 22 51 40 20 15
* Odstotki niso računani pri številih pod 15
Percentages are not calculated for less than 15 cases
Cancer Incidence in Slovenia 2001 73
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
74 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 12. Število umrlih za rakom po lokaciji, spolu in starosti - Slovenija 2001*
Table 12. Number of cancer deaths by site, sex and age - Slovenia 2001*
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+
Skupaj 4813 2 3 2 3 5 8 29 44 88 209 314 371 521 726 832 763 430 463
Vse lokacije TotalMoški 2692 1 3 0 2 3 6 13 21 42 128 199 225 339 448 474 394 197 197
All sites MaleŽenske 2121 1 0 2 1 2 2 16 23 46 81 115 146 182 278 358 369 233 266
Female
C01 Baza jezika M 3 - - - - - - - - - 1 1 1 - - - - - -Base of tongue Ž - - - - - - - - - - - - - - - - - - -
C02
Jezik, drugi deli M 16 - - - - - - - - - 2 4 - 2 2 2 4 - -Tongue, other & 
unspecified parts Ž 4 - - - - - - - - - - - - - 1 1 1 - 1
C04 Ustno dno M 12 - - - - - - - - 1 1 3 2 - 1 3 1 - -Floor of mouth Ž 3 - - - - - - - - - - - - 1 1 1 - - -
C06
Usta, drugi deli M 7 - - - - - - - 1 - - 1 2 - 1 1 1 - -Mouth, other & 
unspecified parts Ž 1 - - - - - - - - - - - - - - - - - 1
C07 Parotidna žleza M 1 - - - - - - - - - - - - - - 1 - - -Parotid gland Ž 2 - - - - - - - - - - - 1 - - - - - 1
Druge in neopredeljene 
velike žleze slinavke M 1 - - - - - - - - - - - - - - - 1 - -C08 Other & unspecified Ž 1 - - - - - - - - - 1 - - - - - - - -
major salivary glands
C09 Tonzila M 2 - - - - - - - - - - 1 - - - - 1 - -Tonsil Ž 1 - - - - - - - - - - - - - - - - - 1
C10 Orofarinks M 62 - - - - - - - - 1 9 14 10 10 8 6 2 2 -Oropharynx Ž 4 - - - - - - - - - - - - - 2 1 - - 1
C11 Nazofarinks M 1 - - - - - - - - - - - 1 - - - - - -Nasopharynx Ž 2 - - - - - - - - - - - - 1 - - - - 1
C12 Piriformni sinus M 1 - - - - - - - - - - - - - 1 - - - -Pyriform sinus Ž - - - - - - - - - - - - - - - - - - -
C13 Hipofarinks M 41 - - - - - - - - 1 5 10 9 7 5 4 - - -Hypopharynx Ž 3 - - - - - - - - 1 1 - - - - - 1 - -
Druga in slabo oprede-
ljena mesta na ustnici, 
C14 v ustni votlini in farinksu M 10 - - - - - - - - 1 3 - 1 - 5 - - - -Other and ill-defined Ž 1 - - - - - - - - - - - 1 - - - - - -
sites in the lip, oral cavity 
and pharynx
C15 Požiralnik M 64 - - - - - - - - - 3 6 8 14 15 7 5 2 4Oesophagus Ž 18 - - - - - - - - 1 - 1 1 - 3 4 2 2 4
C16 Želodec M 219 - - - - - - - 1 2 9 11 16 35 31 38 36 25 15Stomach Ž 149 - - - - 1 - - 2 1 4 1 5 8 20 31 36 16 24
C17 Tanko črevo M 4 - - - - - - - - - - 1 - - - - 1 1 1Small intestine Ž 8 - - - - - - - - - 1 2 - - 1 - 2 - 2
C18 Debelo črevo M 161 - - - - 1 1 1 1 3 4 8 6 27 28 25 25 16 15Colon Ž 145 - - - - - - - - - 1 5 10 14 9 22 32 27 25
C19 Rektosigmoidna zveza M 25 - - - - - - - - - - 1 1 2 6 2 4 5 4Rectosigmoid junction Ž 20 - - - - - - 1 - - 2 - 2 4 - 4 2 2 3
C20 Rektum M 131 - - - - - - 1 - 1 2 6 15 18 15 28 23 8 14Rectum Ž 97 - - - - - - - - 3 3 2 4 4 10 21 23 12 15
C21 Anus in analni kanal M 4 - - - - - - - - - - - - 1 - - 1 1 1Anus and anal canal Ž 2 - - - - - - - - - - - - - 1 1 - - -
C22
Jetra in intrahepatični vodi M 83 1 - - - - - - - 3 2 4 10 14 19 13 10 4 3
Liver and intrahepatic Ž 48 - - - - - - - - - 1 1 2 5 9 7 10 7 6
bile ducts
C23 Žolčnik M 7 - - - - - - - - - - - - 1 2 1 1 1 1Gallbladder Ž 40 - - - - - - - - - - 1 3 2 3 5 16 4 6
Drugi in neopredeljeni 
deli biliarnega trakta M 26 - - - - - - - - 1 - - - 4 8 6 3 1 3C24 Billiary tract, other and Ž 25 - - - - - - - - 1 - 1 - 3 2 8 1 4 5
unspecified parts
C25 Trebušna slinavka M 121 - - - - - - - 1 3 9 7 9 15 18 29 14 11 5Pancreas Ž 125 - - - - - - - 1 2 4 7 7 12 18 18 29 14 13
nadaljevanje / cont’d ➝
Cancer Incidence in Slovenia 2001 75
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 12. – table 12. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+
C26
Druga in slabo 
opredeljena mesta 
v prebavnih organih M 4 - - - - - - - - - - - - 1 1 1 1 - -
Other and ill-defined Ž 11 - - - - - - - - - - - 1 1 - 2 2 - 5
digestive organs
C31 Obnosni sinusi M 3 - - - - - - - - - 1 - - - 1 - - - 1Accessory sinuses Ž 1 - - - - - - - - - - - - - - - 1 - -
C32 Grlo M 54 - - - - - - - 1 1 6 7 10 9 10 6 2 1 1Larynx Ž 8 - - - - - - - - - 1 1 - 1 1 - 3 1 -
C33 Sapnik M 1 - - - - - - - - - - - - 1 - - - - -Trachea Ž - - - - - - - - - - - - - - - - - - -
C34 Sapnica in pljuča M 738 - - - - - - 1 4 7 38 75 69 94 147 152 99 34 18Bronchus and lung Ž 209 - - - - - - - 1 9 14 13 21 19 42 46 23 13 8
Srce, mediastinum, 
plevra M 8 - - - - - - - - - - 2 1 - 1 1 2 1 -C38 Heart, mediastinum, Ž 7 - - - - - - - - - - - - 2 1 1 1 1 1
pleura
C39
Druga in slabo oprede-
ljena mesta v dihalih 
in prsnih organih M 1 - - - - - - - - - - 1 - - - - - - -
Other and ill-defined sites Ž - - - - - - - - - - - - - - - - - - -
in the respiratory system 
and intrathoracic organs
Kosti, sklepni hrustanec 
udov M 2 - - - 1 - - - - - 1 - - - - - - - -
C40 Bone and articular Ž - - - - - - - - - - - - - - - - - - -
cartilage of limbs
C41
Kosti, sklepni hrustanec, 
drugje M 3 - - - - 1 - - - - - - - 1 - - 1 - -Bone and articular  
Ž 3 - - - - - - - - - - - - - - 1 - 1 1cartilage of other and 
unspecified parts
C43 Maligni melanom kože M 40 - - - - - 2 2 2 3 3 5 3 8 4 5 - 1 2Malignant melanoma of skin Ž 35 - - - - - - - 1 1 4 4 2 2 2 3 9 3 4
C44
Druge maligne 
neoplazme kože M 4 - - - - - - - - - - - 1 1 - - - 1 1
Skin, other malignomas Ž 10 - - 1 - - - - - - - - - - - - 2 2 5
C45 Mezoteliom M 7 - - - - - - - - - - 2 1 1 1 - 2 - -Mesothelioma Ž 5 - - - - - - - - - - - - 2 1 - 2 - -
C46 Kaposijev sarkom M 1 - - - - - - - - - - - - - - - - 1 -Kaposi's sarcoma Ž - - - - - - - - - - - - - - - - - - -
C48 Retro- in peritonej M 7 - - - - - - - - - - - 1 - 4 - - - 2Retro- and peritoneum Ž 8 - - - - - - - - - 1 2 - - - 1 2 2
C49
Drugo vezivno in 
mehko tkivo M 6 - - - - - - - - - 1 - 1 2 1 1 - - -
Other connective and Ž 9 - - - - - - - - 3 - 2 2 - - 1 1 - -
soft tissue
C50 Dojka M 4 - - - - - - - - - - - - - - 1 - - 3Breast Ž 380 - - - - - - 5 5 12 17 36 36 43 53 47 49 33 44
C51 Žensko zunanje spolovilo M - - - - - - - - - - - - - - - - - - -Vulva Ž 8 - - - - - - - - - - - - - 1 1 3 2 1
C52 Nožnica M - - - - - - - - - - - - - - - - - - -Vagina Ž 7 - - - - - - - 2 - - - - - 1 2 1 1 -
C53 Maternični vrat M - - - - - - - - - - - - - - - - - - -Cervix uteri Ž 49 - - - - - - 2 2 3 4 3 2 7 6 6 4 5 5
C54 Maternično telo M - - - - - - - - - - - - - - - - - - -Corpus uteri Ž 39 - - - - - - - - - 1 1 3 3 8 10 6 5 2
C55
Maternica, 
neopredeljeno M - - - - - - - - - - - - - - - - - - -
Uterus, unspecified Ž 31 - - - - - - - - - 1 2 2 2 3 6 4 5 6
C56 Jajčnik M - - - - - - - - - - - - - - - - - - -Ovary Ž 110 - - - - 1 - - 3 2 5 9 13 12 15 22 16 10 2
76 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
nadaljevanje / cont’d ➝ 
Tabela 12. – table 12. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+
C57
Drugi in neopredeljeni 
ženski spolni organi M - - - - - - - - - - - - - - - - - - -
Other and unspecified parts Ž 13 - - - - - - - - 1 - - - 1 4 2 2 - 3
of female genital organs
C60 Penis M 1 - - - - - - - - - - - - - - - - - 1Penis Ž - - - - - - - - - - - - - - - - - - -
C61 Prostata M 252 - - - - - - - - - - 5 9 20 24 45 62 38 49Prostate Ž - - - - - - - - - - - - - - - - - - -
C62 Modo M 7 - - - - - 2 3 1 1 - - - - - - - - -Testis Ž - - - - - - - - - - - - - - - - - - -
C63
Drugi in neopredeljeni 
moški spolni organi M 1 - - - - - - - - - - - - - - 1 - - -
Other and unspecified Ž - - - - - - - - - - - - - - - - - - -
male genital organs
C64 Ledvica razen meha M 61 - - - - - - - - - 3 4 8 4 10 12 9 6 5Kidney, except renal pelvis Ž 56 1 - 1 - - - - - - 1 4 2 2 12 13 7 6 7
C65 Ledvični meh M 1 - - - - - - - - - - - - - - - - 1 -Renal pelvis Ž 2 - - - - - - - - - 1 - - - - - 1 - -
C66 Sečevod M 1 - - - - - - - - - - - - - - - 1 - -Ureter Ž 1 - - - - - - - - - - - - - - - 1 - -
C67 Sečni mehur M 91 - - - - - - - - - 1 5 4 2 15 18 22 11 13Bladder Ž 33 - - - - - - - - - 1 - 1 2 5 4 6 9 5
Drugi in neopredeljeni 
sečni organi M 2 - - - - - - - - - - - - - 1 - - - 1C68
Other and unspecified Ž 2 - - - - - - - - - - - - - 1 - 1 - -
urinary organs
C69 Oko in očesni adneksi M 1 - - - - - - - - - - - - - - - 1 - -Eye and adnexa Ž - - - - - - - - - - - - - - - - - - -
C70 Meninge M 5 - - - - - - - 1 - 1 - 1 1 - - 1 - -Meninges Ž 2 - - - - - - - - - - - - - - 1 1 - -
C71 Možgani M 67 - 2 - 1 1 - 3 2 5 11 3 9 6 10 9 5 - -Brain Ž 50 - - - - - - 3 3 1 3 5 6 6 8 6 6 2 1
Hrbtni mozeg, možganski 
živci in drugi deli CŽS M 2 - - - - - - - - - - - - 1 1 - - - -C72 Spinal cord, cranial nerves Ž 2 - - - - - - - - - - - - - - - 1 1 -
and other parts of CNS
C73 Ščitnica M 4 - - - - - - - - - - - - - 1 2 - - 1Thyroid gland Ž 12 - - - - - - - - - - 1 1 1 2 3 2 - 2
C74 Nadledvična žleza M 6 - - - - - - - - - - - 1 1 4 - - - -Adrenal gland Ž 5 - - - - - - - - 1 - - - 1 1 1 1 - -
C75
Druge endokrine žleze 
in sorodne strukture M - - - - - - - - - - - - - - - - - - -
Other endocrine glands Ž 1 - - - - - - - - - - - - - - - - - 1
and related structures
Druga in slabo 
opredeljena mesta M 11 - - - - - - - - 1 1 1 2 2 - 2 1 - 1C76
Other and ill-defined sites Ž 32 - - - - - - - - - - 1 1 2 - 3 8 4 13
C77
Metastaza in 
neopredeljena maligna 
neoplazma bezgavk M 2 - - - - - - - - - - - - 1 - - - - 1
Metastasis and Ž 1 - - - - - - - - - - - - - - 1 - - -
unspecified malignant
neoplasm of lymph nodes 
C78 Metastaze dihal in prebavil M 19 - - - - - - - - - 1 - 2 2 4 5 4 - 1Metastases of respiratory
and digestive organs Ž 16 - - - - - - - - - - 2 1 2 1 1 5 1 3
C79 Metastaze, drugje M 9 - - - - - - - - - 1 1 - 1 3 2 - - 1Metastases of other sites Ž 5 - - - - - - - - - - 1 - 1 1 - - - 2
Maligna neoplazma brez 
opredeljenega mesta M 67 - - - - - - - 1 3 4 5 2 9 14 11 9 6 3
C80 Malignant neoplasm Ž 71 - - - - - 1 - - 1 1 4 7 2 4 11 17 8 15
without specification of site
C81 Hodgkinova bolezen M 6 - - - - - 1 - 1 1 1 - - 1 - - 1 - -Hodgkin's disease Ž 6 - - - - - - - 1 - - - 1 - - 1 2 - 1
Cancer Incidence in Slovenia 2001 77
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
Tabela 12. – table 12. Nadaljevanje – continued 
Šifra Primarna Vse S t a r o s t i
MKB lokacija Spol starosti
A g e
ICD Primary Sex All
code site ages 0– 5– 10– 15– 20– 25– 30– 35– 40– 45– 50– 55– 60– 65– 70– 75– 80– 85+
Folikularni ne-Hodgkinov 
limfom M 6 - - - - - - - - - - - 1 - 1 2 1 - 1C82 Follicular non-Hodgkin's Ž 9 - - - - - - - - - - 1 - 1 - 5 1 - 1
lymphoma
C83
Difuzni ne-Hodgkinov 
limfom M 10 - - - - - - - - - - - 1 2 - 3 3 - 1
Diffuse non-Hodgkin's Ž 4 - - - - - - - - - - - - - 1 - 2 - 1
lymphoma
Limfomi celic T in 
kožni limfom celic T M 1 - - - - - - - - - - - - - 1 - - - -C84 Peripheral and cutaneous Ž 3 - - - - - - - 1 - - - - - - - - 1 1
T-cell lymphomas
C85
Druge in neopredeljene 
vrste ne-Hodgkinovega 
limfoma M 43 - - - - - - 1 2 1 1 1 1 3 5 8 6 8 6
Other and unspecified Ž 39 - - - - - - 1 - 2 3 - 2 2 6 7 2 9 5
types of non-Hodgkin's 
lymphoma
Maligne imunoprolife-
rativne bolezni M 1 - - - - - - - - - - - - 1 - - - - -C88 Malignant immunopro- Ž - - - - - - - - - - - - - - - - - - -
liferative diseases
C90
Difuzni plazmocitom 
in maligne neoplazme 
plazmocitov M 32 - - - - - - - 1 - - 1 2 2 4 8 10 1 3
Multiple myeloma and Ž 40 - - - - - - - - - 2 - 5 4 3 12 2 6 6
malignant plasma cell 
neoplasms
C91 Limfatična levkemija M 38 - 1 - - - - 1 1 - 1 2 - 5 5 3 9 1 9Lymphoid leukaemia Ž 25 - - - 1 - - 1 1 - - - - 1 5 - 6 8 2
C92 Mieloična levkemija M 31 - - - - - - - - 1 2 - 3 6 4 4 3 5 3Myeloid leukaemia Ž 27 - - - - - 1 1 - 1 1 1 1 1 5 8 3 3 1
C93 Monocitna levkemija M 2 - - - - - - - - 1 - - - - 1 - - - -Monocytic leukaemia Ž - - - - - - - - - - - - - - - - - - -
C95
Levkemija z neoprede-
ljenim celičnim tipom M 1 - - - - - - - - - - - - - - - - 1 -
Leukaemia, unspecified Ž 10 - - - - - - - - - - 1 - 1 1 2 2 - 3
cell type
Druge in neopredeljene 
maligne neoplazme 
limfatičnega, krvotvornega 
in sorodnega tkiva M 3 - - - - - - - - - - 1 - - - 1 1 - -C96 Other & unspecified Ž 3 - - - - - - - - - - - - 2 - - 1 - -
malignant neoplasms 
of lymphoid, haemopoetic 
& related tissues
C97
Maligne neoplazme 
na več neodvisnih 
(primarnih) mestih M 23 - - - - - - - - - - - 1 1 5 5 5 3 3
Malignant neoplasms Ž 22 - - - - - - 2 - - 2 - - 2 4 4 5 3 -
of independant (primary)
multiple sites
Zgoraj neupoštevani
Not included above
Meninge, benigna 
neoplazma M 1 - - - - - - - - - - - - - 1 - - - -D32 Benign neoplasm Ž 6 - - - - - - - - - - - - - 2 2 - 1 1
of meninges
D33
CŽS, benigna neoplazma M 1 - - - - - - - - - 1 - - - - - - - -
Benign neoplasm of brain Ž - - - - - - - - - - - - - - - - - - -
and other parts of CNS
D43 CŽS, neopredeljeno M 10 - - - - - - - - 1 1 1 - 2 2 1 1 1 -CNS, uncertain or  unknown Ž 2 - - - - - - - - - - - 1 - - - - - 1
* Vir: Inštitut za varovanje zdravja
Source: Institute of Public Health
Tabela 13. Število  vseh živih bolnikov z rakom po spolu in izbrani primarni lokaciji -  
Slovenija, 31. 12. 2001
Table 13. Prevalence of cancer patients by sex and selected primary site - Slovenia, December 31, 2001
Lokacija Skupaj Moški Ženske
Site Total Males Females
Vse lokacije 51271 19623 31648
All sites
Koža, drugi malignomi 10611 4756 5855
Skin, other malignomas
Dojka 8526 58 8468
Breast
Maternica, vrat 3363 – 3363
Uterus, cervix
Maternica, telo 3159 – 3159
Uterus, corpus
Debelo črevo 2585 1285 1300
Colon
Danka 2379 1238 1141
Rectum
Koža, maligni melanom 1980 775 1205
Skin, malignant melanoma
Prostata 1704 1704 –
Prostate
Želodec 1661 932 729
Stomach
Pljuča 1642 1262 380
Lung
Jajčniki 1231 – 1231
Ovary, Fallopian tube
Ledvica 1199 677 522
Kidney, urether
Moda 1141 1141 –
Testis
Usta in žrelo* 1057 827 230
Mouth and pharynx*
Mehur 969 751 218
Bladder
Grlo 866 774 92
Larynx
* MKB-10 / ICD-10: C01-C06, C09-C10, C12-C14
78 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
Cancer Incidence in Slovenia 2001 79
Institue of Oncology Ljubljana, Cancer Registry of Slovenia
IZBOR PUBLIKACIJ, ki so jih sodelavci
Epidemiologije in Registra raka objavili 
v zadnjih petih letih (tudi v sodelovanju 
z drugimi raziskovalci)
SELECTION OF PUBLICATIONS, published by the
members of Epidemiology and Cancer Registry 
in the last five years (also in cooperation with
other researchers)
1999
– Alexander FE, Boyle P, Pompe Kirn V et al. Population density
and childhood leukaemia: results of the EUROCLUS study. Eur
J Cancer 1999; 35(3): 439-44.
– Boffetta P, Garcia Gomez M, Pompe Kirn V et al. IARC
multicentre study of cancer risk among workers of four
European mercury mines and mills. Lyon: IARC, 1999. 
– Gatta G, Capocaccia R, Hakulinen T et al and the EUROCARE
Working Group. Variations in survival for invasive cervical
cancer among European women, 1978-89. Cancer Causes
Control 1999; 10(6): 575-81.
– Pompe Kirn V, Čufer T. Preživetje bolnic z rakom dojk v Sloveniji.
Zdrav Vestn 1999; 68(6): 365-9.
– Pompe Kirn V. Epidemiološke značilnosti raka mod v Sloveniji.
In: Skela Savič B, Velepič M, Bobnar A, eds. Rak mod. 24.
strokovni seminar iz onkologije in onkološke zdravstvene nege
za medicinske sestre, Ljubljana 1999. Ljubljana: Sekcija
medicinskih sester v onkologiji pri Zbornici zdravstvene nege
Slovenije, 1999: 5-6.
– Pompe Kirn V. Epidemiološke značilnosti kožnega malignega
melanoma v Sloveniji. Radiol Oncol 1999; 33: Suppl 1: S14-S19.
– Pompe Kirn V. Osvežimo si spomin, zakaj je bilo uvajanje
programa ZORA umestno. Onkologija 1999; 3(2): 78-9.
– Pompe Kirn V. Rak v Sloveniji. In: Štabuc B, ed. 7. seminar "In
memoriam dr. Dušana Reje". Rak pri moškem. Ljubljana: Zveza
slovenskih društev za boj proti raku, 1999: 5-7. 
– Primic Žakelj M. Screening mammography for early detection of
breast cancer. Ann Oncol 1999; 10: Suppl 6: S121-S127. 
– Primic Žakelj M. Slovenski kodeks proti raku - kaj lahko svetuje
zdravnik za preprečevanje in zgodnje odkrivanje raka?
Onkologija 1999; 3(1): 31-3.
– Primic Žakelj M. Prehrana in rak. In: Skela Savič B, Velepič M,
Drolc H, eds. Pomen prehrane pri nastanku in zdravljenju
malignih obolenj. 25. strokovni seminar iz onkologije in
onkološke zdravstvene nege za medicinske sestre, Radenci
1999. Ljubljana: Sekcija medicinskih sester v onkologiji pri
Zbornici zdravstvene nege Slovenije, 1999: 11-4.
– Webb PM, Crabtree JE, Forman D and the EUROGAST Study
Group. Gastric cancer, cytotoxin-associated gene A-positive
Helicobacter pylori, and serum pepsinogens: an international
study. Gastroenterology 1999; 116: 269-76.
2000
– Pompe Kirn V, Japelj B, Primic Žakelj M. Future trends in breast,
cervical, lung, mouth and pharyngeal cancer incidence in
Slovenia. Cancer Causes Control 2000; 11(4): 309-18.
– Pompe Kirn V, Japelj B, Primic Žakelj M. Trend incidence
pljučnega raka in kadilskih navad pri moških v Sloveniji. Zdrav
Vestn 2000; 69(2): 97-9.
– Pompe Kirn V, Japelj B. Trend incidence pljučnega raka in
kadilskih navad pri ženskah v Sloveniji. Zdrav Vestn 2000; 69(10):
679-82.
– Pompe Kirn V. Epidemiološke značilnosti raka glave in vratu v
Sloveniji. In: Gale N, Žargi M, eds. Epithelial tumours of the head
and neck. 31st memorial meeting for professor Janez Plečnik,
Ljubljana 2000. Ljubljana: Institute of Pathology; Faculty of
Medicine, 2000, 63-4.
– Pompe Kirn V. Petdeset let dela registra raka za Slovenijo.
Onkologija 2000; 4(1): 39-42.
– Pompe Kirn V. Pogostnost raka in preživetje bolnikov z rakom v
Republiki Sloveniji. In: Velepič M, Skela Savič B, eds. Priročnik iz
onkološke zdravstvene nege in onkologije. Ljubljana: Onkološki
inštitut, 2000: 20-8.
– Pompe Kirn V. Prehrana in rak. In: Štabuc B, ed. Prehrana in rak.
8. seminar "In memoriam dr. Dušana Reje", Ljubljana 2000. Ljublja-
na: Zveza slovenskih društev za boj proti raku; Onkološki inštitut;
Inštitut za varovanje zdravja; Rdeči križ Slovenije, 2000: 60-3.
– Pompe Kirn V. Rak v Sloveniji. In: Bergant O, ed. Slovenija proti
raku: desetletni program 2000-2010. Ljubljana: Zveza slovenskih
društev za boj proti raku, 2000: 15-7.
– Pompe Kirn V. Rak v Sloveniji. In: Lah A ed. Zdravje in okolje:
kakovost okolja in življenja konec 20. stoletja. Ljubljana: Svet za
varstvo okolja Republike Slovenije, 2000: 61-4.
– Primic Žakelj M. Dejavniki tveganja in preprečevanje raka. In:
Velepič M, Skela Savič B, eds. Priročnik iz onkološke zdravstvene
nege in onkologije. Ljubljana: Onkološki inštitut, 2000: 29-37.
– Primic Žakelj M. Desetletni program boja proti raku:
zdravstvena osveščenost prebivalstva: pomemben prispevek
v boju proti raku. In: Bergant O, ed. Slovenija proti raku:
desetletni program 2000-2010. Ljubljana: Zveza slovenskih
društev za boj proti raku, 2000: 18-26.
– Primic Žakelj M. Priporočila o presejanju za raka v Evropski uniji.
In: Lindtner J, Štabuc B, Bešić N et al, eds. Družinski zdravnik in
rak. 15. onkološki vikend, Ljubljana 2000. Zbornik. Ljubljana:
Kancerološko združenje Slovenskega zdravniškega društva;
Zveza slovenskih društev za boj proti raku, 2000: 21-9.
– Robertson C, Perone C, Primic Žakelj M, Pompe Kirn V, Boyle P.
Breast cancer incidence rates in Slovenia 1971-1993. Int J
Epidemiol 2000; 29(6): 969-74.
– Vercelli M, Capocaccia R, Quaglia A, Casella C, Puppo A,
Coebergh JWW and EUROCARE Working Group. Relative
survival in elderly European cancer patients: evidence for
health care inequalities. Clin Rev Oncol Hematol 2000; 35(3):
161-79.
2001
– Boffetta P, Saellsten G, Pompe Kirn V et al.  Mortality from
cardiovascular diseases and exposure to inorganic mercury.
Occup Environ Med 2001; 58(7): 461-6.
– Capocaccia R, Gatta G, Magnani C, Stiller C,  Coebergh JW,
eds. Childhood cancer survival in Europe 1978-1992: the
EUROCARE Study. Milano: European School of Oncology, 2001.
(Eur J Cancer 2001; 37 (6): 671-816).
– Collaborative Group on Hormonal Factors in Breast Cancer.
Familial breast cancer: collaborative reanalysis of individual
data from 52 epidemiological studies including 58209 women
with breast cancer and 101986 women without the disease.
Lancet 2001; 358(9291): 1389-99.
– Debeljak A, Triller N, Pompe Kirn V et al. Smernice za
internistično obravnavo bolnika s pljučnim rakom: uradno
stališče Združenja pulmologov Slovenije, ki bo sprejeto na letni
konferenci decembra 2001. Zdrav Vestn 2001; 70(12): 751-70.
80 Incidenca raka v Sloveniji 2001
Onkološki inštitut Ljubljana, Register raka za Slovenijo
– Ećimović P, Pompe Kirn V. Incidenca raka v Sloveniji 1998 - novo
letno poročilo Registra raka za Slovenijo. Onkologija 2001; 5(1): 45.
– Pompe Kirn V, Japelj B, Primic Žakelj M, Šircelj M. Kaj je vplivalo
na incidenco raka dojk v Sloveniji in kako bo z zbolevnostjo v
tem desetletju. Zdrav Vestn 2001; 70(6): 341-5.
– Primic Žakelj M, Pompe Kirn V, Čeh F. Najpomembnejši
dejavniki tveganja raka. In: Več znanja - manj raka: didaktični
komplet za učitelje. Ljubljana: Zavod Republike Slovenije za
šolstvo, 2001: 11-6.
– Primic Žakelj M, Pompe Kirn V, Škrlec F, Šelb J: Can we rely on
cancer mortality data? Checking the validity of cervical
cancer mortality data for Slovenia. Radiol Oncol 2001; 35(4):
243-47, 317. 
– Primic Žakelj M. Epidemiology of breast cancer in the XXI
century. Evidence based management of breast cancer,
Sarajevo 2001. Sarajevo: European School of Oncology, 2001:
10 str.
– Pompe Kirn V. Kajenje in rak pri ženskah. In: Štabuc B, ed.
Kajenje in rak pri ženskah. 9. seminar "In memoriam dr.Dušana
Reje", Ljubljana 2001. Ljubljana: Zveza slovenskih društev za boj
proti raku; Onkološki inštitut; Inštitut za varovanje zdravja RS;
Rdeči križ Slovenije 2001: 16-20. 
– Robertson C, Van Den Donk M, Primic Žakelj M, MacFarlane T,
Boyle P. The association between induced and spontaneous
abortion and risk of breast cancer in Slovenian women aged 25-
54. Breast 2001; 10(4): 291-4.
– Sant M, Capocaccia R, Coleman MP et al. and the EUROCARE
Working Group. Cancer survival increases in Europe, but
international differences remain wide. Eur J Cancer 2001;
37(13): 1659-67.
– Uršič Vrščaj M, Bebar S, Primic Žakelj M. Hormone replacement
therapy after invasive ovarian serous cystadenocarcinoma
treatment: the effect on survival. Menopause 2001; 8(1): 70-5.
2002
– Capocaccia R, Colonna M, Corazziari I et al. and the
EUROPREVAL Working Group. Measuring cancer prevalence in
Europe: the EUROPREVAL project. Ann Oncol 2002; 13(6): 831-9.
– Collaborative Group on Hormonal Factors in Breast Cancer.
Breast cancer and breastfeeding: collaborative reanalysis of
individual data from 47 epidemiological studies in 30 countries,
including 50302 women with breast cancer and 96973 women
without the disease. Lancet 2002; 360(9328): 187-95.
– Debeljak A, Triller N, Pompe Kirn V et al. Strokovna izhodišča za
internistično obravnavo bolnika s pljučnim rakom. Zdrav Vestn
2002; 71(6): 385-90.
– Ećimović P, Pompe Kirn V. Second primary cancers in
laryngeal cancer patients in Slovenia, 1961-1996. Eur J Cancer
2002; 38(9): 1254-60.
– Lambert R, Guilloux A, Pompe Kirn V et al. Incidence and
mortality from stomach cancer in Japan, Slovenia and the
USA. Int J Cancer 2002; 97(6): 811-8.
– Micheli A, Mugno E, Krogh V et al. and the EUROPREVAL
Working Group. Cancer prevalence in European registry areas.
Ann Oncol 2002; 13(6): 840-65.
– Pompe Kirn V. Epidemiological features of laryngeal cancer in
Slovenia. Zdrav Vestn 2002; 71: Suppl 3: 59-63.
– Pompe Kirn V. Rak v Sloveniji - število in preživetje bolnikov. In:
Frankič D ed. Prepoznavanje in zdravljenje raka. Strokovno
izpopolnjevanje magistrov farmacije v letu 2002, Ljubljana
2002. Ljubljana: Lekarniška zbornica Slovenije, 2002: 5-8.
– Pompe Kirn V. Preživetje bolnikov z rakom v Sloveniji - novosti iz
Registra raka za Slovenijo za obdobje 1988-1997. Onkologija
2002; 6(1): 28-31.
– Primic Žakelj M. Rak danes in rak šest desetletij nazaj. In: Skela
Savič B, eds. Razvoj onkologije in onkološke zdravstvene nege.
Kakovost v zdravstveni negi. 29. strokovni seminar, Ljubljana
2002. Zbornik. Ljubljana: Sekcija medicinskih sester v onkologiji
pri Zbornici zdravstvene nege Slovenije - Zvezi društev
medicinskih sester in zdravstvenih tehnikov Slovenije, 2002: 19-24.
– Uršič Vrščaj M, Primic Žakelj M, Kirar Fazarinc I. Epidemiologija
raka materničnega vratu v Sloveniji in v svetu ter nacionalni
program ZORA. In: Možina A ed. Zgodnja detekcija raka
materničnega vratu : kolposkopski tečaj, Ljubljana 2002.
Zbornik predavanj. Ljubljana: Klinični center - Ginekološka
klinika, 2002: 5-7.
2003
– Benedičič Pilih A, Pompe Kirn V, Kokol P, Povalej P, Arzenšek J.
Kožni melanom v Sloveniji in potreba po preventivi. In: Miljković
J ed. Dermatološki dnevi. Strokovno izpopolnjevanje iz derma-
tologije z mednarodno udeležbo, Maribor 2003. Maribor:
Splošna bolnišnica, 2003: 27-37.
– Berrino F, Capocaccia R, Gatta G et al, eds. Survival of cancer
patients in Europe: the EUROCARE-3 study. Ann Oncol 2003:
14(Suppl 5).
– Lutz JM, Francisci S, Pompe Kirn V et al and EUROPREVAL
Working Group. Cancer prevalence in Central Europe: the
EUROPREVAL study. Ann Oncol 2003; 14(2): 313-22.
– Pompe Kirn V. Rak v številkah: da bi ga bolje razumeli in lažje
obvladovali. Okno 2003; 17(1): 27-9.
– Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bolnikov z rakom
v Sloveniji 1983-1997. Ljubljana: Onkološki inštitut, Register raka
za Slovenijo, 2003.
– Primic Žakelj M, Arko D, Rener M, Žgajnar J. Rak dojk v Sloveniji:
epidemiologija in presejanje. Zdrav Vestn 2003; 72: Suppl 2: 
II-179-II-181.
– Primic Žakelj M, Zadnik V. Epidemiologija raka dojk. In: Takač I,
Arko D eds. 30 let Centra za bolezni dojk v Mariboru. Simpozij
z mednarodno udeležbo, Maribor 2003. Zbornik predavanj.
Maribor: Splošna bolnišnica, 2003, 15-27.
– Primic Žakelj M, Zadnik V. Rak dojk: razširjenost in nevarnostni
dejavniki.In: Štabuc B, ed. Več znanja o raku, manj smrti.
Seminar, Strunjan 2003. Ljubljana; Koper: Zveza slovenskih
društev za boj proti raku; Obalno društvo za boj proti raku, 2003:
55-63.
– Primic Žakelj M, Zadnik V. Staranje prebivalstva in rak. In: Skela
Savič B ed. Starost in rak. 30 strokovni seminar, Ljubljana 2003.
Ljubljana: Sekcija medicinskih sester v onkologiji pri Zbornici
zdravstvene nege - Zvezi društev medicinskih sester in
zdravstvenih tehnikov Slovenije, 2003: 5-11.
– Uršič Vrščaj M, Primic Žakelj M, Kirar Fazarinc I. Epidemiologija
raka materničnega vratu v Sloveniji in v svetu ter nacionalni
program ZORA. In: Možina A, ed. Zgodnja detekcija raka
materničnega vratu in kolposkopski tečaj in Praktična
kolposkopija in ambulantno zdravljenje prekanceroze,
Ljubljana 2003. Zbornik predavanj. Ljubljana: Klinični center;
Ginekološka klinika; Združenje za ginekološko onkologijo,
kolposkopijo in cervikalno patologijo, 2003: 92-5.
– Zadnik V, Šelb J. Osnovni vzroki smrti s kazalniki umrljivosti v
Sloveniji v letu 2001. Zdrav Vestn 2003; 72(7-8): 429-4.